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SUMMARY 
239 
The dosimetry of internally deposited alpha emitters such as Pu 
has been of interest for many years as a means to determine directly such 
quantities as maximum permissible body burden (MPBB) instead of the present 
7 7 fi\ 
practice of setting these values based upon comparison with Ra. A new 
technique that will yield this dosimetry information directly by experi-
mental measurement is a desirable task to perform and would provide data 
sorely needed by health physicists. 
A procedure involving the electrochemical etching of polycarbonate 
foils to amplify the damage tracks produced by the alpha particles emitted 
239 
by Pu deposited in the skeletons of dogs and man was investigated to 
examine its feasibility for this application. This electrochemical etch-
ing technique was used to provide dose measurements and has been shown to 
be feasible for bone dosimetry applications of internally deposited alpha 
emitters. The technique delineated is general in nature and could be 
used for the dosimetry of other internally deposited alpha emitters, even 
in tissues other than osseous tissue. 
During examination of the feasibility of the electrochemical etch-
ing system, several parameters were examined prior to the bone dosimetry 
application since the dosimetry system had not been calibrated for alpha 
particle dosimetry prior to this time. Several foil reading techniques 
were examined such as the transparency projector and microfiche reader. 
The compound microscope operated in the phase contrast mode was used for 
bone dosimetry. Background reduction studies resulted in a background of 
2.0 tracks/cm of foil surface, routinely achievable. Optimization of 
the electrochemical etching of polycarbonate foils considering background 
and sensitivity indicated 800 V, 2 kHz, 45% KOH etchant solution and four 
hours etching time provided low background and reasonable sensitivity. 
Sensitivity as a function of etching time and waiting time (time between 
irradiation and etching) were also examined. Efficiency of alpha particle 
track production as a function of energy was determined. A Bragg curve 
was achievable and the efficiency obtained at the peak of the Bragg curve 
was obtained when the energy of the monoenergetic alpha particle was 
lowered by the injection of 27-28 p̂m of polycarbonate absorber between 
"3a 
the source and detector giving an efficiency of 1.0 x 10 %. A device 
called the vacuum-sealed alpha calibrator was designed for this purpose 
239 
and housed a 2.0 p,Ci Pu source as well as either polycarbonate foils 
or a surface power detector. Track diameter as a function of etching 
studies resulted in the discovery of two categories of track diameters 
appearing on foils irradiated by alpha particles and etched electrochemi-
cally. This effect was quantified as a function of incident alpha energy 
and a proposal offered to explain the effect. Reproducibility studies 
yielded an error of ± 15% in the dosimetry studies. These studies in-
cluded foils etched weeks apart with different 45% KOH etchant solutions 
and different energies of alpha particles incident on the foils. 
The bone dosimetry studies utilized undecalcified sections of beagle 
dog bones and decalcified human bone sections. The procedure used was as 
follows: (1) Polycarbonate foils were pressed tightly against the bone 
samples plus infinitely thick calibration sources and then etched electro-
chemically after appropriate exposure times. (2) Counting was performed 
XIV 
by randomly scanning the foils and counting tracks in a square 120 pjn on 
each side. (3) Dose in rads/year was presented in two sets, one included 
the scans resulting in zero scans, D , the other did not, D . Efficien-
o w 
cies obtained from the infinitely thick calibration sources ranged from 
2.22 x 10" % to 0.38%. Doses ranged from 16.7 rads/yr to 39580 rads/yr 
for D and 440 rads/yr to 317900 rads/yr for D . A factor was found that 
o w 
could be multiplied by the experimentally determined dose to make it equal 
to the ICRP permissible limit of 0.3 rad/yr (15 rem/yr). This value was 
then multiplied by the known skeletal burden to find an experimental maxi-
mum permissible skeletal burden for each bone section taking into account 
the mass difference of the dog and human skeleton. The average of these ex-
perimental maximum permissible skeletal burdens was one half the present 
ICRP value of 0.036 p,Ci, the maximum and minimum values were four times 
greater and 700 times less than the ICRP standard, respectively. 
CHAPTER I 
INTRODUCTION 
Alpha particles are emitted in natural radioactive decay by 
numerous elements. Physically the alpha particle is a helium nucleus, 
4 ++ 
_He , and as such is considered to be densely ionizing as it passes 
through an absorbing medium. The ionization produced by an alpha particle 
is confined to a region very close to the track of the particle (Vaughan 
et al.). In fact, ninety percent of the ionization is contained in a 
cylinder of radius 0.01 y,m whose axis lies along the track. This dense 
ionization can cause dramatic effects in tissue; therefore, health 
physicists are very concerned with the dosimetry of internally deposited 
alpha emitters. There are several methods available to measure the local 
dose deposited in bone. These include a number of autoradiographic tech-
niques whereby photographic film, e.g. NTA emulsions, is placed over the 
bone for various exposure periods and developed. The tracks are then 
2 3 4 
counted visually (Rowland and Marshall), (Jee et al.), (Wronski et al.), 
(Smith et al.), or the track density determined densitometrically (Twente 
and Jee) to obtain an estimate of the relative dose deposited on the bone 
surface. Another technique (James and Kember) uses a thin "stripping 
film" about 3 p,m thick so the emulsion can be removed from the backing, 
and after exposure the film is viewed with an eyepiece marked with 5 |im 
circles. Counting tracks in the circles will yield the particle fluence 
and then the dose. The effects produced in tissue after irradiation by 
alpha particles can be quite severe indeed, even at a fairly low, macro-
scopically calculated dose. Carcinoma involving epithelial cells of the 
sinus cavity and the surrounding bone, pulmonary neoplasia fibrosis, 
necrosis, spontaneous bone fractures, tooth and tooth socket effects, 
osteomyelitis, osteoporosis, osteosarcoma, hemorrhage, edema and even 
leukemia are all possible results of alpha irradiation iji vivo. It has 
been reported that death can be caused by an average skeletal dose of 
8 239 
only 60 rads (Mays and Lloyd) in beagles when injected with Pu 
224 
citrate intraveneously, a dose of 90 rads in humans injected with Ra 
9 
solution (Spiess and Mays), or by an average skeletal dose of 1200 rads 
in humans ingesting '' Ra (Evans et al.). Our primary concern here 
will be plutonium-239. Its toxicity has been shown to be quite great in 
/i 
a number of studies at the University of Utah (Twente and Jee) , (Mays 
and Lloyd), (Jee), ' ' (Arnold and Jee), (Stover and Jee), 
14 13 
(Mays et al.), (Stover et al.), at the University of California (and 
"I R _ 9 9 
in conjunction with the Metallurgical Lab)(Durbin and co-workers), 
(Hamilton and co-workers), in France (Lafuma and co-workers), 
rj -I / Cs. 
and at Hanford (Bair, Thompson, Clarke and co-workers). A good sum-
47 
mation is given in Bustad et al. This toxicity can be attributed to a 
large extent to the chemistry of plutonium-239 (aside from its radio-
48 
activity) which distinguishes plutonium from other actinides (Taylor). 
Not unlike the other actinides, plutonium is a bone seeker, but unlike 
most of the other actinides (except thorium) plutonium is preferentially 
deposited on the bone surfaces (Jee), (Arnold and Jee). This action 
brings the radiosensitive proliferative cells under heavy alpha irradia-
239 
tion by plutonium. The amount of Pu which is deposited on the bone 
3 
surfaces depends on such factors as mode of administration, species of 
animal, state of health, age of patient, chemical form of the plutonium 
and chemical state. 
Due to the possibility of widespread use of plutonium for power 
and military purposes it behooves our society to ensure the safe contain-
ment of this highly toxic substance as well as to be aware of the effects 
239 
of Pu in man at various concentrations ±u_ vivo. Of course this tacitly 
239 
requires the availability of adequate and accurate dosimetry of Pu in 
239 
bone (the present critical organ for Pu). 
239 
To assist in this task, the dosimetry of Pu in bone was the 
goal of the work described here. To accomplish this by the track-etch 
method chosen, several parameters were needed in the new dosimetry system 
selected for this research. This system is the electrochemical etching 
49 
system (Sohrabi). Results obtained from work on the etching system 
itself are also presented. 
1.1 The Alpha Radiation Hazard 
1.1.1 Characteristics of Alpha Particles 
Alpha radiation was first characterized as such by Rutherford in 
1899 by noticing the absorption of this radiation in relation to other 
50-54 
radiations which he denoted as beta radiation (Rutherford et al.). 
It was during that same year when Rutherford and F. Soddy identified 
"alpha" radiation as an inert gas. We now know this inert gas was 
4 ++ created when the alpha particle, a He nucleus, captured two electrons 
after emission during the radioactive decay of another nucleus and sub-
sequent slowing down in an absorbing medium. Normally alpha particles 
4 
are emitted in a monoenergetic fashion but can occur in discrete energy 
groupings if the product nucleus is left in various states of excitation. 
These excited states will be subsequently transformed to the ground state 
by gamma emission. Known alpha particle energies in radioactive decay 
range from about 1.5 MeV ( Ce) to about 11.7 MeV ( Po). This rela-
tively small range in energies is contrasted with an enormous range in 
half-lives of the various alpha emitting nuclei. These half-lives range 
-ft i n 
from less than 10 second to more than 10 years for the various alpha 
27 
emitting radionuclides, a variation by a factor of 10 
As alpha particles traverse a medium, they lose energy by the 
processes of ionization and electron excitation with some contribution 
from inelastic scatter reactions with low Z absorber atoms. Upon traversal 
of air or tissue an alpha particle will lose, on the average, about 34 eV 
of energy for every ion pair it creates. This value is about twice the 
ionization potential of the medium because excitation of the atoms and 
molecules diverts part of the available energy away from the ionization 
process to the excitation process and recombination. Possession of a 
high electrical charge and relatively low velocity, due to its large 
mass, causes the specific ionization of an alpha particle to be very high 
compared with photons and beta particles, on the order of tens of thousands 
of ion pairs per centimeter in air (Cember), compared to ten to a hundred 
ion pairs per centimeter for a beta particle. 
Because of this high rate of energy loss, alpha particles are ex-
tremely limited in their ability to penetrate matter. The dead outer 
layer of skin of the adult is sufficiently thick to absorb all alpha 
5 
particles emanating from external alpha sources. As a consequence, alpha 
radiation is not considered to be a serious external hazard. The effects 
of an internal deposition of alpha emitting nuclides, though, are quite 
different and serious in their consequences as will be discussed later. 
In air, even the most energetic alpha particles from alpha emitting nu-
clides travel only several centimeters, while in tissue the range is of 
the order of a few tens of microns. For a given alpha particle energy, 
Bragg has shown that (Price) 
*—?•• — a constant (1-1) 
/A 
where 
R = alpha range in a particular absorbing material 
p = density of this same absorbing material 
A = atomic weight of the material 
This relation allows calculation of the approximate range of a particular 
alpha particle in any uniform medium if the range of this alpha particle 
is known in another medium and the density and atomic weight of both 
media are known. The alpha particle has the characteristic that the 
rate of energy loss in an absorbing medium is approximately a constant 
for most of the trajectory of the alpha until the end of the path is ap-
proached, see Figure 1. The sharp rise in ionization at the end of the 
range is caused by the increase in the interaction cross section of the 
electrons of the absorbing medium with respect to the alpha particle. 
This increase can be attributed to the larger impulse (Ft) received by 
the orbital electrons when the alpha particle is moving at a slower 
RtblDUAL (C/A) 
Figure 1. Plot of Specific Ionization versus Alpha Particle Energy (Bragg Curve). (Here residual 
range is used as a measure of the particle energy, the greater the residual range the 
greater the alpha particle energy.) 
7 
velocity (at the end of its range) than when it is moving at a more rapid 
velocity (at the beginning of its range). The larger impulse results 
from the longer time elapsing while the alpha particle is close enough to 
the electron to cause interaction at the slower velocity than at the 
faster one. In fact, at the end of the path of the alpha particle, its 
velocity is approximately equal to the velocity of the orbital electron 
allowing maximum possible interaction between the two. 
1.1.2 Effects of Alpha Particle Energy Deposition in Tissue 
The effects of alpha particle irradiation In vivo tend to be 
localized in the volume surrounding the alpha tracks and to a short dis-
tance from the point of deposition of the alpha emitter due to the short 
range in tissue of these particles. This is somewhat different from the 
effects of electromagnetic radiations which can cause widespread effects 
throughout the body, such as erythema, anemia, necrosis and temporary 
sterility at high doses, and cataracts, leukemia and other tumorigenic 
57 58 
effects at low doses (Morgan and Turner) and (Warren). 
58 
Warren notes three problems found in the final determination of 
the late effects of photon irradiation. These problems are also worth 
considering for alpha particles induce tumorigenic effects. The first is 
a special susceptibility believed to be present in some individuals. The 
evidence supporting this theory is found in his multiple malignancy 
studies. Here an individual with one malignancy was shown to have a 
probability significantly greater than the population average of contract-
ing other malignancies. Presumably this could be interpreted as a genetic 
influence. The second problem involves confusing the tumorigenic effects 
8 
attributable to radiation alone. As the age of an individual increases 
so does the probability of observing a malignancy in this individual. It 
is known that radiation can increase the aging process (Morgan and Tur-
ner) . Therefore it could be difficult to determine unambiguously 
whether the tumorigenic effect observed was caused by the radiation itself 
or the effective increased age of the individual and his resultant higher 
probability of incurring a malignancy. The third problem is the wide 
variation observed in individual radiosensitivity to various biological 
effects such as tumorigenic effects and white blood cell count. Warren 
found variations by as much as a factor of fifty or more in the doses 
needed to induce certain malignancies in various strains of mice. He 
also noted wide variations in the response of white blood cells among 
four men receiving approximately 60 rads from a cyclotron beam in the same 
radiation accident. 
Other effects also should be considered when considering long 
term effects of radiation. One phenomenon is the latency period. La-
tency is the time elapsing between the induction of the tumorigenic change 
to the clinical presentation of the tumor. The latency period varies 
widely among the different types of tumors of course but varies among 
individuals as well for the same type of tumor. This latter variation 
could be due to differences in individual immune systems. An example of 
this variation is the latency period for osteosarcoma in humans, three to 
59 
six years (Marshall and Groer). This variation in latency period also 
needs to be included in calculations of overall dose-effect relationships 
for tumorigenic change. 
Although some of the above effects are observed after the admin -
239 12 
istration of alpha emitters such as Pu (Stover and Jee), (Bair et 
34 35 36 41,43 
al.), ' ' (Thompson et al.), effects such as anemia, necrosis and 
sterility are not observed until toxic doses are reached. On the con-
trary, effects due to internally deposited alpha emitters tend to be more 
subtle and require a longer latency period before manifestation of the 
effect. These effects include osteosarcoma (Vaughan et al.), (Stover 
12 11 8 10 
and Jee), (Jee), (Mays and Lloyd), (Evans et al.), (Hasterlik et 
al.), pulmonary neoplasia and other lung and lymph node effects (Bair 
31 32 34 37 38 41 42 44 
and co-workers), ' ' ' ' (Thompson and co-workers), ' ' 
(Bustad et al.), tooth effects (Evans et al.) (Hasterlik et al.) 
19-21 
and liver effects (Durbin), " spontaneous fractures, other non-fatal 
bone effects (Stover and Jee), (Evans et al.), (Vaughan et al.), 
fin ^ 
(Hasterlik et al.) , and altered osseous circulation (Jee et al.). 
In general for cells in tissue cultures, the mechanism of radiation 
from alpha radiation seems to be characterized as a "one-hit" process 
with no repair at LET's above about 25 keV/|im (Vaughan et al.) as sup-
ported by James and Kember. It does appear that the sensitive portion 
of the cell is the nucleus (Lea) and (Vaughan). Due to the high 
ionization density, there is a very high probability, approaching one, 
that an alpha particle passing through the cell nucleus will render the 
cell incapable of division "reproductive death" (Lea), (Casarett) and 
(Vaughan). However, Marquart has shown the mitochondrion to be the 
most susceptible cellular component to radiation damage from alpha par-
224 
tides in his study using mice injected with Ra salt solution. But 
damage to a mitochondrion may not be as debilitating as damage to the 
chromosomes of the cell nucleus. 
Even though the last statement concerning the cell's nucleus is 
generally true, it cannot be assumed that the same effect will be produced 
in any type of cell for a given dose. In fact some cell types in human 
tissue show an extraordinary resistance to radiation damage from deposi-
239 239 
ted Pu, even when the cell contains enough Pu to make irradiation 
of the cell nucleus inevitable. Macrophages in the lung and peritoneal 
239 
cavity are capable of containing hundreds of PuO^ particles of the 
37 
order of one micron in size and still function (Bair). They tend to 
lose reproductive capability, however, and are therefore incapable of 
malignant transformation; these cells do retain phagocytic activity for 
as long as seven days while in this condition. It appears, in fact, that 
the lifetime of a macrophage in this particulate-filled condition is at 
least a factor of one hundred greater than the time required to replace 
a damaged macrophage because a damaged macrophage is not seen under micro-
scopic examination (Vaughan). Macrophages could be considered among the 
most radioresistant cells in terms of cell function, whereas some cells 
(S1 fiL. 
such as epithelial and stem cells (Lea) and (Evans) are very sensi-
tive to ionizing radiation. What then are the criteria which determine a 
cell's sensitivity to ionizing radiation? These criteria were examined 
by Bergonie and Tribondeau and stated in what has now become known as 
the "Law of Bergonie and Tribondeau" (Bergonie and Tribondeau) which 
states that cells are more radiosensitive if: (1) they have a high mi-
totic rate, (2) they have a long mitotic future and (3) they are of 
primitive type (stem cells). Thus we can see why certain cells exhibit 
more radiosensitivity than others. One notable exception to this "law" 
11 
is the lens of the eye. Lenses are high radiosensitive, yet the cells 
present do not have a high mitotic rate. Possibly for high LET radia-
tions, such as fast neutrons, little or no repair occurs allowing damage 
to accumulate. 
Bone cells possessing the most primitive character are the pre-
osteoblasts, also called osteoprogenitor cells. These normally reside on 
the surface of the bone and out to a distance of about 10 microns removed 
from the surface of the bone (Vaughan). ' Since this subject will be 
discussed again in the section concerning plutonium toxicity, let it suf-
fice to say that, if an alpha emitting nuclide is positioned such that 
these cells receive the majority of the alpha irradiation, maximum damage 
will be inflicted upon the bone possibly resulting in a malignancy. 
When mentioning a leukemic transformation, or any malignant change, 
one is referring to the change in a cell causing it to lose the prior 
function it had and to be removed from the controlling influence of the 
body. This change does not indicate an increase in mitotic rate. In 
fact, the leukemic white blood cells divide only one third as rapidly as 
normal white cells. The reason an accumulation of leukemic cells occurs 
and normal white cells remain constant (or decreases) is leukemic cells 
do not travel to the spleen to be destroyed after 120 days, upon a signal 
from the body, as do the normal cells. Tumor cells cannot undergo repair 
as is common among normal cells. This latter property is the biological 
basis for treating malignant tumors with radiation therapy. Although 
healthy tissue is irradiated with the cancerous tissue, the healthy tissue 
will attempt to repair itself whereas damage to cancerous tissue is cumu-
lative. The other malignancy we have discussed, the osteosarcoma, seems 
to be caused by a two hit mechanism by alpha particle irradiation (Mar-
59 shall and Groer). The osteosarcoma is one cancer in a group collectively 
named bone tumors. Bone tumors have a maximum natural incidence during 
adolescence with a rate of about three per 100,000 (Rubin). About 28 
percent of these bone tumors, the most common, is the osteosarcoma. This 
tumor is of osteoblastic origin and is more radioresistant than some of 
the other bone tumors. When considering combination treatments of osteo-
sarcoma utilizing chemotherapy, radiotherapy and surgery, the five year 
survival is between five and twenty percent, the second lowest of the nine 
bone tumors considered by Rubin. Marshall and Groer envision this 
tumor to be induced by two separate hits on two targets. Then a promotion 
period follows after which the tumor is clinically presented. The two 
hits could occur along the path of one alpha particle or by two separate 
alpha particles. The calculated areas of each of the two targets are 
about the size of 100 pairs of nucleotides along the DNA double helix. 
These nucleotides could be the ones controlling the biologic switch which 
in turn controls mitosis. Competing with this two-hit mechanism is cell 
killing and cell replacement, occurring about 10 more times than pro-
gression down each step in the chain to malignancy. They found an initia-
Q 
tion probability of 4 x 10 /rad for osteosarcoma in man based on the 
radium cases and the probability of cell killing to be 10 /rad. In 
this theory only the initiation and killing probabilities are controlled 
by radiation, cell replacement and promotion proceed at the same rate re-
gardless of the radiation. This two-hit mechanism of damage by alpha 
particles does not conflict with the one-hit previously mentioned since 
the latter one was concerned only with single cells in cultures and the 
two-hit mechanism is concerned with an entire man. 
The macroscopic effects of internal deposition of alpha emitting 
radionuclides were discussed above but the question arises as to what is 
occurring on the microscopic, cellular, level which could cause these ob-
served gross effects. There are of course many effects observed in the 
cell after irradiation depending upon the amount of absorbed dose, as 
well as other factors (Casarett). The one effect which seems to be 
most sensitive to radiation, especially at the low dose end, is the fre-
quency of chromosome aberrations (Muller), (Lyons et al.). This ob-
servation can be used to quantify the various types of radiation accord-
ing to a dose response relationship (Lea). When this is done, it be-
comes apparent LET is one of the most important factors in determining 
the degree of increase in frequency of chromosome aberrations (Lea). 
Another crucial effect on the cell after irradiation is inactivation or 
reproductive death. 
In an effort to explain inactivation of cells as a result of 
ionizing radiation, the Target Theory was developed by Lea. According 
to this theory, inactivation of a cell will result when a hit (or hits) 
occurs within a specific sensitive region (or regions). The hitting of 
this one particular region will result in inactivation of the cell. Hits 
in other locations can possibly occur without causing inactivation of the 
cell but can result in some of the indirect radiation effects to be dis-
cussed later. The sizes of targets vary from about 4-40 nanometers. 
There are many changes which can occur in a cell that has been 
irradiated by ionizing radiation. Some of the immediate changes encoun-
tered can be summarized as follows (Bacq and Alexander) : 
(1) Delay in the onset of mitosis followed by normal mitoses. 
The first cell division after irradiation may show some tem-
porary disturbance in the chromosome separating mechanism 
(called chromosome stickiness), which does not usually per-
sist and as far as can be seen histologically does not pro-
duce ordinarily permanent injury unless it does persist. In 
humans chromosome stickiness can result in Down's syndrome, 
accounting for one eighth of all mentally defective infants. 
(2) Complete inhibition of mitosis. The cell continues to live, 
i.e. to metabolize, but has permanently lost its capacity 
to divide and is said to have suffered reproductive death. 
(3) Death of cells following one or more divisions after irra-
diation . 
(4) Death of the cell occurs many hours after irradiation but 
without any intervening division. This effect is known as 
interphase death. 
(5) Instant death under the beam following very high doses 
(~ 100 krads), called "beam death." This quantity of radi-
ation will coagulate many proteins causing "instant" death. 
(6) Chromosome aberrations and breakage. 
(7) Interference with the functions of the cell. This may be 
temporary or permanent and the dose needed to achieve it 
varies widely. 
(8) Other effects such as damage to cell blood supply, forma-
tion of radicals in the water surrounding the cell, etc. 
Not only is the number of effects seen in the cell upon irradiation 
large but also the sensitivity of cells and components of cells varies 
widely. The dose that will kill all but 37 percent of the cells present 
in an experimental setup, called the D dose, ranges from 100-200 rads 
for mammalian cells to millions of rads in enzymes (Casarett). To com-
plicate the situation even further, the radiosensitivity of cells and 
cellular components is subject to considerable variation within identical 
groups. This sensitivity will change by a factor of two or three depend-
ing on the conditions existing before, during and after irradiation within 
a group of identical cells (Elkind and Whitmore). Some of the condi-
tions during irradiation that affect radiosensitivity are temperature, 
water content, oxygen and the presence or absence of certain substances. 
The various post-irradiation treatments commonly studied include heat, 
exposure to NO, presence or absence of oxygen, etc. The presence of 
water is important in determining the effect of ionizing radiation in 
tissue (Casarett). The radiochemistry of water is quite complex and 
tends to amplify the effect of the incident radiation. Water causes this 
amplification by the formation of free radicals, which we might mention 
parenthetically is the operational basis for chemical dosimeters such as 
the ferrous-ferric ion dosimeter. The role of these free radicals in 
determining the damage inflicted on tissue containing radicals depends 
on such factors as presence of oxygen and magnitude of the deposited dose 
72 
(Okada). These radicals can cause damage in cells which have not even 
suffered a direct hit by the radiation. This could be accomplished by 
72 
a number of mechanisms (Okada). First the free radical is formed, say 
the peroxyl radical HO? , in a location removed from the chromosomes of 
the cell nucleus. This radical could then migrate to the chromosomes 
and interact with one of them causing a large radical to be formed by 
abstraction of a hydrogen ion from the chromosome. This is now quite a 
different molecule from the original chromosome and will therefore inter-
act with its surrounding medium in a different manner. The chromosome 
could become disabled in this manner even though it was not directly hit 
by ionizing radiation. This effect is called an indirect effect of 
ionizing radiation and has the capability to alter significantly the 
final effect caused by ionizing radiation (Casarett). 
To move from the effects realized at the cellular level to the 
more macroscopic effects mentioned earlier, the various tissues in the 
body need to be discussed. In the human body there are four major tis-
73 
sues (Villee and Dethier) ; these are epithelial, connective, muscular 
and nerve tissues, each containing cells of varying functional and morpho-
logical characteristics. The collective connecting tissues are vascular 
tissues (blood, lymph), connective tissue proper (white fibrous, yellow 
fibrous, reticular, adipose and areolar), cartilage and bone. The major 
functions of the connective tissues are the support of body structures 
and the binding of its parts together. Tissue histologically is referred 
to as the assemblage of similar cells with a specific function. The dif-
fering characteristics and functions of the cells in tissue cause them to 
exhibit varying degrees of radiosensitivity. When looking at the risk of 
tumor formation from internal alpha emitting nuclides in bone, the risk 
is found to be associated with the following factors (Jee) : 
(1) The volume of cells at risk from alpha irradiations, i.e. 
related to the alpha particle range in tissue 
17 
(2) The intensity of the alpha radiation impinging on the 
bone surface 
(3) The proliferative potential of the cell. 
The effects of alpha emitters retained ln_ vivo have been examined 
by a host of researchers at many different locations throughout the world: 
at the University of Utah by Jee, Mays and co-workers ' ' ' ' ; at the 
University of California by Durbin, " Hamilton and co-workers ; at 
Hanford, at Washington by Bair, Thompson, Clarke and co-workers ; in 
England by Vaughan and Bleaney ; and in France by Lafuma and co-
26-30 „ 10, 64 , „ + .... _ . 60 , ^ . . _ ,. , workers. Evans and Hasterlik et al. have extensively studied 
what is certainly the largest body of human data concerning internally 
deposited alpha emitters, human exposure to radium. Data on radium depo-
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sition in man are derived primarily from three sources (Evans). The 
first category includes radium dial painters, who ingested a radium con-
taining self-luminous compound when they used their lips to point the 
fine brushes used to paint numerals on watches, clocks and instruments. 
This mouth tipping was ordered discontinued in the United States around 
1926 following identification of "radium jaw" in 1924 by Theodore Blum, 
64 
a New York dentist (Evans). In this country there were about fifty 
dial painting "studios" and the total number of employees at risk during 
the high exposure period was of the order of at least 2000. The median 
64 
age of the survivors of this group in 1966 was about 60 years (Evans). 
The second category includes radium chemists who were employed in about 
23 refineries and radium laboratories. The total number of chemists and 
technicians so employed seems to be difficult to determine but appears 
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to be between 500 and several thousand (Evans). The median age of 
those surviving until 1966 in this group was 75 years. The third and 
also the largest category comprises iatrogenic cases, i.e. those individu-
als to whom radium was administered by a physician internally by ingestion 
or injection for medical reasons. The internal use of radium was removed 
from the "American Medical Association New and Nonofficial Remedies" 
about 1932. Prior to that time and for some years thereafter it is known 
there were more than 53 physicians or clinics administering radium intern-
ally to patients. The total number treated was estimated by Evans ' to 
be several thousand. One clinic alone, during a five year period around 
1920, gave more than 14,000 intravenous injections of radium (usually 
10 |j,Ci each) and more than 22,000 oral administrations of radium. Aside 
from these iatrogenic cases several patent medicines containing radium 
were available. One of the most popular was Radithor which was a mixture 
of one (j,Ci of radium and one |j,Ci of mesothorium in one-half ounce of 
water. It was sold in cartons of 30 vials, to be taken at the rate of 
three per day after meals. Some 22,000 vials of Radithor were sold in 
1925 alone and between 1926 and 1930 the records indicate that 406 mg of 
radium and 471 mg-equivalents of mesothorium, or enough for between 
400,000 - 500,000 treatments, were sold. The median age of the survivors 
of this large group of iatrogenic and nostrum (patent medicine) cases was 
74 years in 1966. Evans found that, for residual skeletal burdens greater 
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than about 0.5 (j,Ci Ra, the occurrence of osteoporosis, dense bone ne-
crosis, trabecular coarsening and spontaneous fractures increased with 
increasing residual skeletal burden. For residual skeletal burdens fall-
0 0 C\ 
ing in the range 0.5 - 60 u,Ci Ra, the fractional incidence of osteo-
genie sarcoma and carcinoma of the paranasal sinuses or of the mastoids 
was about 40 percent and seemed to be independent of the residual body 
burden within this range. There was a difference however in the tumor 
appearance time or induction-plus-latent period. It tended to increase 
substantially as the residual body burden decreased until finally the 
tumor appearance time could be considered to be greater than the life span 
of man for sufficiently small residual body burdens. The body burden 
fulfilling this latter criterion is referred to by Evans as the "practi-
cal threshold" and in support he points out he observed no clinically 
significant symptoms below a residual body burden of 0.5 \iCi. The ini-
tial burden tended to exceed the final skeletal burden by a factor of 
about 20. Therefore, Evans believed these two facts give a degree of 
confidence in the current value of the maximum permissible body burden 
o o c* 
(MPBB) in bone equal to 0.1 ^Ci for Ra. 
It could be agreed that the degree of confidence placed in the 0.1 
ÎCi value by the above is actually less than the confidence level ex-
74 
pressed when the value was originally established in 1941 by the NCRP. 
It was stated at that time (1941) that the value of the MPBB for bone 
was established at 0.1 ^Ci because no serious injury to radium dial 
workers was known to have occurred with a burden ten times this value 
(Morgan and Turner). At the present time, however, that MPBB value for 
0 1 Cs. 
Ra has been opened to question. Hasterlik has found a tumor in a per-
son whose residual body burden was 0.1 |j,Ci. Gofman and Tamplin have 
challenged Evans' hypothesis of the "practical threshold," where the 
r\ r\ s_ 
burden of Ra is so low that the latency period for the tumor is beyond 
the remaining life span of the individual. They point out the vast in-
20 
crease in population size needed to observe an effect occurring with 
decreasing frequency as dose decreases. In fact, their calculations indi-
cate one would not expect to observe cancer at the lower dose ranges con-
sidered by Evans and Hasterlik for the population sizes they were forced 
75 to use. But, as Gofman and Tamplin point out, no real conclusion can 
be drawn to support or disprove a linear hypothesis from Evans' and Has-
terlik' s data ' and certainly a practical threshold is not supported 
in an irrefutable manner. Therefore, we cannot be absolutely comfortable 
9 0 C-\ 
with the 0.1 ^Ci burden of Ra in a man as an acceptable burden in the 
occupational radiation worker. 
Another study of thirty persons exposed to radium by the mechanisms 
mentioned above was performed by Aub et al. They divided the examined 
cases into four groups as shown in Table 1 . 
Table 1. Dose-response Relationship for Ingested Radium in Man 
Group Radium Number Size Tumor Average 
Body of of Incidence Latency 
Burden Tumo r s Group Period 
(lig-eq) (%) (yr) 
I > 8 2 8 25 19.5 
II 2-8 3 9 33 24.6 
III 0.7-2 3 9 33 23.6 
IV < 0.7 0 4 0 --
The four patients placed in Group IV had less than 0.7 microgram equiva-
lent of radium in their bodies, the greatest being about 0.5 microgram 
equivalent of radium. The results of their study proved to be quite 
inconclusive from the viewpoint of establishing a dose-response realtion-
ship for radium. No clinical symptoms were observed at a body burden 
below 0.5 microgram equivalent of radium. No conclusions could be drawn 
other than for the small number of cases considered, the tumor incidence 
and induction time showed little variation with different degrees of 
radioactivity. 
Twenty-two radium patients were studied by Hasterlik et al. They 
reported fifteen cases of osteosarcoma and eleven other tumors of the 
cranial sinuses which were not osteosarcomas. In no patient with a body 
o o c*. 
burden less than 0.6 jj,Ci Ra could a tumor be found at the time of 
measurement. The range of radium burden was 0.6 - 10 |iCi, 30-40 years 
after exposure. Again, this result could be construed to be somewhat 
reassuring since the current MPOB in bone for Ra is 0.1 p,Ci and these 
are burdens measured 30-40 years after exposure; the initial burdens 
would have been much greater. But before any conclusions can be drawn 
from these data, the Gofman discussion concerning population size would 
need to be examined once more and applied accordingly. In addition, 
Morgan ' has shown there is a tendency toward malignancy even for these 
data down to a body burden of 0.1 |i,Ci. 
There is another category supplying information as to the effects 
of internally deposited alpha particle emitters. This category includes 
the men working in the Schneeberg cobalt mines of Saxony and at the 
Joachimsthal pitchblende mines of Bohemia who inhaled particulates and 
32 57 
radon daughters (Bair), (Morgan and Turner). The high incidence of 
lung disease which occurred in these miners was noted as early as the 
1500's but was not systematically examined until the end of the nineteenth 
century. The incidence of lung cancer was very high among these miners 
32 
and was actually approaching 40 percent between 1875-1912 (Bair). From 
1922-1939 the lung cancer incidence was even higher, averaging 50 percent 
with a peak around 83 percent; this was believed to be caused by the 
32 
startup of radium and uranium mining (Bair). These data from miners 
are not considered as the direct or inclusive evidence for the effects of 
alpha irradiation in man as would first be thought. This unfortunate 
situation is due to the many different contributing factors which were 
present and also known to be carcinogenic. Therefore it appears radia-
tion may have been only one of several factors involved. These mines 
were not very clean mines compared to today's standards. The miners 
inhaled large quantities of dust containing silica, arsenic, cobalt, etc. 
32 
as well as the alpha particle emitters (Bair). Another factor to be 
considered is the large percentage of miners who smoke cigarettes. Lung 
cancer among the smoking miners in the Colorado plateau uranium mines 
occurred at an incidence equal to 700 cancers/lO miners whereas the in-
cidence among miners who did not smoke was only 4 cancers/lO miners 
32 
(Bair). Thus there appeared to be a synergistic effect when smoking 
78 
was combined with working the Colorado plateau uranium mines. Martell 
210 
believes the Po present in the cigarette smoker's lung is the cause 
of lung cancer and other effects associated with cigarette smoking. 
There have been studies of human exposure to other alpha emitters 
79 232 
such as the Looney studies of patients ingesting Thoratrast ( ThO in 
suspension) which produced hepatic tumors primarily, described briefly in 
57 79 
Morgan and Turner and in greater detail in Looney, to which the reader 
is referred. Before ending this discussion of the human data available 
23 
concerning the internal deposition of alpha emitters, we can examine one 
224 239 
nuclide, Ra, for which human data exist and have close bearing to Pu, 
the nuclide of main concern in this paper. The reasons for interest in 
239 
this nuclide in relation to the effects of Pu in man are threefold: 
(1) when first administered, bone seeking nuclides tend to concentrate 
on bone surfaces before moving into the bone, (2) the time required for 
the nuclide to move into the skeleton is long enough so that about half 
224 
the skeletal deposit of " Ra (half-life 3.62d) will decay on the surface 
of bone and finally (3) the data are human data which are of value since 
239 
no adequate human data exist for the effects of Pu in man (Spiess and 
Mays). ' This study is a quantitative examination of a group of pa-
224 
tients in Germany who were injected with large amounts of Ra from 1944-
1951 as treatment for tuberculosis, ankylosing spondylitis (similar to 
rheumatoid arthritis) and various other diseases. The injections involved 
224 
large amounts of essentially pure Ra with its daughters removed. Ac-
tivities ranged between 329 ^Ci injected over a twelve month period ad-
ministered to a girl just over fourteen years old, up to 4116 ^Ci over a 
fourteen month period administered to a boy almost seventeen years old. 
The total number of patients studied here was 854: 212 juveniles 
and 642 adults (Spiess and Mays). ' To calculate the doses to bone re-
224 
ceived by these patients certain data concerning the behavior of Ra 
45 90 
were needed. After a comparison with existing radium, Ca and Sr data, 
it was decided that 50 percent of the injected dose appears in the ex-
creta, primarily feces, 10 percent decays in the gut and 40 percent decays 
in either bone or soft tissue. Of this 40 percent there is about an equal 
24 
amount deposited in bone and soft tissue and about half the 20 percent 
in bone decays on the bone surface (10 percent of the injected dose) 
(Spiess and Mays). ' It was found by this technique that the dose cal-
culated to have been deposited on endosteal tissues out to a distance of 
10 microns from the bone surface was nine times greater than the dose 
224 
calculated for the same amount of Ra assuming it was homogeneously 
distributed throughout the bone, i.e. the average dose multiplied by nine 
224 
gave the endosteal dose for Ra. In an analogous manner, they found 
226 
the endosteal dose for "' Ra was the average dose multiplied by 0.63. It 
was concluded that an average (whole bone) dose of 90 rads deposited by 
224 
Ra was the lowest dose observed to have caused an osteosarcoma (Spiess 
and Mays). For Ra, Evans ' had found that 1200 rads was the esti-
mated lowest dose to cause the induction of an osteosarcoma in man. 
These numbers compare favorably if appropriate factors are used to observe 
224 
only endosteal surface dose. Calculating this dose for Ra, 90 rads x 
9 = 810 rads and for Ra, 1200 rads x 0.63 = 760 rads, using the weight-
ing factors described above. So it seems an endosteal surface dose equal 
to about 800 rads is sufficient to cause the induction of an osteosarcoma 
(Spiess and Mays). The average whole bone doses calculated to cause 
induction of osteosarcoma in dogs is 60 rads for beagles injected with 
239 228 
Pu citrate and 130 rads for beagles injected with " Th citrate (Mays 
o 
and Lloyd). The value of 90 rads (whole skeleton) for osteosarcoma in-
duction in man is between these latter two values for the surface seekers 
239 228 
Pu and ' Th when considering osteosarcoma induction in beagle dogs 
but quite different from the 1200 rads required to induce osteosarcoma 
25 
in man using Ra. Therefore ' Ra is better compared with a surface 
seeker than a volume seeker when describing its ability to induce osteo-
sarcoma. 
1.2 Objectives of This Research 
Because it is difficult to determine actual plutonium concentra-
tions in the surfaces of bone, it was felt that it would be useful to 
develop a new approach that would lend itself to a more direct determina-
tion of alpha particle dose to trabecular bone surfaces. 
The main objectives of this research, therefore, were: 
1. To find the best dosimeter that can be adapted to the deter-
mination of the average dose to the endosteal surface of bone out to a 
distance of 10 p,m. 
2. To examine the parameters of this system with regard to read-
ing methods, background reduction, bulk etching rate and reproducibility. 
3. Since the dosimetry system selected, the electrochemical 
etching of thick polycarbonate foils, had not been applied to alpha 
particle dosimetry before, the characteristics of polycarbonate foils 
after alpha particle irradiation required better definition. These in-
cluded track production efficiency and track diameter as a function of 
etching time and sensitivity as a function of etching time and waiting 
t ime. 
4. The determination of the average dose to the 10 pjn layer 
removed from the endosteal surface of various bone sections as a func-
239 
tion of total body burden of Pu. 
CHAPTER II 
BONE SEEKING RADIONUCLIDES 
2.1 Osseous and Concomitant Tissues 
Bone is a highly specialized form of connective tissue. There are 
certain characteristics that differentiate it from other forms of connec-
tive tissue, the most striking difference being that much of the tissue 
is extremely hard due to the deposition within a soft organic matrix of 
a complex mineral substance largely composed of calcium phosphate, 
O 1 
carbonate and citrate (ICRP). Bone can be regarded as a two component 
system comprising (1) a mineralized part, which consists of crystals of 
a calcium salt embedded in a matrix of collagen fibrils and a ground 
substance, occupying the intercellular spaces in bone. It has an effective 
atomic number, Z as 14, determined by the summation a.Z., where a. is the 
L 1 1 
fraction of element i in bone and Z. is the atomic number of element i, 
3 
and bone has a density ^ 1.9 g/cm . Bone is also composed of (2) soft 
tissues which include cells within the mineralized part and adjacent to 
82 
its surfaces (Spiers). The nonliving part of the hard bone consists 
mainly of cortex (compact bone) and trabeculae (spongy bone), Figure 2 
8 3 
(Thomas). The surfaces of bone are covered with non-mineralized layers 
of connective tissue called periosteum on the external surface, endosteum 
on the surfaces lining the marrow cavities and the Haversian canals 
throughout the mineralized bone in which run blood vessels. Also within 
the mineralized bone are much smaller spaces, lacunae, containing single 
27 
bone cells called osteocytes, connected with one another throughout the 
matrix by extremely fine processes running in the bone canaliculae, 
Q 1 
Figure 3 (ICRP). 
Periosteum 
Compact bone 
I Spongy bone 
I Trabecular 
Figure 2. Cutaway of the Shaft Portion of Bone 
n CROSS-SECTION THROUGH BONE * A U 
Figure 3. Diagrammatic Representation of the Relation 
of Osteogenic Cells to Bone Surfaces 
(not to scale) 
In bone, the radiosensitive cells appear to be located 
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(1) among the osteogenic cells of the bone surfaces; 
(2) in hematopoetic marrow; 
(3) in certain epithelial cells close to bone surfaces. 
The cells of bone are organized in a manner analogous to that in 
most tissues. A proliferating cell population (often referred to as stem 
cells) exists which differentiates into the nondividing functional cells 
of bone. These latter cells are the osteoblasts, the cells responsible 
for cell formation and the osteoclasts, the cells responsible for bone 
removal. 
Cells on the periosteal surface of growing bone are arranged in 
well defined layers. Adjacent to the bone surface are the osteoblasts. 
Further away from the bone surface are the precursors of the osteoblasts 
called preosteoblasts or osteoprogenitor cells which are the main region 
of cell division. Beyond these is a region of fibroblasts, Figure 3 
(ICRP).81 
It is likely that the same cellular organization exists on endos-
teal surfaces and within Haversian canals though it is more difficult 
to distinguish the different cellular layers in these regions. To identify 
cell density, cell nuclear size, cell nuclear distance from bone surface 
84 
and the cell DNA synthetic activity, Jee and Kimmel have examined the 
thoracic vertebral body #2 from an adult beagle. Using a Merz grid they 
examined fine sections at 1000 X and identified four cell types. These 
were flat cells, osteoprogenitor cells, osteoblasts and osteoclasts. 
Flat cells possessed a nucleus about 8 p,m by 1 ̂ m and little visible 
cytoplasm. The 8 |j,m length of the nucleus was arranged parallel to the 
29 
trabecular bone surface. There were about 3 x 10 of these flat cells 
2 
per mm of trabecular surface, about one percent of which were synthe-
sizing DNA. They tended to adhere quite tightly to the bone surface, 
91 percent were within 2 |jm of the bone surface, but a few were found as 
far as 8 pjn away. The distances refer to the distance between the bone 
surface and the nucleus of the respective cell considered. About 
2 
600-1000 osteoprogenitor cells were found per mm of trabecular surface, 
one to two percent of which were synthesizing DNA. Each cell nucleus 
was about 11 (j,m by 6 ^m arranged in a variable manner with respect to the 
bone surface. They found 48 percent of the osteoprogenitor cells within 
2 ujn of the bone surface, 27 percent within 2-4 ^m 15 percent between 
4-6 u.m and a few as far away as 10 ^m from the trabecular bone surface. 
Osteoprogenitor cells also tended to have little visible cytoplasm. This 
2 
work indicated about 500 osteoblasts per mm trabecular surface, of which 
approximately five-tenths percent were synthesizing DNA. These cells 
had round nuclei containing one or two nucleoli with abundant cytoplasm 
and golgi apparatus. They were usually found in groups within 3 u,m of 
bone surfaces. The final cell type, osteoclasts, were seen to occur in 
2 
a frequency 200 osteoclasts per mm , none of which were synthesizing 
DNA. Osteoclasts contained many nuclei (usually two, three or four) 
and vacuolated cytoplasm. They were also found quite close to the bone 
surface. The work of (Arnold and Jee) implicates the osteoclast in 
bone resorption (removal). This work will be discussed in greater detail 
in the section on plutonium but here we will just mention the steps 
proposed to occur during osteoclastic resorption of a bone surface. 
First the osteoclast acts in some manner to fragment the bone surface. 
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The osteoclasts then ingest the bone fragments and finally digest them. 
84 
Kimmel and Jee were somewhat surprised to find DNA synthesis in one 
percent of the flat cells on quiescent trabecular surfaces. The osteo-
blastic activity and osteoprogenitor cell synthetic activity were not 
surprising, since the latter is the stem cell and found mainly in areas 
of bone formation. Cells in the narrow spaces between trabeculae of 
growing metaphyseal bone (between diaphysis (shaft) and epiphysis, 
83 
Figure 4 (Thomas) ), similar in character to the preosteoblast of the 
periosteal surface have been described as reticulum, spindle and mesen-
81 
chymal cells, Figures 3 and 5 (ICRP). The active osteoblasts on the 
surface may lay down sufficient matrix to surround themselves and thereby 
become osteocytes, laying in bone lacunae. 





Figure 5. View Looking in from the Side of Figure 3 
The layers of cells on the bone surfaces, often spoken of as the 
osteogenic layers, varies in thickness and in proliferative potential, 
depending on the age of the animal and the particular region of the skele-
ton. Recalling from Chapter I, radiation damage is most rapidly expressed 
in cells which are going to divide, the cell most likely to be at risk 
is the cell with greatest proliferative potential; in bone this is the 
preosteoblast or osteoprogenitor cell. However, it is possible that in 
abnormal circumstances other cells may be stimulated to divide as in the 
O 1 
case of a fracture, osteoblasts and fibroblasts (ICRP). 
The area of bone covered by the periosteum is very much less than 
the area of bone covered by the endosteum since the latter covers the 
surface of all trabeculae. Until recently, numerical estimates have only 
been available for certain trabecular and periosteal surfaces. In man 
3 
the trabecular surface area in a vertebral body of approximately 40 cm 
O O O 1 
is ~ 1000 cm whereas the periosteal surface area is only 80 cm (ICRP). 
Spiers has just added the six human long bones to the list of bones 
which have been measured with respect to cortical and trabecular surface 
area. Of course, in all bones there are variations, depending particularly 
on age, in trabecular surface area but these variations do not alter sig-
nificantly the relative proportions of endosteal and periosteal surfaces. 
Due to greater surface area, except in young animals, the processes of 
resorption and apposition (burying and building, respectively) are much 
more active on trabecular surfaces than they are on periosteal surfaces 
and within Haversian systems. These two factors, namely the greater number 
of cells at risk and the greater activity of these cells, probably account 
for the fact that the endosteal osteogenic cells, particularly those 
associated with marrow spaces, appear to be at greater risk than the 
81 
periosteal osteogenic cells (ICRP). 
Now let us turn our attention to the hematopoietic cells. Hema-
topoietic stem cells, whether multipotent to form all cell lines of the 
peripheral blood or unipotent and differentiated to one line, originate 
in the bone marrow. There is evidence that stem cells may pass into the 
Q "I 
general circulation (ICRP). Nothing conclusive is known about the 
number and precise location of such stem cells in man. It can be assumed, 
until better evidence is available, that in children the stem cells are 
randomly distributed in young active hematopoietic marrow throughout 
bone and in adults in active hematopoietic marrow within trabecular bone 
(Morgan and Turner). 
Whether or not only the most differentiated ancestral cell is at 
risk in marrow is not known. The blast cell mentioned above which shows 
some differentiation may again divide without further differentiation. 
It can be argued that cells as differentiated as the myelocyte (the large 
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cell in active bone marrow from which leukocytes are derived) can con-
stitute a self-sustaining pool. Furthermore, in granulocytic leukemia 
(leukemia involving granulocytes, a granular leukocyte) the pH' chromo-
some appears to be not only in the leukemic population of myelocytes but 
in erythroblasts (red corpuscles) and megakayocytes (marrow cells with 
O 1 
large or multiple nuclei) as well (ICRP). This suggests that the final 
stage of the leukemic transformation occurs in the largely self-sustaining 
pool of myelocytes If both blast cells and myelocytes are capable of 
active proliferative activity the number of cells at risk may be con-
siderable. Lymphocytic cells (lymph cells or white blood cells without 
cytoplasmic granules) are also found in blood marrow, but it is not yet 
clear what the relation of these cells to hematopoietic stem cells might 
81 
be (ICRP). Next, let us examine the epithelial cells surrounding bone. 
On general radiological principles it would be expected that the cells 
at risk for tumor induction in the epithelium close to bone surfaces 
would be the stem cell with greatest proliferative potential when irrad-
iated by alpha and beta particles originating in bone. This has been 
shown to be the case in rabbits developing squamous cell carcinoma 
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(involving flat epithelial cells) of the external ear (Vaughan). 
In human skulls carcinomas arise in the mastoid air cells and the 
paranasal sinuses. Anatomically these are among the few areas in the 
human skeleton where the epithelium is directly adjacent to bone. The 
total thickness of the epithelium and connective tissue in man in the 
paranasal sinuses and the mastoid air cells (spaces in temporal bone) 
is reported to be 50-100 p,m causing those proliferating cells to lie 
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within the range of high energy alpha particles emerging from the under-
lying bone. 
It can now be realized from the foregoing discussion that radiation 
dose to certain identifiable tissues within or associated with bone is 
likely to be the important parameter in determining maximum permissible 
levels rather than dose to "bone" considered as a single uniform entity. 
The geometry of the micros trueture and the location of a particular 
nuclide in relation to the radiosensitive portions of the bone micro-
structure would then become important. This microstructure will also 
determine the type of biological abnormality observed. There are obser-
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vations on man (Evans) that suggest that if the endosteal osteogenic 
cells or epithelium close to bone surfaces are selectively irradiated, 
osteogenic sarcoma or carcinoma will result but that if hematopoietic 
tissue is equally at risk, as with x-rays or neutrons during whole body 
irradiation, leukemia is the more likely hazard. 
Now we can perceive a clearer picture of the complexity of the 
situation when concerned with deposition of a radionuclide in bone. De-
pending on its location in the bone different components of the bone of 
varying radiosensitivity come under irradiation by the deposited nuclide. 
Also of importance in determining the effect a particular radionuclide 
will produce at a position on the bone surface is the activity occurring 
at the site. In other words which of the three states of bone are present, 
the resting, resorbing or forming state. Specific tissues could then be 
considered the critical "organ" depending on the nuclide of concern and 
its type of emitted radiation. Also the dose to these critical organs 
would necessarily need to be determined in setting maximum permissible 
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limits, just as with any critical organ, even though these critical 
organs are a part of the bone microstructure, e.g. osteogenic cells of 
trabecular bone. It is toward this end that this study is directed. 
2.2 Categories of Bone Seekers 
All the actinide elements and alkaline earth metals (Ca, Sr, Ra, 
etc.) are placed into a category called "bone seekers" due to their 
preferential deposition in the bone. After deposition into the bone, 
though, all these elements are not found at the same location in the 
osseous tissue. Some elements, such as radium, strontium, calcium, 
phosphorus and carbon are distributed more or less in a reasonably even 
fashion throughout the entire bone volume including cortical, trabecular 
and periosteal bone although radium may have a component in hot spots 
of the bone. Other elements like plutonium, americium and probably 
other transuranics are found preferentially on the endosteal and peri-
osteal surfaces as well as the linings of the Haversian systems. The 
former group is referred to as "volume seekers" due to the character-
istics of the distribution pattern, whereas the latter group is referred 
to as "surface seekers" due to their specific distribution pattern. 
Due to variations among the constituents of the two classifications 
of bone seekers, a further division into four groups can be fashioned 
(ICRP)81: 
(1) the alkaline earths 
(2) plutonium and thorium 
(3) americium and probably a large group of rare earths and trans-
uranic elements the distribution of which has not yet been 
studied in detail 
36 
(4) phosphorus and carbon. 
The alkaline earths (1) (calcium, strontium, radium, etc.) tend 
O 1 
to be associated with the mineral portion of bone (ICRP), (Momeni et 
1 S 8 7 , 8 8 , T , , -1x89... ...90 m, ,. ., . ^ 
al,), (Lloyd et al.), (Lloyd). The distribution of these 
alkaline earths tends to be somewhat uneven but governed mainly by the 
presence of the processes of apposition and resorption. This uneven 
distribution tends to smooth into a more even distribution if the alkaline 
earth is administered in a continuous fashion. On the other hand, plu-
tonium and thorium (2) tend to collect mainly on the endosteal, Haversian 
canal and periosteal surfaces, decreasing in concentration in that order 
91 
(Jee et al.). The ratio of plutonium on the endosteal face to that on 
the periosteal face of bone is about 1 to 3.6 in Beagles (Jee). Amer-
icium (3) is taken up on all bone surfaces but does not seem to be con-
centrated on the endosteal surface to the extent that plutonium is 
81 9? 
(ICRP), (Taylor). In dogs the ratio of periosteal to endosteal 
Americium concentration is 1 to 2.0 (Jee), " about half that of plutonium. 
Other elements with probably the same distribution as americium are 
actinium, curium, cerium, berkelium, californium, einsteinium, etc. 
Phosphorus and carbon (4) become incorporated into the bone mineral not 
unlike the alkaline earths but in addition are incorporated into the 
O 1 
nucleoprotein fraction of all cells (ICRP). In particular this refers 
to the proteins of the lymph nodes, spleen and bone marrow. Carbon and 
phosphorus are both taken up in the DNA contained in the cell nucleus 
O 1 
(ICRP). Of particular interest to the discussion here is the charac-
teristic of plutonium to become preferentially concentrated on the bone 
surfaces, especially the endosteal face, as mentioned several times before. 
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This point is raised again to give added stress because it appears to hold 
the key to the explanation of the profound toxicity of plutonium. 
2.3 Desirable Characteristics for a New In-Situ Osteogenic Cell 
Microdos imeter 
The determination of the average dose to the endosteal surface 
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of bone from Pu alpha particles is a highly specialized task indeed. 
There are many characteristics we would consider desirable for a dosimeter 
to possess to perform the given task. Some of the dosimetry systems 
which have been tried before have possessed some of these characteristics 
but the system chosen here is believed to be the most readily adaptable. 
We would like the dosimeter to 
1. be of a geometry allowing the desired spatial resolution 
(micron range) to yield a meaningful dose distribution 
2. be sensitive down to the low doses expected to be encountered 
with body burden levels of the radionuclide 
3. resist fading so that rechecking of results at various inter-
vals and over various time spans would be possible 
4. operate without the use of any residual or induced activity 
to avoid the radiation hazards therein 
5. be economical to use 
6. operate without an excessively complex procedure to obtain 
data, thereby expediting reproducibility 
7. have a small background correction 
8. be adaptable to large scale usage to obtain as many data 
points as possible at one time. 
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2.4 Previous Bone Dosimetry Techniques 
In general, methods of detecting alpha particles, including alpha 
spectrometry, tend to be more numerous than methods of determining absorbed 
dose due to alpha particle energy deposition. Physical characteristics of 
alpha particles can be determined by analysis of the pulse height distri-
bution in proportional counters, pulse ionization chambers or scintillator 
93 
spectrometer arrangements (Kiefer and Maushart) and information on the 
spatial distribution of alpha emitters from solid state detectors (Becker 
94 95 96 98 97 
and Johnson), (Hamilton), (Simmons et al.), ' (Schlenker and Oltman). 
In the past there have been several techniques used to obtain 
indirectly an estimate of the dose delivered to localized areas of bone. 
Before describing the method used in this research to obtain a more direct 
dose reading we will first discuss some of the basic principles under-
lying these past methods then discuss the methods themselves. 
One device that will be considered as a possible selection for 
this research is the scintillation counter. The scintillator counter 
consists of several components including the photomultiplier tube, scin-
57 
tillator material and a photocathode (Morgan and Turner). A configura-
tion which can be used in a scintillator type detector is shown in Figure 
6 and a schematic configuration in Figure 7. Light photons produced 
by the scintillator material impinge upon the photocathode located inside 
the photomultiplier tube, so that the electrons produced will be tra-
versing a vacuum. The electrons produced by the photocathode are directed 
to the first dynode of the photomultiplier tube by a potential difference 
applied between the first dynode and the photocathode. Another potential 
difference exists between the second and first dynode of the photomultiplier 
5PRAY£D A\z0 
REFLECTOR 
klol (Tl) CRYSTAL 
•PACKED Al203 
OPTICAL WIUDOW 
OPTICAL COUPUkJG fLUiP 
:5PUU ALU t t lUUM BODY 






Figure 6. Scintillation Counter Assembly 
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Figure 7. Schematic Diagram of a Scintillation Detector 
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tube which drives the incident electron plus several more electrons 
(multiplication has occurred) to the second dynode. This process is 
continued through the third, fourth, etc. dynodes until the anode is 
c 
reached. At this point a multiplication of about 10 (assuming 10 dynodes 
and four additional electrons released at each dynode per each incident 
electron) will have been effected. The number of electrons arriving at 
the anode is proportional to the number of electrons released by the 
photocathode, which is proportional to the number of light photons created 
by the scintillator which, in turn, is propoportional to the energy 
released within the scintillator volume. So the scintillator is usable 
as a spectrometer. Several desirable characteristics for the detector 
to possess are: (1) the scintillator should be transparent to its own 
light photons, (2) the photocathode should have a high probability of 
producing electrons at the energy of the photons created by the scin-
tillator and (3) the scintillator should have a high photon production 
efficiency for the desired incident radiation. 
Inorganic scintillators are normally used to detect alphas 
Sfi 
(Price). These scintillators combine several desirable features for 
this application including large light output, high stopping power which 
allows a relatively small volume to be used and reasonably fast decay 
times. The most common phosphor for alpha counting is silver-activated 
zinc sulfide phosphor. This phosphor has a very high efficiency for con-
version from particle kinetic energy to photons, but its transparency is 
low. However, by preparing the zinc sulfide scintillator in a layer of 
thickness comparable to the range of alpha particles, the loss due to low 
2 
transparency is minimized. Around 5 to 10 mg/cm is the optimum thickness 
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for detecting most alpha particles emitted in radioactive decay. Although 
other types of radiation such as gamma photons may be present and will 
also produce scintillations in the zinc sulfide, these can be discrim-
inated against because of the relatively small amount of energy they 
convert to light in the medium. Zinc sulfide scintillators can be coated 
directly on the glass envelope of the photomultiplier tube or coated on 
a transparent material such as lucite. For these latter cases, the trans-
parent backing for the zinc sulfide is optically coupled to the photo-
cathode. 
Certain semiconductor detectors are useful for the detection of 
alpha particles (Morgan and Turner) and will be examined as a possible 
choice for this research. Detectors such as the surface barrier detector 
are useful for measurements of the energies of particles of high specific 
ionization and in particular for alpha particle energy analysis. These 
semiconductor detectors can be used for detecting heavy particles such 
as alpha particles, protons and fission fragments in the presence of 
other radiations. 
The properties possessed by semiconductor detectors which make them 
so useful in this area include linearity of pulse height versus energy, 
rapid response time, high energy resolution, thin entrance windows into 
the sensitive volume, variable sensitivity with respect to particle energy 
and relative insensitivity to gammas and neutrons (Price). On the other 
hand, there are also certain drawbacks with respect to various other 
detector types. These include small output signal, variations of operating 
conditions with ambient conditions such as temperature and radiation 
damage. 
In recent years, the availability of semiconductor detectors has 
revolutionized the spectrometry of charged particles. As compared with 
proportional counters, the semiconductor detector has the advantages of 
better resolution, better stability, essentially windowless operation and 
the ability to discriminate between particles of different ranges by 
simply varying the applied voltage. Inasmuch as the semiconductor spec-
trometers are essentially windowless, they can be used to detect fission 
products. It might also be mentioned, though, when large surface areas 
are to be counted for alpha contamination, the proportional counter is 
the instrument of choice. 
As mentioned above, surface barrier detectors are generally the 
semiconductor detectors used for alpha spectrometry (Kiefer and Maushart). 
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If a surface barrier detector of one cm area is used, a full width at 
half peak maximum (FWHM) of 17 keV is obtainable when spectrometry is per-
formed jjn vacuo. Of course air in the detecting system and the use of 
any casing over the sensitive face of the detector or appreciable thick-
ness of the source reduces energy resolution. 
Another technique which can be used for both dosimetric and detec-
tion applications is the photographic emulsion. Due to the high specific 
ionization of the alpha particle, a great number of latent images will be 
created and in fact essentially every silver halide crystal along the 
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alpha particle path will be affected (Rogers). Therefore, the track 
of an alpha particle in a nuclear emulsion will be very dense and quite 
straight apart from the chance of deviation as the end of the alpha 
particle range is approached, i.e. if it suffers a collision with a heavy 
atomic nucleus in the emulsion after it has already been slowed down 
(elastic scatter). The alpha particle track will also be relatively short; 
in Ilford G5 emulsion, all alphas of initial energies between 4 and 8 MeV 
will have ranges between 15 and 40 |j,m in the emulsion. The delta rays 
created along the alpha particle track give the track an irregular, 
fringed appearance when viewed at high magnification. An emulsion of low 
sensitivity will be sufficient to record the tracks of alpha particles in 
the presence of a gamma field and mild development will make the alpha 
particle track visible and discriminate against the much fainter gamma 
produced tracks. The tracks tend to be quite characteristic and easy 
to record and count, but the quantitative procedures involved requiring 
observation through a microscope, although simple and reliable, are 
tedious to perform. It is also possible to extrapolate the tracks back 
to their point of origin to accurately determine the source location 
within a few microns (Barkas). 
Certain nuclear emulsions such as Eastman Fine Grain Alpha have an 
extremely low sensitivity to both visible and ultraviolet light and can 
be exposed by placing a polished alpha emitting surface in direct contact 
with the emulsion (Yagoda). The developed image is a measure of the 
alpha particle activity on the surface and the immediate thin layer above 
the surface of the alpha emitting solid defined by the range of the alpha 
particles in the solid. Emulsions have been used to determine the dis-
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tribution and relative activities of long-lived alpha emitters (Till). 
Fading in emulsions is not too severe if they are maintained at low 
temperature and placed in a desicator (Yagoda) but it is difficult to 
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know quantitatively the amount of fading. 
These autoradiographic techniques can be used also to obtain 
estimates of doses deposited in small volumes of bone. Rowland and 
2 
Marshall described a technique used to determine doses to bone sections 
taken from persons exposed to radium by various modes. In this case, 
three autoradiographs were made to illustrate, in three different fashions, 
the deposition of radium in bone. The first autoradiograph was made with 
a sensitive emulsion (Eastman Kodak Autoradiographic No-Screen) which 
yielded a visual picture of the diffuse distribution of activity. The 
second autoradiograph recorded the alpha particle tracks utilizing Eastman 
Kodak NTA, 25 um emulsion. It was from this second autoradiograph that 
the actual number of alpha particle tracks produced were counted, to be 
used in subsequent calculations to obtain activity and then dose rate. 
The third autoradiograph was obtained by covering the bone section with a 
thin stripping film emulsion (Eastman Kodak permeable-base stripping film) 
which was developed and fixed in contact with the bone section. By micro-
scopic examination of this third emulsion in conjunction with the bone 
section beneath, the locations of the sources of the various alpha parti-
cles were determined. From the data obtained by counting the alpha tracks 
appearing on the second autoradiograph the activity was calculated. This 
was accomplished by using the alpha particle range in bone which is 
2 
6.3 mg/cm for radium alpha particles, the efficiency of creating a track, 
here one-fourth of the emitted alpha particles within one alpha particle 
range into the bone section was estimated to produce a track. Also they 
determined 2.53 alpha particles would be released per disintegration of 
46 
a radium nucleus, one from radium, and three immediately from radon 
210 
daughters and one emitted following the longer lived Pb (21 year half-
life) . Assuming a 40 percent retention factor for radon daughters would 
yield 1 + 0.4(3 + 0.82) = 2.53 alpha particles per disintegration after 
thirty years. The number of radium disintegrations per unit time per 
unit mass would then be 
4 x no. of tracks 1 1 .̂  ... 
A x R 2.53 alpha particles per Ra disintegration t 
where 
A = exposed area 
R = alpha particle range 
t = time of exposure 
Exposure time is determined by the activity of the sample. The dose 
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rate could then be calculated from the Spiers relation Eqn. (2.2) or 
104 
a slightly modified form of this equation derived by Kononenko. 
Spiers' equation for a planar surface of bone containing a uniform con-
centration of radium has the form 
N a *T 3 
Dose rate = — = — — x F ergs/|j,m /day (2.2) 
where 
N - the number of alpha particles emitted per cubic micron per day 
CT = the average energy loss of the alpha particles in soft tissue 
(Spiers used 0.21 x 10 erg/um) 
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R = the alpha particle range in soft tissue (Spiers' value, 44 u.m) 
p1 = the ratio of alpha particle ranges in soft tissue and in bone 
(Spiers' value, 1.36; range in bone = 32 yjn) 
F = a tabulated geometry coefficient, dependent on cavity size. 
2 
For a 0o8 |iCi terminal burden Rowland and Marshall determined the dose 
(terminal dose rate x number days carried) was 460 rads for diffuse con-
centration of radium taken from selected areas of bone; it was found to 
be relatively constant throughout the bone. 
Another method using densitometric techniques to determine the 
activity that created the various alpha track patterns on autoradiographs 
has been used to determine dose deposited in a localized section of bone 
r Q O Q 
(Twente and Jee). In this study Pu was the nuclide of interest. They 
used a 70 p,m opening in the densitometer used for the activity determina-
tions. This figure was decided upon by the following argument. The 
239 
range of the Pu alpha particle in bone is 24.1 u,m and in the substance 
used to embed bone samples, Scotch Cast Resin no. 2, it is 29.5 ŷ i. Then 
the widest imaginable diameter needed would be for an alpha emitter 
located at the bone-resin interface corresponding to a diameter of 53.6 pjn, 
It was then decided to use 70 um as a conservative choice. The densi-
239 
tometer was calibrated using a Pu standard and various samples were 
then analyzed. It was found that the values obtained for activity by this 
technique were about 76 percent of the values obtained for the same sam-
ples radiochemically. The average dose rate distributed throughout a 
volume having radius equal to one alpha particle range was calculated by 
the following equation: 
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0 'E 
average dose rate = -*—— (2.3) 
ZRp 
where 
Q' = the disintegration rate per unit area of the source 
E = the energy of the emitted alpha particle 
R = alpha particle range in the medium considered 
p = the density of this medium. 
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For a dog injected with about 30 jiCi Pu citrate and sacrificed thirty 
days later, the dose rate to bone tissue at time of death (average) 
determined by the above equation for the endosteal bone surface was found 
to be 41 rads/day. It can be inferred from these two range equations that 
the dose rate is not very dependent on range since in one case range is 
in the numerator and in the other it is in the denominator. 
There is another method which can be used to determine the local 
dose once the fluence of alpha particle tracks has been determined by 
scanning of the autoradiograph through a microscope (James and Kember). 
The eyepiece of the microscope is equipped with an array of 5 pjn diameter 
circles with a straight line placed in front of the first row of circles 
which is set on the bone surface when measurements are being recorded, 
see Figure 8. The circles are placed at distances of 5, 12.5 and 20 
microns removed from the bone surface. The technique involves first 
counting the number of tracks within the various circles and then con-
verting to particle fluence (number of particles crossing unit area per-
pendicular to the directions of the incident particles). Approximation 
of a spherical volume is obtained by using a cylinder of similar height 
and diameter where the thickness of the film, 3 ̂ m, is the height of the 
cylinder and the 5 ̂ m circle is the diameter. 
Figure 8. Diagram Showing the Positions of the Array of Circles 
Marked on the Microscope Eyepiece and Projected onto the 
Section under Examination (The line is shown placed over 
the bone surface and the 5 yjn diameter circles are at 5, 
12.5 and 20 \xm distance removed from the bone surface.) 
These two quantities, average cross-sectional area of the cylinder and 
number of tracks within the various cylinders, yield fluence. Once fluence 
is found, dose is given by D = 0 x LET/p, where tf is fluence, LET is linear 
energy transfer and p is density. Problems encountered from this method 
include the error introduced by reading the fluence from an altitude 1.5 
^m from the bone surface rather than on the bone surface, differing ab-
sorptions in the emulsion and tissue (differing ranges) and LET variations 
which tend to give different values for the microdose for different loca-
tions of the circles. They used this technique to determine the incidence 
of one-hit events to cell nuclei, i.e. the number of cell nuclei receiv-
ing one alpha particle hit as opposed to none or two or more. They found 
the number of cells receiving two or more hits increased as time progressed 
239 
after Pu deposition. 
Another method, used by the Utah group, involves the technique 
of NIAR which stands for Neutron Induced Autoradiography (Stover), ' 
(Kimmel et al.), (Smith et al.) and (Wronski et al.). First 300 ^m 
thick bone sections were cut from a bone sample and sandwiched between 
two foils of Lexan polycarbonate. This assembly was then irradiated in 
1 f\ 9 
a thermal neutron column to a fluence of approximately 10 n/cm . Next 
the foils were counted on a microscope stage at a power of 100X to deter-
mine the lineal track density, F tracks/cm. This value could then be 
. 239 2 
converted into activity, or concentration, v(pCi Pu/cm ) by the equa-
5 4 
tion (Smith et al.), (Wronski et al.) : 
v = imF {2A) 
where 
239 
a = thermal neutron fission cross section for Pu, 742b 
0 = thermal neutron fluence 
R = fission fragment range, 18 p,m 
T| = fission fragment detection efficiency, empirically determined, 
0.488 
c = a units conversion factor 
The concentration would then be converted to dose in rads by one of the 
51 
previous formulations. Problems were encountered in this conversion 
due to the assumptions required, i.e. planar source of alphas and use 
of the peak energy of the alpha particle which does not allow alpha 
particles to originate below the bone surface. 
Sometimes it is desirable to determine the whole body burden of 
239 
a nuclide such as Pu, especially during the course of animal studies. 
37 
A procedure has been used by Bair which utilizes four arrays of Nal(Tl) 
crystals, thirteen crystals to an array (fifty-two total), connected in 
23 5 23 9 
parallel to detect the L X-rays from U (after the alpha decay of Pu) 
241 241 
and 60 keV y-rays from Am (after the beta minus decay of Pu) being 
emitted from dogs after inhalation experiments involving various forms 
239 239 
of Pu. About four percent of the Pu disintegrations result in X-rays 
235 
from U which occur in three energy groups, 13.6, 17.0 and 20.2 keV. 
241 
If the beta emitter impurity Pu is present, then in about 35.9 percent 
241 
of its disintegrations a 60 keV y-ray is emitted from the daughter Am 
241 
nuclide. But the Am (halflife = 458. yr) builds up slowly from the 
241 
Pu (halflife = 13.2 yr). In fact ten years after the deposition of 
241 241 
1.0 |a,Ci pure Pu only 0.012 jj,Ci Am have formed. There are also 
other low energy radiations present but of only minor significance, 
241 
these include 100 keV gammas from Am (0.04 percent) and 52 keV gammas 
239 
from Pu (0.02 percent). These gammas occur in such a low yield, they 
241 
would not be expected to give meaningful counts using the levels of Am 
encountered. The 60 keV Y _ r ay would be ideal to use unless the samples 
239 241 
is so highly purified Pu that the Pu activity is so weak as to 
become lost in the detector noise. To use this method of in vivo whole 
body counting several factors need to be considered. The irradiation 
history and knowledge of the use of chemical processing of the plutonium 
241 
prior to release are important because if significant amounts of Pu 
are present, the X-ray activity will actually increase with time due to 
241 241 
the buildup of Am (the half-life of Pu is 13 yr whereas the half-
239 
life of Pu is 24,390 yr). In addition, the apparent activity will 
be a function of time even for a constant body burden due to the different 
attenuations possessed by the various tissues, the HVL at 17 keV for bone 
is 0.03 cm whereas for lung it is 1.3 cm, and translocation. Another 
problem is encountered due to the different metabolic pathways followed 
by americium and plutonium. The differences are slight in the two path-
ways but do become noticeable when plutonium is administered in the 
form of the nitrate. Since americium tends to concentrate to a lesser 
degree at the endosteal surfaces than plutonium (about half as much), 
a shift of radioactive material from the endosteal to the periosteal 
surfaces and Haversian canals would result (americium is also a surface 
seeker). At a window setting of 13.6-25.6 keV, which includes the 17 keV 
X-ray, Dr. Bair found for the plutonium he was using a detection limit 
of 8 nCi, and a limit of 7 nCi for a window setting of 13.6-66.3 keV, 
which includes the 60 keV y-ray. 
When a bone sample is being examined after sacrifice of the exper-
imental animal or after the bone sample has been removed during surgery, 
it is desirable to determine the alpha activity contained within this 
sample. If uniform distribution of the alpha activity is assumed, the 
dose to this bone sample could be calculated,but no information as to 
the spatial distribution of this deposited dose could be elicited using 
this method. This task can be accomplished easily by the method outlined 
by McDowell and Weiss. Here the bone sample whose deposited activity 
is to be determined is dissolved and then placed in a liquid scintillator 
material and counted using a beta sensitive liquid scintillation counter. 
To prepare the sample, the bone is placed in solution with concentrated 
nitric acid and some small quantities of 30 percent hydrogen peroxide. 
This solution is heated over a gentle heat, to prevent bumping, until 
a clear solution is obtained. If an aqueous-phase-accepting scintillator, 
such as dioxane, is used, about one ml of this highly salted aqueous 
phase solution (just prepared from the nitric dissolution process) can 
be added directly to the scintillator. This method seems to work best 
at high activity levels, about 200 counts per minute or more and when 
the contribution to the background from other beta or gamma emitters 
in the sample is sufficiently low. Again due to the nature of the sample 
preparation, no information is obtained concerning the spatial distribu-
tion of the dose received by the various parts of the bone. 
There has been much effort placed on theoretical calculations of 
dose to a small volume since many of the experimental techniques employ 
emulsions to display the alpha-produced tracks. Then by some method, 
e.g. visual counting, densitometric or the volume counting technique one 
finds the activity present and converts it to dose using one of these 
, • -. • /o • N 82,103 /T, . s 104 , ,„, derived equations (Spiers), (Kononenko) and (Charlton and 
108 
Cormack). The equations of Spiers, eqn. 2.2, and Kononenko were 
mentioned earlier. In some of the first calculations, the dose near a 
planar interface between bone and soft tissue was determined on the 
basis of simplifying assumptions regarding alpha particle ranges 
82 103 
(Spiers). ' This method has also been applied to the mean dose in 
cylinders and the dose at any point in a spherical cavity irradiated by 
alpha particles arising in the surrounding medium. 
Numerical integrations have also been made to derive the dose near 
a planar interface and within cylindrical cavities both for external 
irradiation by x-rays and internal irradiation by alpha particles (Charl-
108 
ton and Cormack). In each case, allowance was made for variation of 
energy deposition along the track of the ionizing particle on the basis 
of the range-energy relationship: 
R = AE m (2.5) 
where 
R = the range of an alpha particle 
E = alpha particle energy 
A = an empirical constant 
m = 1.75 for secondary electrons released by photons of less than 
200 keV and m = 1.5 for alphas 
This equation is valid for initial alpha particle energies from 1 to 10 
MeV. 
109,110 
Thorne has performed Monte Carlo type computer calculations 
using modified forms of the Bragg equation similar to Harley and Paster-
nak to calculate the endosteal and bone marrow dose rates for various 
239 226 
activities of Pu and Ra. He assumed the endosteal surface was a 
planar source over the range of the alpha particle. Thome's calculations 
239 
indicated Pu was unlikely to be more than fifteen times as toxic as 
a n / 
Ra. This result is interesting since we employ a factor of only 5 
239 
in our dose-equivalent calculations for Pu. 
In summary, we have examined six ways to experimentally determine 
dose deposited in man resulting from the internal deposition of an alpha 
239 
emitting nuclide such as Pu. One involved using a whole body scin-
235 
filiation counter to look at the X-rays emitted from U and V-rays from 
241 
Am to determine an estimate of the body burden of the nuclide, e.g. 
239 
Pu. From the activity and literature knowledge concerning the dis-
tribution of the nuclide in the body, an estimate of the dose can be 
obtained. A second method involved the liquid scintillation counting of 
239 
a dissolved bone sample containing the Pu. From the mass of the 
sample counted and the activity determined to be in that sample, concen-
tration, e.g. ^Ci/g could be determined. Next, many other samples could 
be counted and the concentration of the nuclide determined for each. Then 
with these various concentrations in u.Ci/g the following procedures 
would be used to calculate dose to the skeleton. Dose received by each 
bone could be calculated in the usual manner from concentration in 
for the bone in question. Then all the doses could be summed to give 
total dose received by the skeleton. If there were not enough samples 
taken to use this procedure, an average value could be calculated from 
the available concentrations and an average dose calculated from this 
quantity or the high and low values could be used to bracket the dose 
received by the skeleton. None of these methods yield any information 
56 
concerning the areas receiving this deposited dose because all of these 
techniques require that the nuclide be homogeneously distributed through-
out the bone. This is not a good assumption for certain bone seeking 
239 
nuclides, especially Pu. Some degree of spatial resolution can be 
obtained however with the four other methods discussed. All the auto-
radiographic procedures employed found the activity in small volumes 
along the exposed bone surface and then used one of the theoretically 
derived relations to convert activity to local dose. Several shortcomings 
can be noted in this general procedure. These techniques determine dose 
only indirectly via some sort of calculation; in reality activity, not 
dose, is the experimentally determined quantity. The conversion to dose 
in tissue is not as clear as would first be guessed because the emulsions 
used are subject to inherent problems such as fading and the NIAR tech-
nique is observing fission fragments, not alpha particles which irradiate 
tissue _ln_ vivo. Therefore a need still exists for a dosimeter to deter-
mine more accurately the average localized dose to the endosteal surface 
of bone in fulfilling the requests of ICRP concerning bone seeking rad-
ionuclides. Better techniques of bone dosimetry have been requested by 
112 3 113 
many different sectors (Mole), ' (Jee et al.), (Natural Science Group), 
(Stover), (Stover et al.), (ICRP), ' (Cross). If such a dosimeter 
existed and a procedure could be found to apply it to local dose measure-
ments on critical osseous tissues, significant knowledge could be obtained 
concerning the actual doses received to these critical tissues from 
239 
deposition _in. vivo of such nuclides as Pu. We believe we now have this 
dosimeter and have the procedure to provide the requested information. 
CHAPTER III 
PLUTONIUM IN VIVO 
239 
3.1 Pu Characteristics and Special Problems 
Incurred Upon Uptake 
There is probably no single element in the periodic table with a 
comparable saga of discovery, development, manufacture and use covering 
a span of only one generation (Stannard). Uranium and its isotopes 
along with its daughter products such as radium and radon have been on 
the scene for decades. Uranium was known in nature and used in industry 
long before its possession of radioactivity was known or became of inter-
est and importance. Plutonium, on the other hand, did not exist on earth 
in measurable quantities, due to its short half-life relative to the age 
of the earth until Seaborg and his colleagues isolated a tracer quan-
n oo 
tity of element 94 on the night of February 23, 1941, and 0.5 micro-
239 
gram of 94 on March 28 of the same year. (The name "plutonium" was 
not assigned until the following year.) The ability of this element to 
undergo thermal neutron fission was found essentially simultaneously with 
its discovery and thus began the tremendous effort to produce it in quan-
tity for military purposes. The details of the remainder of this chron-
ology are familiar so nothing further need be added except to point out 
that kilogram quantities were available by the summer of 1946 and now 
thousands of kilograms are available and being produced in our nuclear 
58 
reactors. To insure maximum safety for the general public it behooves 
those associated with the nuclear industry to know as precisely as pos-
sible the conceivable pathways and points of deposition in the human body. 
It would also be desirable to know the biological effects produced by 
this deposited plutonium. These considerations imply the necessity of 
obtaining accurate dosimetry of plutonium in osseous tissue since, as was 
shown in the previous chapter, it is a bone-seeker. Even if the wide-
spread use of plutonium envisioned by the LMFBR program is never realized 
the need to have this information on plutonium still exists, since many 
radiation workers handle plutonium routinely in connection with the wea-
pons program and continuous exposure to the general public is occurring 
239 
due to atmospheric weapons tests. The amount of Pu estimated to have 
been released to the atmoshpere from weapons tests is about 300 kCi, dis-
tributed globally, mainly by tests in the megaton range that injected 
118 
debris into the stratosphere (Eisenbud). Plutonium tends to be tightly 
bound to soil and is present in biota only in minute amounts. The esti-
mated soil and air contaminations resulting from this source was 1.4 
7 _ o o -I I o 
mCi/km and 0.15 x 10 pCi/m , respectively (Eisenbud). Due to the 
239 
small fraction of Pu in the usual chemical form that is absorbed from 
the GI tract to the blood (covered below) the inhalation of the small 
239 
amount of Pu in the air ordinarily causes the greatest absorbed dose 
following human intake. The absorbed dose expected to be incurred by the 
239 
average person in fifty years due to the inhalation of the Pu environ-
mental contamination is 4.5 mrem to the whole lung and 1000 mrem to the 
118 238 
pulmonary lymph nodes (Eisenbud). The dose received from Pu inha-
238 
lation is less than 10 percent of these values, even after 17 kCi of Pu 
was released by an aborted space vehicle in 1964. All plutonium nuclides 
are chemically toxic since the chemistry of nuclides occurs at the atomic 
level. The radioactive toxicity of alpha emitters depends on specific 
activity, alpha energy and location of the alpha emitter with respect to 
239 
critical tissues. The specific activity of Pu is less than some alpha 
241 
emitting nuclides such as Am and would lead one to believe the toxicity 
241 
is also less. This may not be true, however, since Am does not tend 
239 
to concentrate on the critical endosteal tissues as dramatically as Pu 
(Jee). The effects of alpha emitters internally deposited also depend 
on critical organ and half life. All of these factors taken together 
yield the clinical end result of the deposition of any given alpha emitter 
239 
deposited in_ vivo. The difference between the distribution of Pu in 
osseous tissue and most other bone seekers could override specific activ-
ity considerations in determining clinical effects. 
Plutonium-239 is the isotope of plutonium existing in the greatest 
O O C O O Q 
quantity on a gram basis in a U- U nuclear reactor. The production 
239 238 
of Pu is initiated by the capture of a neutron by U which then de-
239 
cays to Pu by way of two beta-minus decays. The decay scheme can be 
written as 
238U > 239u £ _ > 239 L ^ 239 a > 235 
92u (n,Y) 92U (23.5m)^ 93iNp (2.35d)> 94ru (24,400y) 92u 
At this time bone is still considered to be the critical organ for 
239 120 
Pu (ICRP) but there is some feeling that the critical organ may be 
r>£. o -i 
lung when the inhalation mode of administration is considered (Bair) ' 
60 
239 
and for low level, chronic exposure to Pu, soluble form, the liver may 
20 
be the critical organ (Durbin). The dynamic distribution proceeds in 
20 21 
the following manner (Durbin). ' Plutonium will be cleared from the 
soft tissues other than liver and redistributed to the bone and liver. 
Plutonium deposited in the skeleton is slowly removed a portion of which 
is redeposited in the skeleton and most of the rest deposited in liver 
with a small amount excreted. Plutonium deposited in the liver is changed 
from a soluble form in hepatic cells to insoluble hemosiderin deposits 
and sequestered in reticuloendothelial cells. Therefore loss from the 
liver could be occurring at least as slowly as loss from the bone where 
in past ICRP calculations a biological half life of 200 years has been 
assumed. 
Monomeric plutonium solutions such as citrate deposit primarily in 
12 
the bone (Stover and Jee) " and polymeric plutonium deposits primarily in 
121 122 
the liver and bone marrow (Lindenbaum et al.), (Rosenthal et al.), 
123 
(Markley et al.). 
The retention of plutonium in the body has been examined in differ-
ent animals including man. A review of Langham's original human data 
20,21 
is given by Durbin. Beagle dog retention data have been studied by 
Stover and Stover et al. 
The distribution of plutonium varies among the different bones in 
animals as well as within a particular bone. A whole lumbar vertebrae 
239 
initially takes up about five times as much Pu as a whole ulna (Kim-
mel et al.). The initial surface concentration of the lumbar vertebral 
body in the beagle indicated a large variation with regard to surface 
61 
concentration. Ninety percent of the endosteal-trabecular surface showed 
a concentration sixty times that found on the remaining ten percent of 
this bone surface. This is quite different from the distribution found 
in the ulna. Here seventy percent of the trabecular-endosteal-periosteal 
surface was found to have a concentration twenty times that found on the 
remaining surface composed of the Haversian canal system (Kimmel et 
al.). Additionally, it was possible to relate incidence of osteosar-
coma to some of the same factors as in the other studies described below. 
Only two percent of the observed osteosarcomas originated in the ulna 
239 
which has (1) low initial Pu uptake; (2) a moderate amount of tra-
becular surface relative to the other bone surfaces, 50 percent; (3) no 
239 239 
loss of Pu from the whole bone and (4) a slow loss of Pu from tra-
becular surfaces due to processes such as turnover. On the other hand, 
sixteen percent of the observed osteosarcomas originated in the lumbar 
vertebral body. The characteristics of this bone possibly yielding the 
239 
observed clinical result were (1) high initial uptake of Pu; (2) larg 
amount of trabecular surface relative to other bone surfaces, 90 percent; 
239 
(3) rapid loss of Pu from the whole bone and (4) a very rapid loss 
239 
of Pu from trabecular surfaces by such processes as turnover (Kimmel 
106 85 , 
et al.). The results presented are in agreement with the Spiers ancl 
4 
Wronski et al. studies but do not consider the portions of bone in-
8 5 
dividually, i.e. proximal, distal and mid, as did Spiers and Wronski 
4 
et al. This, of course, does not lessen the importance of the Kimmel et 
al. work; it just indicates a different level of approach. Now we will 
85 4 
examine the Spiers and Wronski et al. studies mentioned above. 
o c 
Spiers has tried to correlate occurrence of osteosarcoma with 
o c 
the various surface areas of bone surfaces. Spiers measured human long 
bone surface areas and examined which portion of the long bones seems to 
be most susceptible to osteosarcoma production. He found excellent agree-
ment between the magnitude of the trabecular surface area and number of 
human radium induced bone tumors. He found quite poor agreement between 
the cortical surface area and bone tumor induction. He was then able to 
show which portions of the long bones (proximal, distal or mid) were most 
susceptible quantitatively. For example, the proximal tibia with a tra-
2 
becular surface area of 0.342 m was the site of four tumors; the distal 
2 
tibia, surface area 0.126 m , was the site of two tumors and the mid 
2 
tibia, surface area 0.036 m , was the site of one tumor. The cortical 
2 2 2 
surface areas for this bone were 0.151 m , 0.097 m and 0.116 m , respec-
tively. We can see the agreement found with the trabecular surface areas 
8 5 
here (Spiers). Similar results were obtained with the other five long 
bones, namely, the ulna, radius, humerus, fibula and the femur. 
8 5 
The data of Spiers above were in agreement with the most recent 
4 4 
findings at the University of Utah (Wronski et al.). Wronski et al. 
noted the bones and location on these bones where all the observed osteo-
sarcomas have been observed in the Utah dogs to date. The order of high-
est to lowest incidence of osteosarcoma as a function of position on the 
O IT 
bones for the Utah dogs agreed with the human data in Spiers. Wronski 
et al. used a somewhat different approach to explain this sequence. 
239 
They examined bone turnover rate and concentration of Pu on the bone 
surface. Bone turnover rate was determined by labeling the bone surfaces 
63 
with tetracycline in a 7-5-7-5 regime. Here the attraction of tetracy-
cline to surfaces involved with active turnover is used. The treatment 
plan was seven days of tetracycline injections, five days rest, seven 
days tetracycline injections, five days rest, then sacrifice, called the 
7-5-7-5 regime. Two labels meant active turnover throughout the treat-
ment time in these beagle dogs and one label indicated turnover was only 
proceeding in one portion of the regime. No label, of course, indicated 
lack of turnover during this time span. Beagle dogs used in this study 
/ 239 
were young adults injected with ~ 0.016 ^Ci/kg of Pu(IV) in the citrate 
form, then serially sacrificed. Twenty-four days prior to sacrifice, 
tetracycline injections were initiated. Areas of tetracycline uptake 
glowed under ultraviolet light, expediting counting of these areas. They 
found both bone turnover rate and plutonium concentration were dramatically 
higher in the portions of bone where the greatest number of osteosarcomas 
have been observed. This study is still in progress as this manuscript 
is being written, but the results thus far are conclusive enough to be 
included in their present form in the discussion here. One point to be 
considered is time cf irradiation of these endosteal tissues versus total 
dose to the endosteal tissues. Although the concentration of plutonium 
on the endosteal surfaces was higher at the time of sacrifice of the 
animals (7-56 days post injection thus far) for the areas of highest inci-
dence of osteosarcoma, this concentration could actually drop below the 
level realized in portions of bone of lowest incidence of osteosarcome 
due to the vast differences in bone turnover rate between the two. There-
fore one could imagine the total dose, t = 0 to infinity, could be greater 
for the bone with longest turnover rate. Since highest osteosarcoma inci-
dence occurs in bones with the shortest turnover rate, where the dose 
could drop below those bones with longest turnover rate, it is conceivable 
there is a critical time span, immediately after injection (or exposure 
in an industrial accident involving humans) when the dose deposited is 
much more effective with respect to tumor induction. Another explanation 
is that any malignant change would be manifested more rapidly in an area 
of high mitotic activity such as is the case in the lumbar vertebrae, 
pelvis and proximal humerus trabecular surfaces than in the distal humerus 
and proximal ulna trabecular surfaces, areas of depressed mitotic activity. 
Regarding the production of the osteosarcoma, the endosteal surface 
of bone has been shown to be the most likely location of the induction of 
O1 or 119 
this tumor (ICRP), (Spiers). Mole has proposed the interesting 
hypothesis that the endosteum, considered as a whole organ, has the same 
sensitivity to the induction of bone tumors in every species. This can 
112 
be interpreted two ways (Mole). Either every species has the same 
number of cells at risk, regardless of the size of the skeleton, or the 
cells at risk in the larger animals are somehow less sensitive to turnover 
induction than the cells of smaller animals. This latter interpretation 
could be indicative of some means of suppressing neoplasia in the larger 
animals. The data supporting this view best are the simple relations ob-
tained in the dose-response relationship of beta particles in bone. In 
the dog and mouse the probability of tumor induction per day followed the 
simple relations, a constant multiplied by the square of the number of 
beta particles released during the tumor induction time (time from injec-
65 
tion of beta emitter to death less the time from tumor appearance to 
death). The constant was remarkably similar in these two dissimilar 
-31 -1 -31 -1 
species, for dog, 0.9 x 10 day and for mouse, 2-3 x 10 day 
The square of the dose is suggestive of the two-hit mechanism of chromo-
some damage by beta particles. For high LET radiation, like alpha par-
112 
tides, Mole believed a one-hit mechanism more applicable but could 
not find a relation for alpha particles as seemed to be possible for beta 
particles. 
When considering plutonium deposition in bone, one quickly finds 
there is quite an array of parameters determining the degree and rate 
239 
with which Pu reaches the bone. These are the species of animal 
1 1 1 1 18 
(Vaughan et al.), age of animal (Vaughan et al.), (Jee), (Durbin), 
mode of entry (Thompson), (Bair), (Jee), (Vaughan et al.), chemi-
n/ 07 1 Q O C\ 1 
cal form (Bair), ' (Durbin), ' (Vaughan et al.), chemical state 
1 O O/ O ^ O T 
(Durbin), (Scott et al.), particle size (if insoluble) (Bair), ' 
(Thompson) and the physiological state of the animal (Durbin). °>^U>Z1 
There has also been discussion on the use of therapy to remove plutonium 
f- . s 26,27,29 ,^ . . , N 123 
(Lafuma), ' » (Markley et al.). 
239 
Translocation describes the movement of Pu from one location in 
vivo, possibly the point of deposition, to another location. Of primary 
interest here is the translocation to bone but it could be mentioned 
that translocation to other parts of the body is also important (Dur-
20 239 
bin). For a wide range of animals with Pu administered in soluble 
form (either nitrate or citrate) the following modes of administration 
proved to provide translocation to the bone, ranked from the greatest 
66 
11 
degree of translocation to the least (Jee) : intravenous == intraperi-
toneal injection > subcutaneous injection > intramuscular injection > 
intratracheal implantation > inhalation > oral administration > direct 
application upon unbroken skin. Although many of these routes of entry 
are very inefficient in delivering plutonium to the skeleton, osteosar-
coma has been induced by all the various modes, with the exception of the 
direct application of the plutonium to unbroken skin. 
239 
In order for the Pu to be deposited in the skeleton, it must 
18 19 22 
first reach the blood to be transported to the skeleton (Durbin), ' ' 
10 1 / Q 
(Stover and Jee), (Vaughan et al.), (Taylor). The question then 
arises as to the form and chemical state in which plutonium exists as it 
239 
travels in the blood. It appears the chemical state of Pu is the same 
in vivo regardless of the chemical state of the administered soluble plu-
24 48 
tonium (Scott et al.). This state is the +4 oxidation state (Taylor). 
The studies of Arnold and Jee indicate that plutonium tends to 
be adsorbed on mineralized oseous surfaces. Additionally, they believe 
the plutonium exists as a colloid which diffuses into the bone, adhering 
to the first mineralized surface encountered by the process of colloidal 
adsorption. 
Once the plutonium has been deposited on the bone surfaces after 
injection, bone apposition can occur burying the old, labeled bone with 
new bone. This new bone appears on autoradiographs as a region of diffuse 
labeling next to the intensely labeled original bone surface. The concen-
tration of plutonium in the new bone, formed after injection, is dependent 
upon (1) the level of plutonium in the extracellular fluid, which depends 
on time after administration, (2) the chemical affinity of the particular 
surface for plutonium and (3) the rate of apposition of new bone at os-
seous surfaces (Arnold and Jee). 
In a previous section we mentioned the unusual role of the osteo-
clasts in plutonium metabolism. Osteoclasts tend to concentrate plutonium 
as they perform the function of bone resorption. Upon engulfing the freed 
bone fragments from a resorbing bone surface, the osteoclast dissolves 
and excretes or metabolizes the bone fragment. However, the plutonium 
particles cannot be reduced by the mechanisms available to the cell. 
Therefore the plutonium not only remains as a colloid but grows in size 
and accumulates, within the cell. The concentration within an osteoclast 
can be much greater than the concentration of plutonium on the bone sur-
face because plutonium from a reasonably large surface area can be con-
tained in one osteoclast (Arnold and Jee). As time progresses, osteo-
clasts continually concentrate plutonium which is later transferred to 
macrophages. Reviewing, once the plutonium has been deposited on the 
bone surface (it does not tend to diffuse into old bone) , it either 
(1) stays, (2) is removed by osteoclastic resorption, or it is (3) buried 
by apposition of new bone (indicated by diffuse labeling) (Arnold and 
Jee), (Jee), (Jee et al.). 
239 
Further studies showed Pu seemed to be tracing the metabolic 
22 1 
pathway followed by iron in the body (Durbin), (Vaughan et al.), 
124 
(Stover et al.). Since iron is moved throughout the body by the iron-
239 
transport protein transferrin, than Pu may also be moved by the same 
mechanism. Three factors that need to be explained in any reasonable 
68 
explanation of plutonium distribution in bone are: (1) the long-term 
239 239 
low level of free Pu in the blood, (2) the deposition of Pu on 
239 
bone surfaces and (3) the initial, early presence of Pu single alpha 
tracks in the marrow that gradually disappear. The transferrin bound 
plutonium theory accomplishes this in the following manner (Durbin et 
22 239 
al.). If Pu is administered in a form that can interact readily 
with plasma proteins, it becomes bound in a manner such that the Pu-TF 
(TF = transferrin) and Fe-TF bonds are isostructural but the Pu-TF bond 
is slightly less stable than the Fe-TF bond. It is known that the iron 
is released in the marrow where it is used in the synthesis of hemoglo-
bin. The release occurs on the surface, or very near the surface of 
reticulocytes located in red marrow. Thus the marrow possesses a ready 
239 
made mechanism to release the Pu from transferrin. Instead of being 
239 
transferred to the interior of the reticulocyte, Pu follows one of 
three fates. First, it could be re-bound to transferrin, second, it 
could diffuse to the nearest bone surface and be bound there, or third, 
it could be released to the blood and circulate as free plutonium. Thus, 
22 
this mechanism delineated by Durbin et al. also seems to account for 
the established facts. 
The degree of translocation to bone would then hinge on the abil-
ity of the chemical form to interact with the transferrin molecule. The 
18 1 
data seem to support this hypothesis (Durbin), (Vaughan et al.), see 
1 o 
Table 2 (Durbin). The values in each row of the table do not add up to 
100 percent because some of the plutonium was retained in other soft 
tissues. 
69 
Table 2. Distribution of Plutonium in Rats 4-8 Days after 
Intravenous Injection of Either Soluble Pu Com-
plexes, Hydrolyzable Pu Salts or Prepared Pu 
Colloids (Durbin)18 
Pu Preparation Pu Content (% Injected Dose) Excreta 




3%1 9 0.6 55 27 
Pu(VI) citrate 9 0.5 56 14 
239Pu(IV) citrate, 
Hydrolyzable Salt 
3%1 10 0.7 57 12 
18 239Pu(III) chloride 23 0.7 45 
239Pu(VI) nitrate 28 0.4 44 
"*Pu(IV) nitrate 40 1.2 29 
7 39 
Pu(II.I) chloride 40 0.7 36 
239Pu(IV) nitrate 64 0.8 13 
Prepared Colloid 
239Pu(IV) citrate, 
0.1%, pH 5 78 1.7 13 
239Pu(IV) carbonate, 





Percent by weight of citrate. 
Those compounds existing in a complexed form can interact easily with the 
protein since complexing shields the plutonium ion from hydrolysis. A 
free plutonium ion generated from a salt, any of the (III), (IV) or (VI) 
forms, will undergo hydrolysis leading to polymers, e.g. [Pu(OH)? ] 
48 
(Taylor). The degree of hydrolysis depends on such factors as pH, 
concentration of plutonium, temperature and the presence of other ions 
48 
(Taylor). Therefore, salts would be expected to demonstrate a somewhat 
erratic behavior i^ vivo depending upon the degree of polymerization 
existing in the injected solution. This is in agreement with the present 
experimental data. The higher the polymerization, or the presence of 
colloidal particles, the more effective the filtering action of the liver 
1 O 
(Durbin). The chemical state also can cause variations in the degree 
of translocation from the point of entry to the blood, and consequently, 
41 19 
to the skeleton (Thompson), (Durbin). This effect would only be mani-
fested when the route of entry was one other than injection, e.g. by in-
halation or a puncture wound. It was shown that the smaller ion diameter, 
i.e. the greater the positive charge, the larger the percentage of the 
injected dose that will be deposited in bone and the smaller the percentage 
19 
deposited in liver (Durbin). The increase in solubility and decrease 
in basicity resulting from decreasing atomic size was suggested to be 
causing this effect. 
The route of entry is significant not only in determining the degree 
of plutonium uptake but also it is a controlling factor in the initial di-
41 
distribution of the plutonium (Thompson). Factors such as age, presence 
of acidity, presence of Pu(VI) and presence of complexing agents (citrate) 
71 
can greatly alter the pattern. For example, in rats administered pluton-
ium in a soluble form by ingestion, the fraction absorbed from the GI 
tract to the blood is about 3 x 10 . By adding Pu(VI) and high acidity, 
pH 1, this factor can be increased by a factor of about 630 to 0.019 
41 
(Thompson). Also, other effects can cause variation in the fraction 
absorbed from the GI tract to the blood, f . If some damage has been in-
flicted upon the GI tract such that abrasions exist in the walls of gut, 
the f value tends to increase. 
w 
239 
With respect to age differences, the initial distribution of Pu 
from liver to bone is more marked in juvenile animals than in the adult 
(Vaughan et al.), (Jee). For example, if sheep are injected with 
239 
Pu(IV) citrate intravenously, at age 23 days (lamb) 62.2 percent of 
the injected dose is retained in the skeleton but only 8.6 percent is 
found in the liver. But if injection occurs at age 180 days (sheep) 36.0 
percent of the injected dose is found in the skeleton and 12.6 percent in 
the liver, a less drastic distribution between bone and liver (Vaughan et 
al.). This means for one given dose, the juvenile will possibly receive 
a greater absorbed dose (rads) to the skeleton than will the adult. Some-
times differences in distribution can be great for one mode of entry even 
164 
within a particular species (Norwood and Newton). 
When considering the inhalation method of exposure, which is so 
important in the industrial accidental exposure analysis, the number of 
variables involved makes the determination of translocation and long-term 
distributions quite difficult. Not only are the chemical form, particle 
size and shape important here, but in the case of the oxide even the method 
Of. 
of particle preparation was shown to be a factor (Bair). Experiments 
35 
with beagle dogs using the inhalation mode of entry (Bair et al.), 
n£ 0-7 00 
(Bair), ' (Thompson et al.) have shown that a small particle size 
for the oxide favors translocation to other tissues. The first experi-
35 239 
ment of the group just mentioned (Bair et al.) used PuO? aerosols 
ranging in size from 0.2 to 7.6 microns mass median diameter (MMD) admin-
istered by a single exposure to their dogs. The particles with a MMD of 
5-7 microns yielded a greater lower lung deposition than the particles 
with a MMD of 0.2-2 microns because the latter had a greater tendency to 
be exhaled. The larger particles tended to be deposited in portions of 
the respiratory tract where clearance processes were not very effective. 
The greater deposition observed with the larger particles and greater 
translocation noted with the smaller particles caused the larger particles 
to have a longer retention in the lung and therefore become the more haz-
35 
ardous of the two. Bair et al. ' attributed the greater translocation of 
the smaller particles to two factors, the increase in the surface to 
volume ratio as particle size decreases resulting in greater solubility 
of the smaller particles and the probability that very small particles 
can be translocated, in tact, in vivo by phagocytosis. The importance of 
the chemical form in determining the magnitude of translocation and final 
distribution for the inhalation route of entry has been recognized (Vaughan 
-1 Q £. O "7 Q Q / ~\ Q £. Q "7 
et al.), (Bair), ' (Thompson et al.), (Thompson). Bair ' has 
examined the relative results obtained for several different compounds 
administered to dogs by the inhalation mode of administration. He used 
239 239 239 
Pu(N0,),, P U F A a n d f o u r oxides of the formula PuO^. The oxides 
differed by the method each was synthesized. The two methods used to 
make these oxides were calcining of the oxalate and oxidation of the 
delta phase form of the metal. The first method was performed at two 
temperatures, 1000 C and 350 C and yielded particles of 0.5 micron CMD 
(2.8 microns MMD) and 0.45 micron CMD (2.8 microns MMD), respectively. 
The second method was carried out at 450 C and 123 C and yielded par-
ticles of 0.50 micron CMD (4.8 microns MMD) and 0.46 micron (1.3 mi-
crons MMD), respectively. The nitrate particles were 0.12 micron CMD 
and the fluoride particles were 0.2 micron CMD. The results for the ni-
trate at one month were as follows: the lung contained 60-70 percent of 
the injected dose, bone 20 percent and liver 12 percent and from 75-119 
days, the lung contained 30-40 percent, 20-50 percent in the skeleton 
and 5-10 percent in the liver. Whole body retention had a half-life of 
400-1000 days and lung retention was 100-200 days. The fluoride yielded 
somewhat different results as would be expected. Here 70-80 percent re-
mained in the lung at three months, 20 percent went out in the feces, 2-9 
percent in the urine and less than 2 percent in other tissues with the 
skeleton retaining more than the liver. Whole body retention proceeded 
with a half-life between 127 and 405 days and lung retention with a half-
life of 78-266 days. The oxides all maintained a whole body retention 
between 1000-3400 days except for the 350 C calcined oxalate particles 
which had a whole body retention between 300-400 days. All the oxides 
yielded lung deposit of 90+ percent except the 350 C calcined oxalate 
particles where the lung deposit was 80-87 percent of the inhaled pluton-
ium. Translocation was greatest for the 350 C calcined oxalate particles 
and least for the 1000 C calcined oxalate. The long-term retention of the 
74 
oxide was clearly demonstrated here as a gradual accumulation in the 
tracheal-bronchial lymph nodes. The toxicity of the 350 C calcined oxa-
late particles seemed less than the toxicity of the other oxides due to 
the higher translocation and excretion rates. 
239 
To illustrate the species differences in the distribution of Pu 
in vivo let us examine the distribution occurring in several animals and 
1 21 
man, see Table 3 (Vaughan et al.), (Durbin). The dog and mouse data 
compare quite well but the man data show a more even distribution between 
the liver and skeleton. For 5-15 months in man, the situation had not 
changed drastically. Here 47.5 percent remained in bone and the liver 
concentration had increased slightly to 31.2 percent. (The increase in 
the liver concentration was offset by a decrease in the soft tissue con-
21 
centration (Durbin). ) 
Now a more complete picture of the problems associated with the 
internal deposition can be appreciated. The number of variables is large 
and each combination can result in a different probability of transloca-
tion and distribution within the body. Translocation occurs at a differ-
ent rate in different animals. But even for the same animal at the same 
age and general state of health, translocation occurs at a different rate 
239 
for different chemical compounds of Pu, different chemical states of 
239 
Pu and different routes of admission as well as varying tissue distri-
butions once initial deposition has been completed. Polymeric plutonium 
favors liver deposition whereas monomeric plutonium (transferrin bound) 
favors skeletal deposition. Injection favors a liver-bone deposition 
239 
whereas inhalation of Pu preferentially deposits mainly in the lung. 
75 
239 Table 3. A Comparison of the Species Variation Seen in Pu 
Distribution When Administered Intravenously in Citrate 
Form 




% of Injected Dose 
Bone Liver 
Rat Pu(IV) Citrate 
Mouse Pu(IV) Citrate 
Dog Pu(IV) Citrate 




8 days 50 10 
5 days 65 22 
29 days 62 22 
4-6 days 53 27 
4 days 43 
NOTE: Rat, mouse and dog data from Vaughan et al. ; man data from 
Durbin.21 
76 
So, some of the greatest problems associated with plutonium are those 
239 
concerned with establishing the critical organ for Pu. At present 
the bone is considered as the critical organ for all soluble intakes of 
239 • , 120 
Pu and the lung for insoluble intake by way of inhalation (ICRP). 
Arguments now exist to set the lung as the critical organ for all inhala-
37 
tion exposures (Bair), the liver for long-term exposure (low level) in 
20 21 
man (Durbin) ' and possibly a different, unspecified, critical organ 
for juveniles (Vaughan). Of course, more accurate microdosimetric tech-
niques would aid in the solution to these problems by providing quanta-
tive numbers to support each of the above claims, or reject them. Better 
dosimetric techniques would also give a more accurate estimate of the 
239 
toxicity of Pu. This toxicity will be discussed in the next section 
and our microdosimetric technique applied to bone will be discussed in 
the next chapter. 
3.2 Plutonium Toxicity 
Plutonium seems to have become a word capable of eliciting remarks 
such as the most toxic substance known to man from certain segments of 
our society. Whether or not this statement is literally true remains to 
239 
be shown but surely no one would question the fact that Pu is a highly 
239 
toxic substance. Small amounts of Pu that can hardly be detected by 
means other than measurement of the radioactive decay of the mass present 
(on the order of micrograms) have been shown to be capable of producing 
Q 11 Of. 
fatal results in experimental animals (Mays and Lloyd), (Jee), (Bair), 
41 
(Thompson). Plutonium-239 derives its high toxicity from several char-
239 
acteristics, mentioned in previous sections. First, Pu is an alpha 
11 
particle emitter with a specific activity greater than alpha emitters 
235TT . , , 238^ . 241. 
such as U but less than other alpha emitters such as Pu and Am. 
239 
Thus Pu is capable of dispensing large amounts of energy in a small 
volume (of radius about 35 microns) due to the emission of this densely 
239 
ionizing but short-range particle. Second, Pu possesses the unfortu-
nate characteristic of concentrating in bone preferentially around the 
cells which are the most susceptible to undergoing neoplastic change 
IT 0 / OO A/ 1 
(Jee), (Scott et al.), (Durbin), (Evans), (Vaughan et al.). 
239 
Finally, once deposited in the bone Pu tends to be removed at a very 
slow rate, with a half-time for removal about 200 years for bone and 
120 20 21 
about 178 years for the whole body in man (ICRP). Durbin ' has 
found somewhat different values for man. She determined the biological 
half-times to be 88 years for the skeleton and 204 years for the whole 
body. 
239 
Looking now at the effects of the deposition of Pu in man we 
find that the only work in the field has been derived from animal studies. 
This is because to date no serious exposures have occurred in man which 
239 
involved a large enough deposition of Pu to cause detectable effects 
for the population size considered and, therefore, one had to fall back 
on animals. This fact is presumably due to the extraordinary precautions 
imposed when plutonium is expected to be present in any activity. The 
many animal studies mentioned earlier have permitted examination of dif-
ferent parameters concerned with animal exposure to plutonium. The most 
significant biological effect detected thus far of plutonium as a bone 
seeker is its ability to induce carcinogenic transformation in the cells 
78 
at risk (Vaughan). Although other severe effects have been noted such 
as severe aplasia of the marrow and dysplasia of the bone (fractures, 
changes in bone growth, etc.) none of these has been noted at less than 
the carcinogenic dose. The most sensitive indicator of the presence of 
239 
Pu deposited in bone, i.e. the effect observed at the lowest dose, is 
1 12 
the incidence of osteosarcoma (Vaughan), (Stover and Jee). But death 
occurs in the shortest time due to lung effects induced by the inhalation 
mode of administration (Bair) ' for beagle dogs and comparable amounts 
of administered plutonium as in the injection studies. Osteosarcomas can 
be induced at extremely low absorbed doses. In the rat, only 3.6 rads to 
the skeleton (averaged over the skeleton) was required to induce an osteo-
sarcoma (Jee). 
The animal used throughout the work at the University of Utah was 
the beagle dog. Plutonium-239 was administered by the intravenous injec-
239 
tion of Pu(IV) in the form of a citrate and maintained at an acidic pH 
12 
(Stover and Jee). Initially they used many different injected activity 
levels ranging from 0.016 ^Ci/kg to 2.9 ^Ci/kg but were forced to use 
still lower levels when osteosarcomas appeared at the lowest level (Stover 
125 
and Stover). Finally levels as low as 0.00064 ̂ Ci/kg were used. The 
0.016 p,Ci/kg level corresponds to about 25 times the present MPOB in bone 
239 / 
for Pu, i.e. 0.04 p,Ci and 0.00064 ̂ Ci/kg corresponds to about one MPBB. 
239 
The various levels of Pu injected in successive runs were as follows 
in Table 4. 
239 
Table 4. Injected Activities of Pu(IV) Citrate in 
University of Utah Dogs (Stover and Stover)125 
Dose Level Injected Activity 
39Pu-cit 
(nCi/kg) 











NOTE: Original dose levels used in the early studies are 
indicated with an integral "code number." 
80 
239 Four principal effects were observed in the dogs injected with Pu(IV) 
12 
citrate (Stover and Jee) : (1) osteosarcomas were observed over the 
entire injected range from dose level 1-5, (2) hepatic lesions and/or 
changes were observed over the range, dose level 1-5, (3) lifeshortening 
was observed from dose level 1.7 to 5, and (4) hematologic changes were 
observed from dose level 2-5. Although these data seem quite conclusive 
concerning osteosarcoma, it must be recalled these exposures were given 
in an acute manner. Here the incidence of leukemia was such that osteo-
sarcoma was the major cause of death. For a chronic, low-level exposure 
it seems just the opposite is true, leukemia ordinarily becomes the major 
O 1 
carcinogenic hazard (ICRP). Aside from the cancerous effects induced 
in the University of Utah dogs, other less toxic malignant consequences 
239 
of the intravenous injection of Pu(IV) citrate were noted (Taylor et 
-i nf. 
al.). At the fifth level a significant number of pathological frac-
tures was noted. The earliest occurred approximately 390 days post-
injection with an average skeletal dose of 3180 rads. The number of these 
fractures decreased until a threshold seemed to be reached at around dose 
level 4 (0.91 ^Ci/kg) where only one fracture was observed in seven life-
span dogs. Most of the fractures developed in the ribs and thoracic 
vertebrae with very few being produced in the weight-bearing bones. 
239 
Another effect of Pu in these studies was an increased incidence of 
tooth loss. A detectable increase above the natural incidence was noted 
down to dose level 1.7 (0.048 ĵ Ci/kg) . The sites of earliest loss were 
generally the first incisor and the second premolar in the upper arcade 
and the first incisor and the third molar in the lower arcade. Although 
81 
an increase in soft tissue tumors was noted at about 3-20 percent greater 
than controls, some doubt was expressed as to whether this increase was 
actually plutonium-induced. In any event, lymph node hyperplasia was 
observed in some dogs injected at dose level 1 to 1.7 (0.016 to 0.048 
^iCi/kg) after relatively long latent periods, but these did not undergo 
neoplastic change. The difficulty in determining the increase in tumors 
in soft tissue was due to the bias introduced by the shortened lifespan 
of the irradiated dogs. Although the level of plutonium in the kidney 
was ten times the plasma level, no neoplasms were observed throughout the 
entire injected range. There were some hot spots noted in the kidney 
which seemed to account for much of the kidney burden. The few plutonium-
induced lesions observed, always occurred adjacent to these "hot spots" 
(Taylor et a l . ) . 1 2 6 
As a side note, the data for dose levels 0.1 to 0.7 will not be 
available for some years to come due to the long lifespan of the beagle 
12 
(Stover and Jee). 
The studies of Bair, Thompson and Clarke at Hanford have been 
concerned with administration of plutonium by inhalation. They have ex-
amined the change in effects observed with parameters such as chemical 
form and physical state. These studies are of particular interest because 
it is felt that the inhalation route of exposure is the one most commonly 
encountered in human exposure as a result of industrial and military ap-
plications of plutonium as well as environmental contamination (Thomp-
son), (Bair). ' Plutonium can cause different effects to occur in 
the experimental animal depending on the form in which it is inhaled, 
i.e. chemical form such as nitrate, oxide, fluoride, etc. and particle 
82 
size. Soluble plutonium nitrate has a greater chance of causing damage 
to bone and liver due to its greater capacity to translocate to other 
areas of the body. In the insoluble oxide form the plutonium does not 
have as much tendency to translocate, so the effects of this form of 
plutonium are mainly confined to the lung and tracheal-bronchial lymph 
37 
nodes (Bair). A summary of the effects seen in lungs due to an expo-
239 
sure to PuO? particles 0.1 - 0.6 p/n count median diameter (CMD) in 
37 
dogs at an acute, high activity level are as follows (Bair). Immedi-
ately after exposure, the activity was distributed throughout the lung 
evenly but after seven days conducting and respiratory vessels were devoid 
of activity. After this time the remaining medium and large particles 
not removed by ciliary action were located mostly in the walls of the 
terminal bronchioles and the smaller particles in the lower part of the 
lung. Except for hyperplasia in some of the alveolar cells and some loss 
of mature bronchial lymph node cells, no clinical symptoms were visible. 
Almost all the plutonium particles had been phagocytized by macrophages 
at this time. At seven days the dose to the lungs was about 150 rads. 
Between 14 and 30 days hyperplasia had increased and the beginnings of 
peribronchiolar fibrosis were noted. By 30 days (D = 700-1900 rads) 
peribronchiolar fibrosis could be seen at many foci, numerous macrophages 
were present and inflammation could be noted. After 65 days alveolar 
cell metaplasia could be seen and was especially heavy in the locations 
239 
of maximum deposit of PuO„ (D = 4000-13,000 rads). The bronchial 
lymph nodes were showing necrosis with only small islands of lymphatic 
tissue remaining. Between 124-384 days metaplasis was severe around the 
alveolar cells and could be seen localized around some of the bronchioles. 
Scars were visible as well as hemorrhage in the lung itself. Fibrosis in 
the bronchiolar epithelium was quite severe by now as well as in the alve-
olar cell region. Beginnings of the transformation from metaplasia to 
neoplasia could be noted in many regions. By 855 days fibrosis was promi-
nent and early bronchopneumonia was detectable in one lobe. Some of the 
other effects of this alpha irradiation were an increase in respiration 
rate as death approached, a change in the blood gas level (oxygen content 
decreased and carbon dioxide content increased), weight loss, and finally 
a decrease in the immune response. Three modes of death were noted in 
nf. 
these dogs by Bair. The first was an acute form of death characterized 
by severe inflammation, edema and destruction of vital lung tissue occur-
ring only at high exposure levels. Death occurred in about one week at 
which time the animal simply drowned in its own fluid. The second mode 
of death occurred after about one to two months post-exposure and was 
also considered to be an acute death. Here fibrosis had time to form 
causing interference with normal breathing and contributing to destruction 
of lung tissue. For this mode, death occurred due to respiratory insuf-
ficiency just preceded by a decrease in the oxygen level in the blood, an 
increase in the carbon dioxide level and increased respiration rate. The 
third mode was considered to be sub-acute but somewhat similar to the 
second mode. Here again fibrosis formed but at fewer loci initially. 
But as time passed, fibrosis slowly involved the entire lung causing death 
by cardiopulmonary insufficiency in one to five years. In some of Bair's 
dogs, death occurred after three to six years by pulmonary neoplasia. He 
84 
also hypothesized a form of death occurring after many years due to the 
long-term low-level effects on the lung, bronchial lymph nodes and liver 
o r 
(Bair). His data seemed to indicate that a lung burden greater than 
0.1 [iCi/g lung would cause death in about one year from pulmonary insuf-
ficiency and a burden less than 0.1 jiCi/g lung would cause death by for-
mation of a pulmonary neoplasm. 
When estimating lung exposures from aerosols in man we employ a 
lung model. In 1966 a new lung model was proposed by ICRP Committee II 
127 120 
(Task Group) superseding the old one (ICRP). This new model divides 
the lung into three regions, the nasopharyngeal, tracheobronchial and 
pulmonary regions with pulmonary lymph nodes as a possible fourth region. 
These regions connect with one another and a cross-flow of material is 
allowed between them and the blood, the gastrointestinal tract and the 
lymphatic system. Here, considerations of the physical and chemical 
nature of the inhaled aerosols are included in estimating deposition and 
retention. All of the fractions of the inhaled aerosol initially appearing 
in the various regions are given as a function of particle size, varying 
exponentially with particle size, with the exception of the fraction 
passing through the nasopharyngeal region and depositing in the tracheo-
bronchial region. This fractional deposition is given as a constant, 
equal to 0.08. Since the masses of these regions are difficult to deter-
mine and they are structurally complex with many branching pathways, the 
Task Group did not discuss the problem of estimating the absorbed dose to 
these tissues. To obtain an idea of the approximate magnitudes of dose, 
one could refer to the curves in Morgan and Turner generated by W. S. 
Snyder under the normalized condition of 1 MeV energy/disintegration, a 
85 
standard particle size of 1 pm and 1 ^Ci inhaled. 
128 
When dealing with dose to lung tissue Cochran and Tamplin pro-
posed the necessity of considering whether the radionuclide was evenly 
dispersed or contained in areas of concentrated activity. This was the 
now famous "Hot Particle Theory" and qualitatively states "when a critical 
tissue mass is irradiated at a sufficiently high dose, the probability of 
tumor production is high." The issue seems to be settled now by majority 
opinion which states that, for an equal amount of activity a diffuse dis-
tribution seems more toxic than the same activity contained in many "hot 
spots." This could be caused by the extensive cell killing occurring 
near the hot spots which eliminates the cells from any possibility of 
undergoing the malignant change. Another possibility is that smaller, 
finely dispersed particles suffer less self absorption and affect a larger 
lung volume, hence causing a larger dose. 
In summary, the most dramatic effects of plutonium observed in the 
animal studies were the induction of (1) osteosarcoma, (2) leukemia, 
(3) carcinomas of the epithelial cells surrounding bone, and (4) liver 
lesions. These consequences were observed in the University of Utah 
239 
beagle dogs after intravenous injection of Pu(IV) citrate. When the 
mode of administration is inhalation, the most dramatic effects are fi-
brosis leading to death by respiratory insufficienty at a high level of 
exposure and pulmonary neoplasia at a low exposure level (less than 0.1 
|iCi/g lung tissue). These effects are of interest to researchers for the 
simple reason that they are all fatal to the animal. It is interesting 
239 
to note that 60 ^Ci of Pu in citrate form, i.e. in soluble form, ad-
ministered by inhalation to one dog and by intravenous injection to another 
dog resulted in the death of the first dog ten times sooner than the 
second dog. 
239 
The toxicity of Pu has been studied in animals at the University 
of Utah (Stover and Jee), (Jee), ' ' (Mays et al.) for deposition 
239 
in bone and liver by the intravenous injection of Pu(IV) citrate com-
pounds and for initial deposition in the lung at Hanford by Bair and 
^ L 31,33-38,45,46 _, . _ . 239„ , . 
Thompson and others. ' The toxicity of Pu and its rela-
tion to other nuclides can be shown by Table 5, drawn from Mays and 
8 
Lloyd, which shows percent incidence of osteosarcoma per rad of the 
nuclide. Mode of administration is by injection for every case except 
the Ra data for man which were ingested radium. This table not 
239 
only shows the high toxicity of Pu but alludes to the similarity be-
224 239 
tween the behavior of Ra and Pu for the female mice that occurs 
for the reasons previously mentioned. The University of Utah experiments 
are utilizing a unique method which they hope will lead to greater knowl-
239 
edge of toxic levels for substances such as Pu for which essentially 
no toxicity data exist directly. This goal can be expressed by the 
"11 C-* / 
following ratio (Stover and Jee), (Evans) : 
Toxicity X (beagles) _ Toxicity X (man) 
n O/ r\ r\ f 
Toxicity Ra (beagles) Toxicity Ra (man) 
where X is the nuclide for which the toxicity data are desired. This 
ratio is making use of the vast information available concerning radium 
exposure in man. Toxicity here is the activity required of a particular 
nuclide to cause a given endpoint. The idea is to determine the toxicity 
87 
Table 5. The Relative Effectiveness of Causing Osteosarcoma 
in Three Species of Animals for Several Bone-Seeking 
Nuclides (compiled from Mays and Lloyd") 
Animal Nuclide Osteosarcoma Incidence 





























1.3 ± 0.12 
1.1 ± 0.1 





of nuclide X and Ra in beagles by experiments to find the value of the 
ratio on the left side of the equal sign. This value could then be mul-
tiplied by the value of the toxicity of radium in man (e.g. in (j,Ci) to 
obtain the similar quantity for nuclide X in man. The assumption involved 
here, of course, that such an equality is in fact valid, is an unproven 
assumption at present. As a numerical example of the use of the above 
equation, let us consider that it has been found osteosarcoma can be in-
226 
duced by injected dose levels as low as 0.34 ^Ci/kg of Ra and 0.016 
239 81 
|iCi/kg of Pu (ICRP) . The left side of the above equation would then 
be about 0.047 or approximately l/21 for osteosarcoma in beagles. 
239 
There has been interest in finding a method to treat Pu expo-
sure due to the consequences of intake of even small amounts of this sub-
Of. _ r>r\ o o A i 
stance (Lafuma and co-workers, (Thompson et al.), (Thompson), 
(Vaughan et al.) and (Markley et al.). Working in France, Lafuma has 
been particularly interested in this area. Some of the substances used 
were zirconium citrate, EDTA and DTPA. The one proving to be most effec-
tive was DTPA (diethylenetriamine-pentaacetic acid) (Thompson). Lafuma 
stressed the need to begin treatment immediately after the accident oc-
curred, even before the magnitude of contamination has been determined. 
When treatment was initiated immediately after exposure in rats adminis-
239 30 
tered Pu(N0„), by intramuscular and inhalation contamination (Lafuma), 
239 
a reduction in the Pu content i_n vivo by a factor of 4 for the case of 
intramuscular injection and by a factor of 8 for the lung administration 
pathway from that present in controls was effected. Lafuma and co-workers 
stated that DTPA acts in two ways to reduce the contamination by prevent-
ing further bone deposition and by acting directly on bone to remove the 
89 
29 
contaminant (Nenot et al.). They also recommended a treatment procedure 
9 A 
(Lafuma ). If the contamination is particulate in nature, DTPA is in-
effective and physical removal is the only possible course (e.g. lung 
lavage). Therapeutic treatment consists of a three step procedure: (1) 
administer DTPA locally and generally immediately after contamination, 
(2) if a port of entry is present, remove as much contamination as pos-
sible by physical means, such as surgery or lavage, and (3) if contamina-
tion persists, begin a chronic treatment, the magnitude and duration deter-
mined by the results of radiological examination. 
One method of quantitative evaluation of the toxicity is by calcu-
lation and comparison of maximum permissible body burdens (MPBB). The 
maximum permissible organ burden is obtained by determining the fraction, 
f9, of the radionuclide in the particular organ to that in the total body 
and multiplying the MPBB by f„. 
The maximum permissible body burden for a bone seeking radionuclide 
is set by the relative effect of the radionuclide considered in bone as 
compared to radium. Radium-226 was chosen as the standard because of the 
large quantity of existing human data (Morgan and Turner), (Evans) ' 
60 239 
and (Hasterlik). For Pu the maximum permissible body burden (based 
120 
on bone as the critical organ) is 0.04 |j,Ci (ICRP) . A number similar to 
this can be calculated by the usual method to determine the maximum permis-
sible organ burden, i.e. one calculates the deposited activity (Ci) which 
will deliver the maximum permissible dose rate to the critical organ. 
239 
This will now be calculated for Pu. First we need to calculate E 
o o q c "7 
(MeV/dis x rem/rad) for Pu (Morgan and Turner) : 
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where 
f. = probability per disintegration of producing radiation type j 
F.. = fraction of the energy from j absorbed in organ i 
E. = energy (MeV) absorbed per disintegration 
Q. . = quality factor and is a function of radiation LET 
N = relative damage factor = 5 for bone-seeking alpha emitters 
when radium is not the parent nuclide and is 1 otherwise. 
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Plutonium-239 emits several possible alpha particles in its decay to U, 
Uranium-235 is sufficiently long-lived in comparison to the half-life of 
239 
Pu and the life span of man that its radiations need not be considered, 
Also, Q = 10, for alpha particles, F.. is 1 and the mass of the skeleton 
is 7000 g so that 
E' = (1) (10)(5)[(0.733) (5.157 MeV) + (0.151) (5.145 MeV) 
+ (0.115) (5.107 MeV)] 
= 257.2 MeV/dis x rem/rad. 
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According to the recommended procedure (ICRP), the bone is allowed to 
receive 30 rem/yr for occupational exposures. This yields finally 
= Q jiCi x 3.7 x 10 dis/sec-jiCi x 257.2 MeV/dis x rem/rad 
yr 
x 8.64 x 10 sec/day x 365.25 day/yr x 1.6 x 10 erg/MeV 
v 7000 g x 100 erg/g-rad 
where 
Q = maximum permissible bone burden = qf~ 
E= 0.04 ^Ci (ICRP gives this value as 0.036 p,Ci) 
239 
This value for the bone burden of Pu has been the center of dis-
239 
cussion in recent years. This value was calculated assuming the Pu 
239 
was distributed homogeneously throughout the bone, yet as we know Pu 
is distributed in a highly inhomogeneous fashion. Additionally, ICRP has 
recently proposed the quality factor for alpha particles be increased to 
114 
20 (ICRP). The 0.04 ^Ci value has remained in use depite the request 
of the ICRP to refine the MPBB for bone based on the dose delivered from 
0 to 10 microns removed from the endosteal face of osseous tissue 
114 (ICRP). Should improved methods of microdosimetry become available, 
such a revision could be envisioned. Whether dosimetry resulting in 
these measurements would cause the MPBB to be raised, lowered or remain 
the same is unimportant to this research. The important objectives should 
be to make certain the MPBB is based on a firm foundation. 
Several of the arguments of critics suggesting the lowering of 
129 
MPBB for bone are quite logical in their approaches. Edsall has sug-
gested we should set the standard of this nuclide in line with those 
standards our society currently accepts as permissible risks. He points 
out the 50,000 traffic deaths occurring each year, 100,000 deaths occur-
129 
ring per year due to occupational causes, etc. Edsall then mentions 
that at one MPBB for lung, approximately one person in eight will develop 
a lung cancer. If plutonium were a food additive this would certainly be 
considered an unacceptable risk according to present Food and Drug Admin-
istration practices which desire a new additive to cause much less than 
239 
two tumors per 1000 individuals. The value for Pu at one MPBB lung 
was one in eight or 125 in 1000. This appears to be a double standard, 
Edsall concludes (though no one proposes using plutonium as a food addi-
tive) . 
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Morgan offers four arguments which lead to a reduction in the 
MPBB by a factor of 240: (1) according to the Utah dog studies the rela-
tive toxicity of Pu to Ra should be 15 instead of the general value 
assigned to all non-radium bone-seeking alpha emitters of 5, a factor of 
3 correction; (2) the surface to volume ratio for the trabecular bone of 
239 
the dog is about twice that for man; therefore, the same amount of Pu 
in man would mean the trabecular concentration in man is twice that in 
the dog, a factor of 2; (3) the rate of apposition in dog bone is about 
239 
10 times that in man which would cause any Pu existing on the bone 
surface to be removed about 10 times faster in dogs to the less radio-
sensitive cortical bone, a correction factor of 10; (4) studies have 
shown that the baboon is about four times as radiosensitive as dogs when 
239 
dealing with PuO? inhalation. Since man is more similar to the baboon 
than the dog, a factor of 4 should be introduced. The total reduction 
would then b e 3 x 2 x l 0 x 4 = 240, which corresponds to a change in the 
MPBB for bone from 0.04 ^Ci to 0.17 nCi. 
239 
Now the need for better dosimetry of Pu as it resides in the 
bone becomes clearer than ever. If the requests of the ICRP to supersede 
the value of the MPBB for bone by a value not based on the admittedly 
incorrect homogeneous distribution assumption are to be fulfilled as well 
as the critics answered by improved quantitative data, a step must be 
93 
taken to acquire the desired dosimetric data. As this section points out, 
the toxicity of this nuclide is great, so a note of urgency should be 
added to the quest for this microdosimetric determination. Now that the 
groundwork has been laid and the need for the research contained herein 
has been established, the system used to determine the average dose to 
the endosteal surfaces of bone will be described. 
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CHAPTER IV 
THE CURRENT ELECTROCHEMICAL ETCHING SYSTEM 
4.1 Principles of Electrochemical Etching 
It has been known for many years that tracks will be left in some 
materials when irradiated by high LET particles and these can be prefer-
entially etched by appropriate chemical etching techniques (Price and 
131 
Walker). In more recent times, this technique has found use in a large 
number of areas including geology, space science and nuclear science 
132 133 
(Fleischer et al.) and (Iyer and Rao). There have been several 
134 
attempts (Boyett et al.) to explain the formation of tracks in solids 
but the one that seems to account for most of the observations in crystals 
135 
is the "ion explosion spike model" of Fleischer et al. According to 
this model, the ionizing particle traverses the solid, stripping away 
electrons from the atoms closest to the path of the ionizing particle. 
The result is many positively charged atoms very close together. These 
repel each other and move rapidly away from each other resulting in the 
track. The boundaries of the affected track region would then be in a 
state of stress which would explain the characteristic of the tracks 
being preferentially etched. A different mechanism would be expected 
in the case of foils composed of polymers such as polycarbonate. Here 
the high LET ionizing particles simply break the polymer chains as they 
traverse the foil. The broken ends of the polymer molecules would be 
left in a chemically reactive state including some radicals. Therefore 
the broken polymers may now be more reactive with the etchant solution 
than the unirradiated volume explaining the preferential etching of the 
track. The simple etch attack procedure for the development of damaged 
track regions was modified in the early seventies when a new process 
-j Q r 
was introduced by (Tommasino et al.) expanding the possibilities of 
etching. The new advances involved placing an alternating voltage across 
the cellulose nitrate or polycarbonate dosimeter to etch the damaged 
tracks in a 30% KOH solution; this procedure was called electrochemical 
etching. 
Improvements have been effected in the plastic foils since then 
49 
and attempts made to better understand the parameters (Sohrabi), 
137-141 142 143 144 
(Sohrabi and Morgan), (Beach and Becker) ' and (Somogyi et al.). ' 
142 
Beach and Becker showed Lexan polycarbonate could resolve tracks from 
143 
two fine U0 ? microspheres placed 5 [im apart. Somogyi et al. examined 
the effects of irradiation geometry, particle energy and environmental 
conditions on such parameters as optical density, etching time and track 
density for three foils, cellulose nitrate, cellulose acetate and poly-
carbonate . 
In 1975 a workable system was proposed with many of the etching 
49 
parameters optimized by Sohrabi. This system used a chamber containing 
two reservoirs of 45% KOH solution separated by the polycarbonate foil 
to be etched. Best results were obtained when an alternating potential 
of 800 volts was applied at 2 kHz for four hours. 
The system selected for the bone dosimetry application described 
here is a version of the Sohrabi-Morgan system (Morgan and Sohrabi). 
The equipment consisted of two plexiglas cylindrical chambers, each 4.8 cm 
long and 10.2 cm in diameter, see Figure 9. Seven 250 (j,m thick Trans ilwrap 
polycarbonate (Transilwrap Co., Doraville, Georgia) foils can be etched 
at the same time and are placed between the chamber halves on non-standard 
sized "0"-rings 1 inch O.D., 5/8 inch I.D. and 3/16 inch thick, con-
structed from neoprene sheets. The portions of the chamber are then 
placed together and bolted tight to insure that the chamber is water-
tight and electrically insulated by the foils themselves. The chamber 
is then filled with the 457o by weight KOH etchant solution at room temper-
ature, Figure 9. The high voltage is applied across the chamber by means 
of two stainless steel electrodes located in the far end of each chamber 
half. The high voltage is generated by an audio generator supplying the 
input to an amplifier of the push-pull type to maintain the necessary 
stability in frequency and voltage. A diagram of this circuit appears 
49 
in Figure 10 (Sohrabi) and a picture of the experimental setup in 
145 146 
Figure 11 (Stillwagon et al.). ' The voltage and frequency used 
throughout much of this study were 800 V at 2 kHz. After the desired 
etching time has elapsed, the foils are cleaned, removed from the chamber 
and prepared for counting. The track counting equipment used included 
a transparency projector, microfiche reader and the light microscope with 
phase contrast and oil immersion capabilities as well as one equipped 
with a Filar micrometer for track diameter measurements. 
The electrochemical etching technique of polycarbonate foils was 
selected to be applied to the bone dosimetry application considered 
herein over all other techniques because it fulfilled more of the desirable 
Figure 9. A Plexiglass Etching Chamber 
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Figure 10. Diagram of Electrochemical Etching System Used in This Study 
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Figure 11. Electrochemical Etching Apparatus Showing Etching Chamber, 
Audio Oscillator, Amplifier and Volt Meter 
characteristics for a bone dosimeter listed on page 37 than any other 
practical system imaginable. With reference to the criteria listed there, 
the advantages of this system over others will be analyzed point by 
point. 
1. The geometry of this system is such that the foils can be 
placed flush against the bone section, thereby allowing tracks 
from only the areas of bone under consideration to be counted. 
If a surface barrier detector was placed against the bone 
sample all alpha particles, regardless of origin on the bone 
sample, would be counted. In addition, it is virtually im-
possible to maintain a surface barrier detector coupled with 
a multichannel analyzer absolutely electrically constant for 
the long irradiation times required at the activity levels 
encountered here. Some photographic emulsions allow a similar 
close geometry. The liquid scintillator suspension technique 
described above suffers from the lack of spatial resolution 
since the sample must be taken whole to obtain sufficient 
activity for the operation of this technique. 
2. The sensitivity of these polycarbonate foils is believed by 
some to be somewhat less than that of emulsions but this 
prohibitively may not be so. It is certainly greater than 
that of the liquid scintillator suspension technique. 
3. Fading with time after irradiation is essentially nonexistent 
with polycarbonate foils. In fact, there is evidence that 
sensitivity may actually increase with time after irradiation 
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before etching. There is no possible fading at all after the 
foil has been etched. Emulsions suffer severely on this point. 
There is fading between irradiation and development, but worse 
it varies with many parameters and from batch to batch, e.g. 
storage temperature and length of storage. 
4. None of the present techniques involve any residual activity 
found in the detection system as is common with neutron activa-
tion methods. 
5. Each polycarbonate sheet used during this work was 24" x 48" 
cost two dollars and provided approximately 1000 foils per 
sheet. Possibly as many as 1500 foils were used during this 
entire project Clearly the cost is almost negligible. 
Photographic emulsions, on the other hand, would have required 
quite an investment if, say, 1500 NTA, 25 (jjn thick nuclear 
track plates had been used (current price: $12.10/plate, 
$18,150.00 with the total not including developing costs). 
6. The developing procedure for the electrochemical etching system 
is quite simple and data can be obtained by a novice his first 
try. It requires only about 5-10 minutes to perform and no 
time limits are required. The entire process is carried out 
in daylight at room temperature. Before using photographic 
emulsions, the developing process must be mastered. This re-
quires not only knowing the procedure involved, using developers, 
fixers, observation of dose time tolerances and maintaining 
careful temperature control, but also adeptness in the darkroom 
102 
since the process must be performed in darkness. During 
mounting of the bone samples and during exposure of the 
emulsions, darkness must be maintained unlike polycarbonate 
which requires no darkness at any time. Therefore there is 
no danger of losing a large quantity of data after a long 
exposure time due to a light leak with our system. Also 
emulsions must be maintained under refrigeration, especially 
if long term storage is required as is the case with low level 
bone dosimetry and controls must be run with each batch. 
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7. Our studies (Stillwagon et al.)> (Su et al.) have indicated 
2 
a constant background of about 2 tracks/cm on the foil surface 
when counting both sides of the foil. Since alpha particle 
irradiation produces tracks on only one side of the foil (the 
foil is infinitely thick to alpha particles) the background 
can be divided by two and becomes negligible for many applica-
tions. Emulsions, on the other hand, have a background that 
can be quite appreciable, though sometimes distinguishable, 
for older emulsions, emulsions improperly stored at a high 
temperature or emulsions improperly developed. It is evident 
that background can vary considerably from batch to batch. 
8. Both emulsions and polycarbonate can be used in large quantities, 
however the economics and ease in development favor polycar-
bonate . 
On consideration of these eight points, the electrochemical etching 
system appeared most attractive. Another point of lesser importance is 
the tissue equivalence of polycarbonate. In fast neutron dosimetry this 
property of polycarbonate was considered quite important. For the bone 
dosimetry application described in this paper, this property may only 
serve to allow one to mention that the tracks in the polycarbonate will 
be of the same shape, structure and length as those formed in tissue. 
For the purpose of track counting alone, this may not be of great im-
portance and so the non-tissue equivalence of the emulsion could be con-
sidered acceptable. Perhaps other, more theoretical uses of polycarbonate 
would make great use of the similarity of track structure here and in 
tissue when considering alpha particle irradiations. In fact the tissue 
equivalence of polycarbonate was used in this study and will be described 
in the next chapter (in the section concerning the two track sizes appear-
ing on our foils after alpha particle irradiation (Stillwagon and 
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Morgan) . It is possible the effect noted there would have never 
been observed using emulsions due to the heavy silver and halide atoms 
present. 
4.2 Further Electrochemical Etching Studies 
These studies were performed by the author and, in some cases, 
in conjunction with Mr. Shian-Jang Su. 
4.2.1 Foil Reading Methods 
Two new techniques were developed to facilitate counting of the 
polycarbonate foils. Both techniques employ optical devices almost every 
laboratory and university possesses in readily obtainable supply, a 
microfiche reader and an overhead (transparency) projector. These two 
techniques offer several advantages over the microscope for low count 
density and thick foils (Tripier et al.). Spark counting requires 
152 
very thin foils (Johnson and Becker) and techniques such as densitom-
etry measurements require a large number of counts (high dose). Advantage 
obtained by utilization of these two observation techniques over our 
earlier conventional microscope counting are: 
1. A larger foil area is actually counted; the overhead projector 
providing greatest viewing area, microfiche reader second, and 
microscope third. 
2,. Image is reviewed on a screen and not through an eyepiece 
causing less eye strain. 
3. Less time is required per foil for counting. 
4. No elaborate equipment is required other than these inex-
pensive pieces of equipment most institutions possess anyway. 
To facilitate counting with the transparency projector a grid was 
constructed on the screen upon which the image was projected, Figure 12. 
The grid consisted of two concentric circles of radius 4.3 and 7.0 cm on 
the screen which were cut into sectors with radii drawn every 20 (18 
total). These lines yielded 36 small areas which could be counted easily, 
their sum equaling the total number of counts contained within the en-
2 
closed area, 154 cm . The counts appear on the screen as black dots on 
a clear background so the viewer encounters little difficulty in recog-
nizing them. 
The procedure adopted to count foils by this technique was as 
2 
follows. The number of tracks within the 154 cm area was obtained, then 
the foil was randomly moved such that another portion of the foil was 
Figure 12 . Grid Used in Foil Counting 
106 
available for counting. This new section was counted then the numerical 
average of the two measurements calculated. It was the average of the 
2 
two countings we called the number of tracks in the 154 cm area. Foil 
magnification was 14X with a screen to projector distance of 5 m yielding 
track diameters of 0.6 mm. Of course almost any magnification could be 
obtained depending upon the distance of separation between the projector 
and screen. Figure 13 is a typical photograph of the overhead projector 
screen indicating results obtainable by this technique. The projection 
shown was found to have 685 counts within the encircled area. 
The second technique developed, the microfiche reader, offers 
other possibilities. The magnification produced by the microfiche reader 
was 53X, greater than the overhead projector. Track diameters were of 
the order of 2-4 mm. The procedure followed to count the foils involved 
placing a set of cross hairs on the microfiche reader screen, dividing 
the screen into quarters. First one quarter of the screen was counted, 
then the foil moved such that a different portion of the foil could be 
counted. This procedure was repeated until four counts were obtained, 
then a sum was calculated. Figure 14 illustrates the results obtainable 
by the microfiche reader for a foil determined to have 142 tracks on the 
entire foil. The actual area of the screen photographed was 17 by 13 cm 
and the horizontal line is a portion of the crosshair. Since the mag-
nification was 53X with the microfiche reader, the tracks were viewed 
in greater detail than when viewed with the transparency projector. 
The star-like outcroppings from individual tracks became visible, similar 
to the appearance of the tracks seen by the microscope. Also, not unlike 
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Figure 13. Portion of Transparency Projector Screen Showing 
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Figure 14. Photograph of Transparency Projector Screen Showing 
High Background Foil 
the case with a microscope, the focus on the microfiche reader can be 
adjusted so the plane of focus includes only tracks in one plane or on 
one side of the foil or the other. The tracks on the side opposite the 
side being viewed appeared as unfocused blurs. This would explain why 
some tracks were viewed sharply and others were out of focus in Figure 14. 
A smaller area of the total foil was visible on the microfiche reader 
than on the transparency projector screen but the tracks were more readily 
distinguishable from other stray marks on the foil. 
It is felt both of these techniques would speed up counting and 
greatly enhance the efficiency of eliciting data from the Lexan foils 
when large numbers of foils need to be counted. 
For reduction of the bone dosimetry data, however, the microscope 
was utilized. The higher magnification allows more precise counting of 
alpha particle tracks than the above methods, since these tracks are 
smaller than the fast neutron recoil particle tracks considered above. 
In addition, track diameter measurements were required and can be obtained 
more accurately with the Filar micrometer attachment on the microscope. 
Further, very small squares had to be counted on the foils exposed to 
our bone samples to calculate a statistical average of the counts. This 
can be easily accomplished by placing a Whipple disk in the eyepiece of 
the microscope. Out- m..£i •ror.r- was a Bau^ch find Lonnb WP6360 microscope 
capable of oro;rating with ph^st contrast and oil immersion objective 
(970X). 
4.2.2 Background Track Density Reduction 
Presence of a high background can sometimes be a problem with 
110 
polycarbonate foils. This problem is thought to occur as a result of 
two factors. Although the duration of a particular irradiation measure-
ment may be fairly short, the foil has been accumulating etchable back-
ground from both background radiation (cosmic rays, trace uranium, etc.) 
and surface abrasions since its production in a factory. Therefore, 
interest exists to maintain this background as low as possible. We have 
tried several methods, including annealing, washing with isopropyl alcohol 
and selection of a foil with an inherently low background. 
In our annealing experiments, six groups of foils, seven to a 
group, were heated to various temperatures for twenty minutes. Then one 
foil from each group was placed in the seven foil chamber along with a 
control which had not been annealed. Etching conditions used throughout 
this study were 
1. Etching solution - 30% KOH 
2. Voltage - 700 Volts 
3. Frequency - 2 kHz 
4. Etching time - 4 hours. 
It was found that a significant reduction in background and increase in 
overall track homogeneity resulted in the foils were washed with iso-
propyl alcohol and rinsed with distilled water prior to annealing. The 
six temperatures used to anneal the foils were 60 , 105 , 130 , 140 , 
155 and 170 C. The foils were counted with the microfiche reader and 
transparency projector. Finally, the data were arranged so that the 
counts for each temperature and control could be examined for the seven 
runs and an average value calculated and plotted, Figure 15. The 
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Figure 15. Percentage of Background Tracks After Annealing for 20 Minutes 
at Different Temperatures Before Etching 
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background in reference to controls dropped to 69 percent at 155 and 
decreased rapidly until it was reduced to 54 percent at 170 . The error 
bars correspond to one sigma. The point at 130 is not considered to be 
a genuine fluctuation in the overall trend. These background on these 
foils always exceeded 100 tracks. Other foil types were then used to 
examine the effect observed on the operational background. The masked 
foil, 250 u.m marketed by Transilwrap, Doraville, Georgia, was utilized 
in an experiment involving 143 background foils plus controls. These 
foils were etched at 800 volts for 5 hours in a 45 percent KOH solution. 
2 
This resulted in a background of 2.2 tracks/cm . Therefore it was decided 
to use this foil exclusively, avoiding any pretreatment of the foils 
4.2.3 Optimization Study 
Once the type of foil to be used in these studies had been deter-
mined, the etching conditions yielding the best results were required. 
49 
Based upon the data of Sohrabi, a series of foils were etched with 
controls to systematically examine the effects observed when the various 
parameters were changed. Different combinations of the following selec-
tions were used: etchant, 30 and 45 percent KOH; etching time, 4, 5 
or 6 hours; voltage, 700 or 800 volts. The etchings were performed as 
indicated on Table 6. The optimal set of conditions to be used was a 
trade-off between several desired effects. It was desired to have the 
largest track diameter possible, of course, to expedite counting but at 
the longest etching times two facts became evident. First, at the longest 
etching time reproducibility suffered because the frequency of premature 
shutdowns of the etching process increased due to etching through of 
Table 6. The Set of Conditions Used During Each Run to Determine 
the Most Optimal Etching Conditions 
Run Percent Etching Time Voltage 
KOH Hours 
1 45 4 700 
2 45 5 700 
3 45 6 700 
4 45 4 800 
5 45 5 800 
6 45 6 800 
7 30 4 700 
8 30 5 700 
9 30 6 700 
10 30 4 800 
U 30 5 800 
12 30 6 800 
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the large tracks and etchant leakage. Second, the background increased 
because deeper layers of the foils were exposed and available for etching 
at the longest etching time. Therefore, we selected the optimal etching 
conditions to be 45 percent KOH, 800 volts and 5 hours etching time ex-
cept when background is less crucial relative to the large track diameter 
and consequent ease of track counting. In this latter case, 4 hours was 
chosen to be the best etching time. 
4.2.4 Large Scale Etching 
One of the problems to be solved in shaping the electrochemical 
dosimetry system into a practical personnel dosimetry system is increas-
ing the number of foils that can be etched in one batch. Toward this end 
M. Sohrabi designed a large etching chamber capable of etching several 
times the number of foils now possible with our laboratory scale chambers. 
The laboratory scale chambers will etch seven (7) and the large chamber 
will etch thirty-five (35) foils at one time. This latter chamber 
141 
(Sohrabi and Morgan) has fixed stainless steel electrodes (24.5 cm in 
diameter and 75 in thickness and 10 cm total length). The diameter of 
the chamber is 25.5 cm. There are two holes in the bottom of this chamber 
connected to two hoses for draining. As pointed out by Sohrabi and Morgan 
141 
in an earlier report, this chamber did not yield a large degree of 
reproducibility due to its tendency to allow etchant to leak around the 
"0" rings, stopping the etching process. 
At the beginning of this research, almost half the etching posi-
tions leaked severely. During the ensuing period, attempts were made to 
correct this problem, although this effort was extraneous to the bone 
115 
dosimetry project. The first attempt to solve the problem culminated 
in the construction of a vise-like device to apply pressure directly to 
the "0" rings at each etching position and thereby reinforce the water-
tight seal. This succeeded in reducing the leakage from eighteen down 
to three or four positions, but the upper limit had been reached as to 
the amount of pressure that could be applied safely to the chamber. 
The problem seemed to arise from another source. It was determined the 
recesses where the "0" rings fit into the chamber had small but detectable 
differences in their machined depth. The "0" rings used were constructed 
from a reasonably hard material and they were thin (3 mm) so it was 
concluded that an uneven seal might be created when these rings were 
pressed together. New "0" rings were ordered to custom specification 
(not a standard size, as before) which were constructed 4.5 mm thick and 
with a softer material to facilitate formation of a watertight seal when 
pressure was applied. This method has been more successful than previous 
ones but leakage still occurred with a greater frequency than is observed 
in the small chambers. In order to use routinely this chamber it would 
probably be advantageous to reconstruct the chamber such that greater 
pressure can be applied to reinforce the watertight seal with the vice-
like device. 
4.2.5 Bulk Etching Rate Determination 
In order to determine the magnitude of polycarbonate lost during 
electrochemical etching we found it necessary to evaluate the bulk etch-
ing rate of polycarbonate during electrochemical etching (Stillwagon 
148 
et al.). Since the surface of the foil actually participating in the 
116 
electrochemical process and the density of polycarbonate are known, it 
was decided the bulk etching rate could be determined by the difference 
in foil mass before and after etching. Groups of non-irradiated 
250 |j,m thick polycarbonate foils were cut and accurately weighed to 0.1 mg 
These foils were then etched under the following conditions: 800 V 
applied at 2 kHz in a 45% KOH solution at room temperature, 25 C. Etching 
times were stepped in 1 hour increments from 2 hours to 6 hours and then 
a final etching run performed until breakthrough occurred at 8 hours, 
23 minutes. Each foil was reweighed to determine its final mass and Am 
was calculated. If we keep in mind that the foil is etched from both 
sides and let D (cm) represent the etched diameter of the foil, X (p,m) 
the thickness of foil removed by bulk etching from one side of the foil 
3 
and (g/cm ) the density of polycarbonate, we have the foil surface 
removed after each etching period X — [(2/\ml0 )/(prrD ) ]u,m . If X is 
divided by the etching time, bulk etching rate results. The data indi-
cated that the bulk etching rate was constant and equal to 0.16 pjn ± 0.024 
^m/hour from each side of the foil for our etching conditions. 
This constant value of bulk etching is in contrast with the track 
49 
etch rate which increases almost exponentially (Sohrabi), but is com-
patible with the constant bulk etching rate found in the chemical etching 
process that also possesses a nonlinear track etching rate (Fleischer 
132 
et al.). It is difficult to compare bulk etching rates between the 
electrochemical and chemical etching systems because the etching condi-
117 
tions are so vastly different, but Fleischer et al. have given the 
chemical bulk etching rate for their material as follows: 
117 
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4.68 x 10 p,m/hr, when considering 10.3 ŷ i thick foils etched in 3. IN 
NaOH at 7.2°C. 
This value of the bulk etching rate found for the electrochemical 
etching process points to the great amplification achievable by this 
process because the loss of only 0.64 M^ of polycarbonate surface from 
one side of a 250 p̂m thick foil during a four hour etching period produces 
a 100 \jjn diameter recoil particle track on a fast neutron irradiated foil. 
Incidently, the etching of background tracks in this determination was 
2 
neglected because the background was so low, 2 tracks/cm . 
4.3 Applications of Electrochemical Etching 
Aside from the present use described here, there are many other 
conceivable uses for the electrochemical etching of polycarbonate foils 
for the purpose of dosimetry. This system has been applied to various 
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fast neutron dosimetry applications (Sohrabi), ' (Sohrabi and Becker), 
(Su) (Stillwagon et al.) involving fast neutron personnel dosimetry 
and the measurement of the fluence of fast neutrons around high energy 
accelerators. Polycarbonate is especially suited for the latter task 
since it is essentially insensitive to photons which allows these foils 
to be placed directly in the beam to obtain a neutron measurement. An-
other recent application of this system is in the field of thermal neutron 
dosimetry (Stillwagon et al.). It is also conceivable these foils 
can be used in neutron depth dose studies inside heterogeneous phantoms, 
including alfedo neutron measurement. The electrochemical etching system 
could be used in many tissue sample dose determinations, such as the 
present one, when one desires to observe the dose deposited to a small 
area of tissue surface. 
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CHAPTER V 
ALPHA PARTICLE TRACK PRODUCTION IN POLYCARBONATE 
5.1 Efficiency of Alpha Particle Track Production 
To date the electrochemical etching system has been used primarily 
49 147 
for fast neutron dosimetry applications (Sohrabi), (Su et al.). 
Up until now the parameters associated with alpha particle track produc-
tion in polycarbonate amplified by electrochemical etching have not been 
determined. The four parameters which have been evaluated during the 
course of our research here are the efficiency of alpha particle etchable 
track production, the track diameter as a function of etching time 
,„•-,! , „ ,149,150 . . . _ . . . 
(Stillwagon and Morgan) sensitivity as a function of waiting time 
and sensitivity as a function of etching time. Reproducibility will be 
discussed also. Throughout these two studies, 250 ^m thick Transilwrap 
polycarbonate foils were used. The etching equipment was the same as 
described and shown on Figures 9 and 11. 
In this section we are concerned with the efficiency of alpha 
particle track production in polycarbonate foils, as amplified by elec-
trochemical etching. The track diameter as a function of etching time, 
sensitivity as a function of waiting time and etching time and reproduci-
bility will be examined in the next sections. To examine the efficiency 
of alpha particle track production, a device called the vacuum-sealed 
alpha-calibrator was designed by this research, Figure 16. It provides 
a constant source to detector distance; one of the detectors being a 
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Figure 16. Closeup of the Vacuum-sealed Alpha Calibrator 
Showing the Vacuum Hookup, Two Compartment 
Design and the Calibrated Source Stand 
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surface barrier detector and the other the polycarbonate foil. Different 
absorber thicknesses can be simulated by varying the air pressure in the 
239 
chamber. The source used consisted of 2.0 ^Ci of Pu. First various 
air densities, using the standard temperature and pressure corrections, 
were used to irradiate an Ortec surface barrier detector which provided 
input into a Model 8100 Canberra multichannel analyzer. The total number 
of alpha particles and peak energies were noted. Then the top made to 
hold polycarbonate foils was employed and, to insure similar geometry 
and irradiation conditions, ceramic rings were obtained from the Ortec 
Company identical to the rings employed in the construction of their 
surface barrier detectors. These were placed on the foil at the position 
formerly occupied by the surface barrier detector. After irradiation 
at the same air densities, the foils were etched under standard condi-
tions (for four hours in 28% KOH utilizing an applied potential of 800 V 
at 2 KHz and 24°C). 
The results obtained from the study to determine the efficiency 
of alpha track production (number of tracks recorded) as a function of 
polycarbonate foil thickness are shown in Figure 17, where equivalent 
polycarbonate foil thickness was calculated from the various density 
thicknesses of air. Each point on the curve represents the average of 
more than one foil, usually two or three foils, and the error bars cor-
respond to one sigma. No correction for attenuation in the small gold 
layer on the face of the surface barrier detector was employed in plotting 
Figure 17 since the surface barrier detector was not in place during the 
polycarbonate foil irradiations. The shape of the curve in Figure 17 is 
0.2+ 
16 24 
Microns of Polycarbonate 
Figure 17. Efficiency of Track Production as a Function of Absorber 
Thickness. Polycarbonate Absorber Thickness was Calculated 
From g/cm2 of Air. Count Rate was 1.6516 x 107/24 hours 
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quite clearly the familiar Bragg-type curve, peaking at 27.5 u,m of 
polycarbonate. The peak of the curve was slightly more than twice the 
flat portion. Also, the peak fell off sharply down to zero at 34 u.m of 
239 
polycarbonate, corresponding to the range of the Pu alpha particle in 
polycarbonate, and again toward the flat portion of the curve on the left 
side of the peak. The total number of counts used in the efficiency 
determination was 1.6516 x 10 counts. This value was the average of 
two separate 24 hour irradiations and was recorded on the Canberra multi-
channel analyzer system described above. 
5.2 Sensitivity as a Function of Etching Time 
To perform the sensitivity as a function of etching time determina-
tion, we used the vacuum-sealed alpha-calibrator, Figure 16. The same 
source to detector distance used in all other determinations, 3.51 cm, 
was used here. The top of the vacuum-sealed alpha-calibrator (VSAC) that 
holds polycarbonate foils was utilized throughout this experiment. The 
experiment proceeded as follows. Transilwrap 250 p,m thick polycarbonate 
foils were placed, one at a time, in the VSAC with the foil masking re-
239 
moved from the side of the foil facing our 2.0 p.Ci Pu source. Then 
the ceramic rings obtained from the Ortec Company, mentioned above, were 
placed over the foil to insure identical geometry and irradiation condi-
tions during the experiment. A series of foils were exposed to the 
plutonium source for 24 hours each at an air density selected to simulate 
a 27 u.m thick polycarbonate absorber. Next the foils were etched in 
45% KOH with an alternating potential of 800 V applied at 2 kHz for 
etching times between 2 hours and 4 hours. About six days elapsed between 
irradiation and etching. The results appear on Figure 18. This plot 
of sensitivity (tracks/alpha particle) versus etching time indicates 
the decrease in sensitivity with decreasing etching time to fall off 
approximately exponentially. The error bars correspond to one sigma 
and the total number of alpha particles impinging on each foil was 
1.6516 x 10 , determined as above. The results of this experiment were 
used to conclude that a four hour etching time would be necessary during 
the bone dosimetry experiment since high sensitivity was a requirement 
239 
for the low activities of Pu encountered. 
5.3 Sensitivity as a Function of Waiting Time 
An experiment very similar to the one described in section 5.2 
was designed to examine the sensitivity of our polycarbonate dosimetry 
system for alpha particle etchable track formation as a function of the 
time lapse from irradiation to electrochemical etching (waiting time). 
We used the vacuum-sealed alpha-calibrator once again with the top 
designed to hold our 250 jĵn thick polycarbonate foils. Exposure time 
239 
to our 2.0 î Ci Pu source was 24 hours for each foil mounted 3.51 cm 
above the source. Air density was controlled to simulate a 27 |im thick 
polycarbonate absorber between the source and target foil to change the 
energy of the alpha particles. We selected 27 |j,m because we found a 
maximum in etchable track formation created by alpha particles at an 
alpha energy corresponding to the 27 ^m thick absorber, section 5.1 
149 
and (Stillwagon and Morgan). After each irradiation period of 24 
hours, various waiting times were allowed to elapse before beginning the 
etching process. Our waiting times varied from 9 minutes to 15 days. 
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Etching Time (Hours) 
Figure 18. Graph Showing Sensitivity., Expressed as Tracks /Alpha, 
as a Function of Etching Time. Foils Were Etched in 
45% KOH, at 800 V and 2 kHz for the Times Indicated 
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The foils remained in a closed lab desk drawer, masked side down, until 
removed prior to etching. The results are plotted on Figure 19. In 
7 
each case 1.6516 x 10 alpha particles impinged upon the foil. Surprisingly 
enough this plot of sensitivity (tracks/alpha particle) versus waiting 
time showed a large increase in sensitivity as waiting time increased. 
One explanation of this result is as follows. When an alpha particle 
passes into the foil creating a track the volume around the track is 
left in a state of mechanical stress. This stress could then be relieved 
by the formation of tiny microcracks. The locations of these microcracks 
would be more susceptible to attack by the etchant because access to the 
inner part of the foil is now available to the etchant. If this explana-
tion is true, then it follows that the longer one waits after irradiation 
of the foils before etching, the more microcracks will have formed as 
the stressed areas around the tracks relieve themselves. It could even 
be hypothesized that the great amplification realized by electrochemical 
etching is the result of an increase in microcrack formation caused by 
the 2 kHz oscillations employed in the electrochemical etching process. 
Another explanation of the mechanism of operation of electrochemical 
etching is the 2 kHz oscillations cause the positive and negative etchant 
ions to act as tiny "hammers" acting on the track to remove sections of 
polycarbonate material resulting in amplification of the original track. 
5.4 Reproducibility 
During the course of any experiment one must examine the reproduci-
bility of his data. Normally, reproducibility evaluated external to any 
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Figure 19. Sensitivity as a Function of Waiting Time Expressed 
as Average Number of Tracks Observed in a 120 ^m Square 
All Foils Were Irradiated by 1.65 x 107 239Pu Alpha 
Particles over 0.9 cm Diameter Circle. Error Bars Are 
± 15%. 
strengthen any conclusions drawn concerning reproducibility. Data 
examined from different experiments, obtained on different days, for the 
purpose of analysis of reproducibility tend to eliminate some of the 
biases that might be introduced during the performance of a particular 
experiment carried out on a particular day. These biases could include 
spurious electrical fluctuations of the line voltage, atmospheric varia-
tions and outside distractions affecting the experimenter, especially 
during tedious track counting, 
To examine the reproducibility of this work, foils from two dif-
ferent experiments were selected, the sensitivity versus etching time and 
sensitivity versus waiting time experiments. These foils were irradiated 
and etched weeks apart, even within one experiment. Foils used for the 
reproducibility determination had been allowed to stand one week before 
etching. As previously mentioned, each foil was irradiated 24 hours in 
our vacuum-sealed alpha-calibrator by alpha particles traversing a 3.51 cm 
239 
air gap (simulating 27 ^m of polycarbonate) from our 2.0 ^Ci Pu source. 
The absorber caused the alpha particles to lose enough energy before reach-
ing the dosimeter to possess an LET at the maximum of the Bragg curve. 
Results of the reproducibility study are shown in Table 7. The collec-
tive average of the variation from the average for groups of comparable 
foils was 11 percent. Therefore 15 percent was selected as a conserva-
tive value to apply to the error in future measurements. 
































































NOTE: Several different absorber thicknesses and waiting times (time 
between irradiation and etching) are shown for these foils etched 
under standard conditions. The foils were etched over a nine 
month period. 
5.5 Track Diameter Variation as a Function of Etching Time 
To examine the track diameter as a function of etching time, the 
250 |j,m thick polycarbonate foils were irradiated by one of three alpha 
241 
particle sources, two 0.1 jiCi Am sources and one 0.2 ^Ci mixed nu-
239 241 244 
elide source containing Pu, Am and Cm. These foils were then 
etched for varying times between 15 minutes and 4 hours in 457o by weight 
129 
KOH using an applied voltage of 800 V at 2 kHz and 24 C, room temperature. 
The results of the measurements of track diameter as a function 
of etching time are plotted in Figure 20, for times ranging from 15 
minutes to 4 hours. Each point represents the average of the extremes 
in the measurements of track diameter performed using a Filar micrometer 
in place of our microscope eyepiece at a power of 430X. The error bars 
in this case are actually marking error ranges because they indicate the 
extreme values obtained for track diameter in each case. No tracks were 
observed for an etching time less than 30 minutes. The two curves reflect 
the presence of the two track sizes that were observed for the alpha 
particle irradiated foils. Figure 20 contains two curves for the follow-
ing reason. After the polycarbonate foils were irradiated by alpha 
particles, etched by the standard technique and viewed, it appeared there 
were two distinct groups or categories of tracks on the foils (see also 
Figure 21). There were a few large tracks and many small tracks, but as 
shown in Figure 22, the number of large tracks decreased and the number 
of small tracks increased with increasing absorber thickness. To check 
if this phenomenon of the two categories of tracks was real, the diameters 
of the tracks on a foil were measured and the relative frequency of the 
various diameters plotted, Figure 23. Here the relative frequency, ex-
pressed in percent, of the track diameters appearing on the y-axis are 
plotted in steps of 0.5 p,m in histogram fashion. One can plainly see 
two categories of tracks present on the foil represented graphically by 
the two large peaks of equal magnitude, one between 3.5 and 4.0 ^m and 
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Figure 20. Variation of Track Diameter with Etching Time. 
Upper Curve Represents the Large Diameter Tracks, 
and the Lower Curve represents the Smaller Diameter 
Tracks 
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241 Figure 21. Tracks Created by the 5.44 MeV Alpha Particles of Am 
at a Source to Dosimeter Distance of 2 mm in Air. Irradia-
tion Time = 14 hours. A. Without Foil Masking. B. With 
Foil Masking. Etching Parameters--45% KOH, 800 Volts, 
2 kHz and Etching Time 5 Hours 
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Figure 22. Change in the Fraction of the Total Number of Tracks on a 
Foil in Each Track Size Grouping as a Function of Alpha 
Particle Energy (Expressed as Microns of Absorber). Upper 
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Figure 23. Relative Frequency of Track Diameters after Alpha Particle Exposure 
for a Foil Etched One Hour at 800 V, 2 kHz, 24°C in 45% KOH 
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smaller than 3.0 am and none were observed greater than 115.5 am 
throughout these measurements. Histograms similar to Figure 21 can be 
drawn also for each of the fouls used to generate Figure 20. These are 
presented in Figures 24 through 27 for absorber thicknesses 27 am , 
24 am, 8 am and 2 am of polycarbonate respectively. By viewing Figure 
24 for 27 am and Figure 27 for 2 am, the dramatic shift from the small 
to the large track diameters can be seen easily. The absorber varies 
alpha particle energy. Thicker absorber results in a smaller energy of 
the alpha particles incident on the dosimeter. 
The data contained on these foils were used to generate Figure 22 
in the following manner. According to Crawford ". . .physical pro-
cesses forming particulate distributions tend to produce a log-normal 
distribution." Distributions such as the Poisson distribution would not 
be expected to apply to the case here, namely single measurements of 
many different tracks, because the normal and Poisson distributions give 
the probability of a value n falling between n and n + dn. In other 
words one is removing samples from one pool of data. It would be ex-
pected, however, that many diameter measurements of one track would 
describe a Poisson distribution. The log-normal distribution is used to 
describe particle distributions where one has many different particles 
of varying diameters, each of which is measured once and then particle 
diameter measurements are fitted to the log-normal distribution. This 
is essentially the situation we have with our track diameter measurements. 
From this point the formulation of Crawford was used. A range of diameters, 
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Figure 24. Relative Frequency of the Various Track Diameters for a Foil Using a 27 ^m Absorber 
Between the Source and Foil. Ratio of Small Tracks to Large Tracks is 69:44. Etch 
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Figure 25. Relative Frequency of the Various Track Diameters for a Foil Using a 24 [i,m Absorber 
Thickness Between the Source and Foil. Ratio of Small Tracks to Large Tracks is 
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Figure 26. Relative Frequency of the Various Track Diameters for a Foil Using an 8 -jxi Absorber 
Between the Source and Foil. Ratio of Small Tracks to Large Tracks Is 29:53. Etch-
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Figure 27. Relative Frequency of the Various Track Diameters for a Foil Using a 2 \jjn Absorber 
Between the Source and Foil. Ratio of Small Tracks to Large Tracks Is 12:78. Etching 
Conditions Were 800 V, 2 kHz, 28% KOH, 24°C, and 4 Hours Etching Time LO 
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range was determined as a fraction of the total number of tracks, AN./N. 
Then each fraction was summed such that the last range of d gave a sum 
equal to 1.0. According to the method, if the values of each respective 
sum, N(d.)/N are plotted against the high end of the appropriate diameter 
range a straight line will result on probability-log paper if one log-
normal distribution will describe the data. This provides not only a 
method of deciding how many tracks to assign to each track grouping, but 
it also allows a method to further prove the existence of two size group-
ings of tracks. These curves appear on Figure 28. Immediately apparent 
is the sharp break in the curve indicating the presence of two distribu-
tions. The point located at a track diameter of 20 |j,m seems to fall 
below the curve for the two transient cases, absorber thickness 8 ^m 
and 24 (jm . These fluctuations are not believed to be real, however, 
since the 20 [\pi point falls nicely on the curve for the extreme cases, 
2 u.m and 27 ^m , that show the shift in track diameter best (see histo-
grams). Now, it is quite simple to determine the fraction of the total 
number of tracks in the small group of tracks. The line drawn through 
the lower end of the curve, corresponding to the small tracks, and ex-
tending unt. 1 it crosses the largest tract diameter encountered will be 
indicating the contribution of this distribution as a fraction of the 
total, 100%. This is the fraction of tracks which fall into the small 
track log-normal distribution. It will be noted that this procedure is 
not unlike the procedure used to separate the contribution of counts 
from a mixture of two nuclides of differing halflives, one short and the 
other long. The log-probability curves were plotted six times for each 
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Figure 28. Plot of Cumulative Probability, N(di)/N versus Track Diameter 
(Increasing to the Left) for Alpha Particle Irradiated Foils 
Electrochemically Etched Four Hours, at 800 V, 2 kHz, 28% KOH 
and 24°C. Probability Refers to the Occurrence of a Particu-
lar Track Diameter. Curve I Represents an Exposure with a 
27 [jjri Absorber, Curve II a 24 |j,m Absorber, Curve III an 8 p,m 
Absorber and Curve IV a 2 ̂ i Absorber. 
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foil and the straight line representing the small track distribution 
plotted six times each, i.e. each one of the curves on Figure 28 repre-
sents one of the six curves used to obtain the values plotted on Figure 22. 
The average of these six values is plotted in Figure 22 and the maximum 
and minimum values are indicated by the error bars (or error ranges). 
Therefore when plotting Figure 20 one curve represents the large track 
diameter as a function of etching time and the lower curve the small 
track diameter as a function of etching time. 
A reasonable explanation for the appearance of two categories of 
tracks on the polycarbonate foils after alpha particle irradiation is as 
follows. It is possible the smaller tracks could have been created by 
the alpha particles themselves and the larger tracks by the recoil of 
carbon and oxygen nuclei present in the polymer molecules composing 
polycarbonate. Of course, these latter interactions would not be of the 
elastic collision type found in fast neutron work due to the + 2 charge 
of the alpha particle. Instead, we could envision a Coulombic repulsion 
event during which the target nucleus does not remain stationary, like 
classical Rutherford scattering, but instead is "pushed" out of its 
lattice site by this repulsive force. This event would be possible 
especially for high energy alpha particles and large angles of alpha-
particle deflection since more energy would be imparted to the recoil 
nucleus than in the opposite situation. This type of interaction was 
158 
introduced by Rutherfore many years ago (Rutherford), (Rutherford et 
159 
al.). Except for the work using protons and helium nuclei, much of 
this early work was concerned with heavier nuclei such as argon, gold 
and copper in which this effect would be considerably reduced in importance 
due to the difference in mass between an alpha particle and, say, a gold 
nucleus. In polycarbonate and tissue the main target nuclei are carbon, 
oxygen and protons. Two pieces of experimental evidence suggest this 
explanation for the appearance of large tracks. First, the track diameters 
for the large group of tracks are approximately the same as we have ob-
served for recoil particle tracks after fast neutron irradiation (Su and 
Morgan). Second, the number of large tracks increased and the smaller 
tracks decreased with decreasing absorber thickness, Figure 22. The in-
crease in large tracks would then be caused by the greater number of alpha 
particles possessing high energy. Thus, with less absorber more alpha 
particles have sufficient energy to "push" the polymer nuclei out of 
their lattice sites.because as energy increases smaller and smaller angles 
of alpha particle deflection will give sufficient energy to the target 
nucleus to push it out of its lattice site, i.e. the larger the number 
of angles that can cause the event the higher the probability of the 
event. The decrease in smaller tracks would be caused by getting farther 
away from the Bragg peak where the highest LET was found for alpha par-
ticles. Energies near this Bragg peak may be the only region where 
alpha particles possess large enough -dE/dx to have a large probability 
of producing tracks of small diameter. With a larger absorber present 
many more alpha particles could be expected to be found within the high 
LET portion of the Bragg curve and fewer possessing high energy or low 
-dE/dx. A decrease in the large diameter tracks, but an increase in 
the number of small diameter tracks as the Bragg peak is approached 
143 
could be anticipated, with this explanation. The data of Rutherford 
also support this explanation of the increase in numbers of large tracks 
with decreasing absorber thickness. His curve for helium nuclei as targets 
clearly shows an increase in numbers of counts with increasing alpha par-
ticle energy, Figure 29. The increase as v is approached is caused by 
helium target nuclei recoiling into the ZnS screen along with scattered 
159 
alpha particles and as Rutherford indicates in the text accompanying 
the Figure, this effect increases with increasing alpha particle energy. 
Here the ratio v /v is the velocity of the alpha particle used in the 
study to the various velocities considered. The alpha sources used were 
., j. • _. • .. u • u 218^ 214 ^ J 214„. . •-,-!_• radium active deposit which was Po, Pb and Bi in equilibrium 
O OQ 
and "thorium active deposit" which was Th. It is believed this effect 
could have ramifications in the field of internal dosimetry. To illus-
trate we could examine the energy expected to be possessed by these light 
recoiling nuclei. A vector diagram for the interaction is shown in 
Figure 30 where OA is the momentum vector for the incident alpha particle 
(mv.), OB for the scattered alpha particle (ravj, 0 the angle of deflec-
tion and BA is the momentum vector for the recoiling nucleus (MV). By 
the law of cosines 
2 2 ? 
(MV) = (mvp + (mv2)^ - 2(mv;L)(mv ) cos0 
and by conservation of energy 
2 2 2 
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Figure 30. Vector Diagram Describing the Collision of an Alpha Particle 
and a Nucleus. The Momentum Vectors Are OA for the Incoming 
Alpha Particle, OB for Scattered Alpha Particle, and BA 
for the Recoil Nucleus 
If we define K — — and v0 = nvn where n < 1 then from these two equations m I r 1 
we quickly find 
K - 1 = p (K + 1) - 2 p c o s 0 
or 
cos0 1 ^ 2 ""~2~N 
p = KTT + ^ n \ K - s i n 0 
If we now assume an initial alpha particle energy of 5.1 MeV, approximately 
239 
equal to a Pu alpha particle, we can calculate the energy expected to be 
given to the recoil nucleus. These values appear in Table 8 for various 
angles, 0. AE? is the scattered alpha particle energy and AE is given to 
the recoiling nucleus. For gold at 90 AE = 0.21 MeV and aluminum 
AE = 1.33 MeV so we can see how much more important this type of scatter-
ing becomes for light nuclei (i.e., C and 0) in these studies than was 
the case for heavy nuclei! studied by Rutherford. For a head-on collision 
with a carbon nucleus almost 4 MeV is imparted to this nucleus. The im-
plications in internal dosimetry are now becoming clearer. Instead of 
this 4 MeV being imparted to tissue by an alpha particle as we would 
assume in calculations of dose equivalent, this 4 MeV has been converted 
to a more efficient energy imparting means, i.e. a carbon nucleus. This 
could cause more severe damage to cells, especially in the close vicinity 
of the alpha emitter, than we would expect when considering only alpha 
particle energy deposition. Also, we have a direct mechanism now present 
to cause chromosome breakage. With this interaction, atoms simply could 
be removed or knocked out of a DNA chain, causing irreparable damage to 
Table 8. The Energy of the Recoil Nucleus, AE, the Scattered Alpha Particle Energy, E, 
and the Ratio of Final to Initial Alpha Particle Velocity, p, Are Shown for 
Various Angles of Deflection of the Scattered Alpha Particle. E-, = 5.1 MeV 
(initial alpha energy), v. = 1.567 x 10" cm/sec and m = 6.647 x 1 0 " ^ g 
K 30v 60v 9CT 150
v 180 
p E (MeV) AE(MeV) AE AE AE AE 
Carbon 3 
Oxygen 4 
0 .956 4 .66 0.44 0.843 3 .63 1.48 
0 .967 4 . 7 7 0 . 3 3 0 .881 3 .96 1.44 
0 .707 2 .55 2 .55 
0 .775 3 .06 2 . 0 4 
0 .523 1.40 3 . 7 1 I 0 .500 1.28 3 .83 
0 . 6 2 1 1.97 3 . 1 3 0 .600 1.84 3 .26 
^ j 
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this chain and possibly other chains due to the higher LET of the removed 
carbon or oxygen nucleus. The interaction indicated here would be oc-
curring in addition to those effects described by Katz. This is a 
direct mechanism for permanent change in a cell nucleus that should be 
considered during discussion of carcinogenicity and other cellular ef-
fects. One interesting side note is the possibility that the effect 
described above may never have been observed if the foils had not been 
composed of light nuclei as in tissue. This effect could actually be 
occurring in tissue as well as polycarbonate since the main components 
of tissue are nuclei whose mass is not greatly different from the alpha 
particle. Therefore large energy transfer can result from the alpha 
particle to the target nucleus in tissue as we observed in polycarbonate. 
Photographic emulsions, on the other hand, are not tissue equivalent. 
As Table 9 indicates, almost 17"%, of the atomic composition of NTA emulsion 
are the heavy nuclei silver and bromide. In polycarbonate foils we are 
observing the actual track created by the incident particle, amplified 
many times but in the emulsion we are only observing silver ions reduced 
by the passage of the ionizing particle close by. Discovery of the two 
track size effect on polycarbonate foils was made by measuring track 
diameters easily distinguishable with a light microscope. The correspond-
ing effect on the emulsion would appear as a narrow track of reduced 
silver ions up to the point of collision, then a wide track of reduced 
silver ions would be present corresponding to the recoil nucleus for a 
180 collision. Of course no tracks would be seen from recoils of silver 
or bromide since they are too heavy to receive enough energy from the 
Table 9. Elemental Composition of Kodak NTA Film 
Element Average Atoms/ml Atom °L 
Concentration in 1 ml 
(g/mole) (g/ml) 
Ag 1.285 7.174 x 1021 8.41 
(107.870) 
Br 0.954 7.189 x 1021 8.42 
(79.909) 
C 0.354 1.775 x 1022 20.8 
(12.011) 
H 0.063 3.764 x 1022 44.1 
(1.00797) 




0.094 4.041 x 1021 4.73 
indicates trace amount 
150 
alpha particle to move far enough to produce a recognizable track on the 
I C O 1 C,Q 
photographic emulsion (Rutherford et al.). ' Due to the inherent 
difficulties in reading particle tracks (angular dependence causes some 
tracks to be unrecognizable if the angle of incidence is close to normal, 
high magnification required to read emulsions and background or artifacts, 
etc.) and non-tissue equivalence the two track sizes would not be expected 
to be observable in large enough numbers to reproduce the histograms 
describing this effect found in this section. The observance of effects 
such as these is one argument in favor of using a tissue equivalent 
material whenever possible to detect the interactions of radiation with 
tissue. If this suggestion is not followed, important interactions may 
be overlooked simply because the dosimeter selected does not interact 
with the radiation in the same manner as tissue. We can not pretend to 
know before hand when tissue equivalence is not necessary. If this inter-
action is occurring in tissue to the degree indicated by the data pre-
sented here, the recoil reaction may be more important than first seemed 
to be the case even though researchers such as Haque state -dE/dx is 





6.1 Description of Bones Utilized in These Studies 
The bones used during the course of this research were removed 
239 
from beagle dogs injected with known quantities of Pu(IV) citrate and 
human bone samples of interest to attempt to obtain human data directly. 
The dog bone samples were generously given to us by Dr. W. S. S. Jee at 
the University of Utah and the human bone samples were donated through 
the courtesy of Dr. B. D. Breitenstein associated with the U.S. Trans-
uranium Registry, Richland, Wash. The method of preparing the bone 
samples was as follows. 
The beagle dog bones had been extracted by the Radiobiology La-
boratory during autopsy of dogs injected at Level 5 (2.9 (jjCi/kg) and 
/ 239 
Level 3 (0.3 ^Ci/kg). As mentioned above, Pu(IV) citrate solutions 
were used throughout all injections. The plutonium injected was part of 
four shipments received by the Radiobiology Laboratory. The first two 
batches came from the same source and had the following isotopic percent 








U £ 1.55 x 10 when Pu = = 1 
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The values for the minor constituents are given as upper limits. The 
239 
results of this study of the beagle dog bones are valid only for Pu 
since all the other alpha emitters are present only in trace amounts. 
239 
The third and fourth batches had an isotopic composition of Pu of 
0 239 
99.89/o Pu but alpha-spectroscopy failed to indicate any other alpha 
emitters present in the sample. Therefore these results are applicable 
239 i_ 
only for Pu deposition in bone since other nuclides are present in such 
small amounts. 
After injection of the plutonium citrate solution into the animal 
it is desirable to determine the skeletal burden of plutonium. The Utah 
workers have determined that the skeletal burden can be obtained from the 
13 
following two equations (Stover et al.) : 
Level 5 
B = 6.9 exp(-0.0011 T) + 42.8 (6.1) 
Level 3 
B = 15.2 exp(-0.0011 T) + 34.4 (6.2) 
Here B is the percent of the injected dose retained uniformly in the 
skeleton after a post-injection time, T, in days. Table 10 lists the 
dogs used during the bone dosimetry portion of this work along with per-
tinent data such as post-injection time (time between injection and sacri-
fice of the animal), skeletal burden at death and type of bone obtained. 
The batches refer to the plutonium batches described above. Because 
severe cellular necrosis was noted at long post-injection times after in-
jection at Level 5, only the shortest post-injection times were selected 
among the available samples (the longest selected was 92 days post-
Table 10. List of the Bones Used During This Research From Beagle Dogs 
Obtained from the University of Utah. Batch Refers to the 
Batch of Plutonium Used (Composition Described in Text). 
Terminal Body Burdens Were Determined Using the Equations 
of Stover. *-3 











T10P5 Distal Femur 1 & 2 
T50P3 Sternum 3 & 4 
T47P5 Lumbar Vertebra 3 & 4 
T44P5 Lumbar Vertebra 3 & 4 
T42P5 Lumbar Vertebra 3 & 4 
T16P5 Lumbar Vertebra 1 & 2 
T56P5.5 Distal Femur 3 & 4 
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injection) to avoid these problems and thus avoid ambiguities in inter-
preting the experimental results. 
The bones were placed in acetone or 70% alcohol to serve as a mild 
fixative after extraction from the dogs. Then the bones were embedded 
in Bioplastic to provide a hard surface for cutting the delicate trabecu-
lar bone surfaces. A vacuum was created and released several times as 
the Bioplastic hardened to remove as much air as possible from the unde-
calcified bones. This process was the end result of many trials by the 
Utah group to find a process to retain living tissue conditions as closely 
as possible for the finished bone section. In biological experiments it 
is always necessary to make some statement as to the degree the completed 
section compares with the original living material. The best bone-
dosimetry technique conceivable could not provide useful data unless the 
bone sample was able to represent closely the original living bone. The 
procedure described here allows fixing of the bone with no detectable loss 
of plutonium, no movement of macrophages or other cells along the osseous 
surfaces but can result in a 307o shrinkage of some cells. Therefore it is 
felt that this technique can represent the living bone quite well since 
the plutonium, cells and osseous structures remain in place at the cost 
164 
of some cell shrinkage (Jee). 
Each bone, now sealed in Bioplastic, is ready to be sawed on the 
bone saw. This saw features a water-cooled blade that also serves to 
control the release of plutonium laden sawdust. Sections of bone 300 ^m 
thick were removed until the bone was sectioned through the cortical bone 
layers. Each swath of the saw blade resulted in the cutting loss of about 
400 p̂ i of bone material in addition to the section removed. Therefore the 
155 
distance between the front portion of each bone section was 700 \jja. 
The human bones were removed from Case #01AT-0555. This man re-
ceived some exposure to plutonium during his employment at Hanford but 
the level was below the level detectable by whole-body detectors and 
urine analyses. We used a rib during our dosimetry studies. The prepar-
ation procedure was as follows. The rib was first placed in the fixative 
formalin for 24 hours. Next the sample was placed in HN0„ for acid de-
calcification. The HN0„ solution was prepared by placing 200 ml of a 70 
weight percent solution of HN0„ solution in 2600 ml of water. The bone 
was checked every eight hours until it was soft. Then the sample was 
washed in water and neutralized with a drop of NH„. Finally the rib was 
returned to the formalin until needed for sectioning. Sections were re-
moved as follows. The bone was placed in a paraffin cassette containing 
bees wax and mounted on a microtome. Sections of 8 |j,m were removed until 
the endosteal face of the bone was exposed. The entire remaining bone 
(infinitely thick to alpha particles) was used during the dosimetry appli-
cation described below. It was learned later that acid decalcification 
will cause the plutonium present in the bone to shift around but not be 
lost from the bone. Therefore, the original amount of plutonium should 
still be present but somewhat displaced from its original location. For 
this reason we were not able to use the human bone samples as extensively 
as first hoped. The final bone preparation procedure involved sawing the 
whole bone longitudinally through the center of the marrow cavity with a 
small hack saw. The halves were sanded down to expose the endosteal 
surface with fine-grain emery paper. 
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6o2 Osseous Microdosimetry 
6.2.1 The Bone Dosimetry Technique 
The technique we designed to determine the dose rate to the layer 
of tissue 10 pjn thick on the endosteal surfaces of bone containing various 
239 
amounts of Pu was as follows. First the bone samples were allowed to 
expose our 250 ^m thick polycarbonate foils for various times under vari-
ous conditions. Some bones were exposed to polycarbonate foils with a 
27 jjjn thick polycarbonate absorber between the foil and bone sample. 
This technique caused the incident alpha particles to have maximum prob-
ability of creating a track, see Figure 17, and maximum spatial resolu-
tion; however, sensitivity is lost due to the large number of alpha par-
ticles attenuated before reaching the polycarbonate dosimeter. The 
majority of foils was exposed by placing a large number of bone sections 
side-by-side on the bare face of a polycarbonate sheet, placing a second 
sheet on top of the bone sections (sandwiching them) and finally laying 
the setup between two pieces of wood and compressing the arrangement with 
C-clamps. Given the malleability of polycarbonate, the flat surface 
created by our bone preparation procedure and the great amount of pres-
sure C-clamps can provide, it is difficult to imagine the air gap could 
be greater than a micron and was probably less. 
The polycarbonate dosimetry foils were exposed to the trabecular 
bone surfaces for various times. We elected to observe only the trabecu-
lar bone surfaces (also called the endosteum of bone) since the radiosen-
sitive osteogenic cells are located here as well as the highest concen-
3 241 
tration of plutonium (Jee et al.). Other nuclides, such as Am do not 
concentrate as much on the trabecular surfaces as plutonium (Polig). 
After removal from the exposure apparatus, the polycarbonate foils were 
electrochemically etched by our usual procedure. Etching time was four 
hours to minimize the large decrease in dosimeter sensitivity as etching 
time decreases, Figure 18. Next the foils were mounted on microscope 
slides for viewing on our microscope. Figure 31 shows results obtained by 
this technique for foils exposed 30 and 64 days and electrochemically etched. 
We were interested in observing small fields during microscopic 
counting of the foils to approach a true average dose for alpha particle 
irradiation (Rossi). A Whipple disk was utilized to aid in the count-
ing. A 120 |j,m square at 430X was used throughout the foil counting pro-
cedure. Many randomly selected fields were counted for each foil, usually 
about 250 separate fields. The same counting procedure was used to count 
the calibration sources described below. From the data thus generated, 
two averages were calculated one including "zero" counts and the other 
not including these "zero" counts. Reasons for this will be presented 
below. Efficiency of detection of alpha particles from these infinitely 
thick bone samples would be expected to differ considerably from the ef-
ficienty for irradiation by monoenergetic alpha particles determined in 
Chapter V; for this reason the infinitely thick calibration foils were 
used to derive the efficiency factors. 
Upon completion of foil counting we have the number of alpha 
particles incident upon the average 120 (j,m square. In order to determine 
dose rate to the 10 ^m thick layer of tissue along the endosteal surface, 
the average energy absorbed in this layer, the mass of tissue involved 




Figure 31. A. Dog T44P5 Section #3A, Exposed 30 Days and Shows one View 
of Tracks Obtained with Whipple Disk in Place, 430X. B. Dog 
T42P5 Section #1, Exposed 64 Days, 400X. Both Foils Were 
Electrochemically Etched by Our Standard Technique. 
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Since we wished to keep this dosimetry technique entirely experimental in 
nature, the experimental alpha absorption measurements of Harley and 
,111,167-170 . . . , , _, 
Pasternack were selected to supply the energy absorbed. They 
determined the average energy transmitted through successive layers of 
polycarbonate absorbers. Then the energy channel number of a multi-channel 
analyzer was weighted by the number of counts and the average of the result-
ing distribution calculated. It is felt this is a better estimate of trans-
mitted energy than merely selecting the peak of the spectrum, especially 
170 
for dosimetry purposes. In Figure 32 (Harley) we can see the curve is 
nearly linear over much of the range of absorber thicknesses. Linearity 
239 
of this curve means that, if a Pu alpha is emitted toward the 10 p,m 
thick layer of tissue along the endosteal surface from depths in bone 
ranging from 0 to about 20 jjjn, approximately the same amount of energy 
will always be deposited in this 10 ĵtrn thick layer. Again, this refers 
239 
to the average energy lost by the Pu alpha particle in traversing the 
10 (j,m layer only and gives no information as to the total energy lost by 
alpha particles emitted from various depths in bone. For this 10 ^m thick 
layer we graphically determined the average energy absorbed to be 1.39 
MeV. For a 20 ^m thick layer the average energy absorbed would be 3.09 
MeV. These values were obtained by reading several measurements directly 
from Figure 32 and calculating the numerical average. The value for the 
average energy absorbed per alpha particle multiplied by the average 
number of alpha particles incident upon the 120 ^m square yields the 
average energy absorbed in the 10 |jm (or 20 ^m) thick layer of endosteal 
tissue. It will be noted, a 10 p̂ i absorber was never used, the dosimeter 






















Figure 32. Curve Showing the Average Energy Transmitted 
by Pu Alpha Particles Versus Absorber Thickness 
Expressed as Microns of Polycarbonate (Harley)171 
traversing the 10 ̂ m thick layer. Harley and Pasternack's data converted 
this value to absorbed energy, thereby avoiding a correction factor that 
would have been required to correct for alpha particles totally stopped 
in a 10 |im absorber placed between the bone and dosimeter and consequently 
not recorded. 
Since exposure time is known, the mass of tissue considered is the 
only requirement still needed to obtain dose rate in rads per year. For a 
10 ̂ m thick layer of tissue on the endosteal surface outlined by the 120 
[im square view port, see Figure 33, the mass m = (120 x 120 x 10) \jjn x 
-3 Q 1 9 " ^ 7 
1.0 (g/cm ) x 1 cm /l x 10 p,m - 1.44 x 10 g, where the density of the 
10 pjn thick soft tissue layer is taken to be 1.0 g/cm (Spiers), ' 
(James and Kember). Similarly, for a 20 \jja thick layer, m = 2.88 x 10 g. 
Using all of these values above, the equation for the dose rate in 
rads/year could be written 
NE 
DR = — C (6.3) 
where 
N = average number of tracks observed in the 120 pjn square 
239 
E = the average energy deposited by the Pu alpha particle in 
traversing the soft tissue layer, for 10 ̂ m thick layers, 
E = 1.39 MeV and 20 ̂ m thick layers, E = 3.09 MeV 
e = efficiency of track registration, tracks/a (see next section) 
m = mass of the small tissue layer, for 10 |jm thick layers, 
m = 1.44 x 10 g, and 20 jjm thick layers, m = 2.88 x 10 g 
T = exposure time in days 




Figure 33. Sketch Showing the 120 x 120 x 10 um Volume 
of Interest in the Endosteal Tissue Dose Rate 
Determination 
The results of the bone dosimetry study are shown on Table 11. 
Columns 7 and 8 give the dose rate in rads per year including all the 
random scans where no tracks were observed in the 120 jĵm square, D , and 
Columns 9 and 10 give the dose rate excluding these zero track scans, D . 
w 
The table indicates the highest dose rate observed relative to the skele-
239 / 
tal burden of Pu causing this dose rate was D = 317900 rads/yr for dog 
w 
T47P5 and the lowest was D =16.7 rads/yr for dog T56P5.5. The wide 
spread in dose rates recorded indicates the inhomogeneous distribution of 
plutonium known to exist on bone surfaces. Therefore the wide variation 
in dose rate noted as one proceeds down the column of increasing bone 
section numbers for one dog bone may not be unrealistic. The method of 
obtaining the efficiencies will be shown in the next section. The dose 
rates were calculated from eqn. (6.3) where the experimental measurements 
were the N values in the equation. There is some possibility the effici-
ency is too high for bone T56P5.5 yielding a low dose. This is suspected 
since the efficiency differs so much from all of the others. The procedure 
of presenting the dose including and not including zero scans offers an 
interesting possibility, the ability to calculate dose only to the volumes 
of tissue actually receiving alpha particle irradiation. In the past, 
dose was averaged over the entire skeleton, endosteal surface or endo-
steal surface with range of an alpha particle (Twente and Jee), (Rowland 
2 
and Marshall). As is known, if the track of an alpha particle does not 
pass through a region of the foil scanned, there is no absorbed dose re-
ceived by trabecular tissue in_ vivo at that point. 
Therefore inclusion of the unirradiated region in an average dose 
Table 11. Bone Dosimetry Resul ts I n d i c a t i n g Dose in Rads per Year 
Bone Bone 
S e c t i o n 
Number 
E x p o s u r e 
Time 
( d a y s ) 
W a i t i n g 
Time 
(days ) 
E f f i c i e n c y S k e l e t a l 
D0 ( r a d s / y r ) Dw ( r a d s hr) 
E x p e r i m e n t a l 
"HP'OEo 
( t r a c k s / o / ) 
DU rds r i 
(uCi ) 
i 
10 ppi 20 p,m 10 jĵ n 20 ^m 10 ^ 20 nm 10 jxm 20 ^m 
T42P5 1 64 Q 2 . 2 2 x 1 0 " 5 1 3 . 5 7 39580 ± 5937 44000 ± 6599 193800 + 29080 215300 ± 32330 1.0 x 1 0 _ J 9 . 2 x 1 0 " 4 2 . 1 x 10"^ 1.9 x 10"** 
2 1169 ± 175 1210 ± 195 45420 + 6814 50480 ± 75730 3 . 5 x 1 0 " 2 3 . 1 x 1 0 ' 2 8 .9 x 10"* 8 .6 x 10" 
3 14330 ± 2150 15930 ± 2390 174800 ± 26230 194300 ± 29150 2 . 8 x 1 0 " 3 2 . 5 x 1 0 " 3 2 . 3 x 10"* 2 . 1 x 1 0 " 4 
4 523 ± 78 582 + 87 39740 ± 5962 44170 ± 6627 7 .8 x 1 0 " 2 7 .0 x 1 0 " 2 1.0 x 1 0 " J 9 . 2 x 1 0 " 4 
8 8168 ± 1225 9078 + 1362 129200 ± 19380 143600 + 21540 5 . 8 x 1 0 " 3 4 . 8 x 1 0 ~ 3 
-I 
3 . 1 x 10 2 .7 x 1 0 " 4 
9 15050 + 2259 16730 ± 2511 192800 ± 28920 214300 ± 32140 3 . 1 x 1 0 " 4 2 . 4 x 1 0 ' 3 2 . 1 x 10"* 
-4 
1.9 x 10 
10 10680 ± 1602 11870 + 1781 98680 ± 14810 109700 ± 16460 3 . 8 x 1 0 " 3 3 . 4 x 1 0 ' 3 4 . 0 x 10"* 3 . 6 x 1 0 " 4 
11 14250 ± 2137 15840 ± 2376 130200 ± 19530 144700 ± 21710 2 . 8 x 1 0 " 3 2 . 6 x 1 0 ' 3 3 . 1 x 10"*1 2 . 7 x 1 0 " 4 
12 3806 ± 570 42230 ± 634 44710 ± 6707 49700 + 7455 3 . 4 x 1 0 " 2 3 . 0 x 1 0 " 2 9 . 1 x 10"*1 8 . 1 x 1 0 " 4 
13 1204 + 181 1338 ± 201 53000 ± 7948 58910 ± 8835 3 . 3 x 1 0 " 2 3 . 0 x 1 0 " 2 
-4 
7 . 7 x 10 
-4 
6 . 9 x 10 
T16P5 8 64 1 2 . 2 2 x 1 0 " 5 14 .96 1104 ± 167 1226 ± 186 39740 ± 5962 44170 + 6627 4 . 1 x 1 0 " 2 3 . 7 x 10~ 2 1.0 x 1 0 "
3 1.0 x 1 0 "
3 
10 8136 ± 1220 9043 ± 1357 108800 ± 16320 120900 + 18140 5 . 5 x 1 0 " 3 5 . 0 x 1 0 - 3 4 . 1 x 10"*1 
-4 
3 . 6 x 10 
T 5 6 P 5 . 5 1 34 0 3 .77 x 1 0 " 3 2 0 . 7 4 50 + 7 .6 5 5 . 9 ± 8 .4 849 ± 128 944 ± 143 1.2 1.1 7 . 3 x 1 0
_ / - 2 6 . 6 x 10 
2 151 + 2 2 . 7 168 .6 + 2 5 . 2 1479 ± 222 1644 + 247 4 . 1 x 1 0 " 1 3 . 7 x 1 0 _ 1 4 . 2 x 10"^ 
-2 
3 . 8 x 10 
3 1 6 . 7 ± 2 . 5 1 8 . 6 + 2 . 7 440 ± 66 490 ± 73 3 .7 3 . 3 1.4 x 1 0 " 1 1.3 x 1 0 " 1 
4 2 8 . 2 ± 4 . 2 3 1 . 3 ± 4 . 7 680 ± 102 755 + 113 2 . 2 2 .0 9 . 2 x 10"^ 
-2 
8 . 2 x 10 
5 136 + 2 0 . 5 151 ± 2 2 . 7 1579 ± 237 1755 + 263 4 . 5 x l O " 1 1 ^ . ! x 1 0 * 1 4 . 0 x 1 0 " 2 : 3 . 5 x 10~ 
8 4 4 . 8 + 6 . 7 4 9 . 7 ± 7 .4 484 ± 725 538 ± 81 1.2 1.3 1 1.3 x 10 | 1.1 x 1 0 _ 1 
9 , 9 1 . 5 ± 1 3 . 8 102 ± 1 5 . 3 1011 ± 151 1123 + 167 
-1 -1 ' -1 -2 
6 . 8 x 10 6 . 1 x 10 6 . 2 x 10 5 . 5 x 10 
10 5 6 . 5 + 8 . 4 . 6 2 . 8 ± 9 .4 565 + 84 1 629 + 94 1.1 | .99 I 1 .1 x 10" I 9 . 9 x 1 0 "
2 
4> 















D (rads/yr) D (rads/yr) 
Experimental 
MP0Bo j (t*Ci) _| MPOR, C„Ci') 
10 um 20 urn 10 gjn i 20 um 10 uJn [ 20 um 10 ym 10 ujn 
T10P5 2 64 6 2.76 x 10"3 16.18 104 + 15.6 115.7 + 17.4 795 + 119 884 + 124 4.7 x 10"1 4.2 x 10"1 6.1 x 10"2 5.5 x 10"2 







64 1 2.22 x 10"5 18.43 16470 ± 2468 
2448 ± 367 
3416 + 512 
2445 ± 367 
17210 + 2582 
3312 + 496 
18300 ± 2743 
2721 ± 408 
37970 ± 569 
2718 ± 408 
19130 ± 2869 
3682 ± 552 
12980 ± 19840 
84460 + 12670 
218600 ± 32790 
317900 ± 47690 
150200 + 22570 
145700 ± 21860 
144300 ± 22047 
93970 ± 14090 
243000 + 36440 
353400 ± 53010 
166900 ± 25090 
161900 ± 24300 
3.4 x 10"3 
2.6 x 10"2 
1.6 x 10"2 
2.3 x 10'2 
3.2 x 10"3 
1.7 x 10"2 
3.0 x 10"3 
2.0 x 10"2 
1.5 x 10"2 
2.0 x 10"2 
2.9 x 10"3 
2.3 x 10"2 
4.3 x 10"4 
6.5 x 10"4 
2.5 x 10"4 
1.7 x 10"4 
3.7 x 10"4 
3.8 x 10"4 
3.8 x 10"4 
5.9 x 10"
4 
2.3 x 10"4 
1.6 x 10"4 















7.75 x 10"A 
2.22 x 10"5 
16.14 2358 ± 354 
2554 ± 384 
3345 + 506 
977 ± 146 
1807 ± 272 
451 ± 68 
1954 + 294 
904 ± 135 
2621 ± 394 
2840 ± 426 
3718 ± 557 
1085 ± 162 
2009 ± 301 
502 + 76 
2173 ± 326 
1004 ± 150 
6189 ± 929 
4984 ± 748 
6642 + 996 
47690 + 7155 
53000 + 7948 
39740 + 5964 
53000 ± 7948 
59620 + 8943 
6879 + 1033 
5540 + 832 
7383 ± 1107 
53010 + 7952 
58910 ± 8835 
44170 + 6629 
58910 ± 8835 
66270 ± 9940 
2.1 x 10 " 
1.9 x 10"2 
1.5 x 10"2 
5.0 x 10"2 
2.7 x 10"2 
1.1 x 10"1 
2.5 x 10"2 
5.4 x 10"2 
1.8 x 10"2 
1.7 x 10"2 
1.3 x 10"2 
4.5 x 10"2 
2.4 x 10"2 
9.7 x 10"2 
,2.2 x 10"2 
k.8 x 10"2 
7.8 x 10"3 
9.7 x 10"3 
7.3 x 10"3 
1.0 x 10"3 
9.1 x 10"4 
1.2 x 10"3 
1 9.1 x 10"4 
8.1 x 10"4 
7.0 x 10"3 
8.7 x 10"
3 
6.6 x 10"3 
9.1 x 10"4 
8.2 x 10'4 
1.1 x 10"3 
8.2 x 10"
4 
7.3 x 10"4 
Human 
Rib-3 159 0 1.00 x 10"5 493 ± 74 548 ± 82 35480 ± 5322 39440 + 5915 6.1 x 10~4*p.5 x 10"44 8.4 x 10"6 + 7.6 5, 10"6* 
Human 
Rib-2 
\ " 159 0 1.00 x 10"5 73.9 + 111 82.1 ± 123 44350 ± 6652 49290 + 7394 4.1 x 10" B.7 x lO'^ 6.8 x 10"6 |6.1 x 10"6 
* 
These values for the human rib are simply the factors needed to reduce the experimental dose to 0.3 rad/yr since the skeletal burden was below the 
detection limits of the Hanford facility. 
NOTE: DQ is the dose including all zero values and D the dose excluding the zero values. The experimental HPOB is the given skeletal burden multiplied 
by the factor required to reduce the DQ or D value to 0.3 rad/yr and a factor of 10 to account for the skeletal mass difference between the dog 
and man. The 10 and 20 yfli refer to endosteal tissue thicknesses. Error is + 15%, obtained from our reproducibility studies. 
calculation tends to lower the calculated dose much the same as if we 
included unirradiated populations in a calculation of man-rem to an irra-
diated population. We could argue, then, the second, higher dose most 
closely simulates reality but both data sets are presented for illustra-
tion. To use these data to determine the experimental maximum permissible 
skeletal burden, the MPOB, Columns 11-13, Table 11, look at bone T47P5 
section #13. The dose rate is 17210 rads/yr and the skeletal burden is 
18.43 jjCi. We could determine a factor to multiply by this dose rate to 
lower it to the recommended limit for the endosteal tissues, 15 rem/yr or 
O 1 tr 
0.3 rad/yr (ICRP). This factor is 1.74 x 10" . Now if this factor is 
multiplied by the skeletal burden, 18.43 p.Ci, the experimental maximum 
permissible skeletal burden for dogs is obtained, 0.00032 ^Ci from these 
data. Now to convert from dog burden to man we multiply by 10, the differ-
ence in skeletal mass between dog and man and find 0.0032 p,Ci as the ex-
239 
perimental maximum permissible skeletal burden for Pu man (given on 
Table 11 as "Experimental MPOB"). Therefore, the present maximum permis-
120 
sible skeletal burden, 0.036 ^Ci (ICRP), would be considered high by 
over a factor of 10 according to these data. The other values in Columns 
11-13 in Table 11 follow in a similar manner. From these data it appears 
the present maximum permissible organ burden (MPOB) of 0.036 p,Ci is high 
by at least a factor of 700, if the minimum values are considered, by a 
factor of 2 if the weighted mean is calculated and about 4 times low if 
the maximum value is used. 
Therefore the bone dosimetry technique used here could be summar-
ized as follows: (1) prepare undecalcified bone sections, (2) press un-
masked side of the polycarbonate foil against the section tightly, (3) 
remove the foil, etch and mount on a microscope slide for viewing, 
(4) count random 120 ^m squares (1.44 x 10 [jjn areas), (5) take the 
average of these values and obtain dose rate from eqn. (6.3). If an ex-
perimental MPOB is desired to be calculated from the results of the dosim-
etry technique, use the following procedure: (1) divide 0.3 rad/yr by 
the experimentally determined dose rate, (2) multiply by 10 to convert 
from dog burden to man maximum permissible skeletal burden. 
6.2.2 Calibration Procedure 
We were not able to use the efficiency found in the previous chap-
ter since monoenergetic alphas were used. Instead, for the bone sections, 
alpha energies will range from zero to the maximum energy since the sec-
tions were infinitely thick to alpha particles. Therefore calibration 
sources needed to be used to meet this latter condition. These sources 
are described on Table 12. They were obtained from Dr. J. M. Smith at the 
University of Utah and made by the Chemistry Group of the Radiobiology 
Laboratory. The values in column 2 of Table 12 were given with the sour-
ces and measured by liquid scintillation techniques before the sources 
were constructed. Each source was made infinitely thick for alpha par-
ticles and considered tissue equivalent. Foils C24 and WBA are constructed 
with Bioplastic (density 1.24 g/cm ) and P.20 with methyl methacrylate 
(density 1.18 g/cm ) . Source strength (column 3) was calculated in the 
usual manner for an infinitely thick planar source, S x R./2 where S is 
v v 
the volumetric source strength (concentration x density) and R is the range 
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of the Pu alpha particle, 34 jjjn. Exposure time, waiting time and aver-
age number of tracks have the same meaning as before and column 7 is column 
4 2 
3 multiplied by 1.44 x 10 ^m with the units conversion of ^Ci and cm to 
Table 12. The Three Calibration Sources Are Shown, SourceC 24 Was Exposed Under Two Conditions. 
Concentration Was Given with the Source and Determined by Liquid Scintillation 
Before Each Source Was Constructed 
Source Concentration Source Exposure Waiting Average Number Efficiency 
Strength Time Time No. Tracks Alphas (tracks/CY) 
in 120 jj,m in 120 ^m 
,-, Square Square 





1.09 x 10"4 2o30 x 10"
7 64 
C24 1.09 x 10"4 2.30 x 10~7 34 
239 
( Pu) 
P.20 2.50 x 10~2 5.02 x 10"5 30 
239 
( Pu) 





2.76 x 10 
3.77 x 10 
-3 
-3 
7.75 x 10 
1 0.485 2.19 x 104 2.22 x 10"5 
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alphas and ^jn and the exposure time. As an example, take row 1, source 
C24. Here 2.30 x 10 _ 7 (iCi/cm2 x 3.7 x 10 dis/Csec-^Ci) x 8.64 x 104 
O Q 0 / 0 
sec/d x 1 cm /l0 ^m x 64 d x 1.44 x 10 (j,m = 6.77. The efficiency is 
column 6 divided by column 7 and these values appear in Table 11. The 
values in column 6 were less than one because not every random scan 
yielded one observable track. Some scans contained more than one track 
but the average was less than one. The same counting system was used for 
the bones and sources. These sources were placed in position between the 
bone samples as the bone samples and sources lay flat beside each other 
with the same polycarbonate sheet pressed tightly against samples and 
sources. This method assured similar irradiation conditions. Also, the 
sources were etched along with the bone samples at the end of the exposure 
period. 
6.2.3 Reproducibility of Bone Results 
The values of reproducibility indicated on Table 11 were obtained 
as follows. Table 7 shows a number of foils, giving energy of the incident 
alpha particles (expressed as pjii of polycarbonate), waiting time and 
tracks recorded on each foil. These foils were etched many weeks, even 
months apart. The average of the percent variations from the mean of 
the number of tracks for each comparable foil is 11%. Therefore a 15% 
error was selected as a conservative number to use throughout the measure-
ments to follow. 
There are few experimental techniques available for determining 
similar dose rates for direct comparison with our results. To compare the 
bone dosimetry results here with results of others we will first compare 
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our data with the calculational techniques of Thorne, Marshall et al. 
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and Spiers and Vaughan. They calculated 7880 rads/yr, 4510 rads/yr 
and 2356 rads/yr for an 18.43 ^Ci skeletal burden delivering a dose rate 
to the 10 nm thick layer of tissue along the endosteal surface, respec-
tively. Many of the experimental values shown in Table 11 fall within 
the range of these measurements, such as T47P5 section #3, 6, 7 and 14 
and T42P5 section #8 and 12. Many other values, however, are much higher 
in Table 11 especially when the zero scans are excluded. This is to be 
expected since such allowance for the regions of zero dose is not made 
in the calculations as it is in this work. 
The one technique involving experimental determination of the 
endosteal dose rate uses photographic emulsion. It is possible to draw 
a direct comparison between the proposed technique here and the one used 
by the Utah workers (Twente and Jee). In the paper mentioned they 
determined the endosteal dose rate to one of the same bones used in this 
work, the lumbar vertebra of dog T16P5. Twente and Jee used Ilford C-2 
nuclear track emulsions clamped to the bone sample. After developing, 
tracks were counted along short lengths of the endosteum and disintegra-
tion rate per unit area of the alpha emitting source calculated. This 
latter value was used to calculate average dose rate delivered throughout 
239 
a specified distance (they used the Pu alpha range) from an alpha 
emitting plane source by the equation 
average dose rate = - (1 + In -) (6.4) 
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where D' = disintegration rate per unit area of source 
E = energy of the emitted alpha particle 
R = range of the alpha in the medium considered 
p = density of the medium 
X — any specified distance from the source 
Using this formulation Twente and Jee found the endosteal dose rate to 
be 22630 rads/yr for the lumbar centrum of dog T16P5. Looking at Table 11 
we found D = 1104 rads/yr and D = 39740 rads/yr for section #8 of dog 
o w 
T16P5 and D = 8136 rads/yr and D = 108,800 rads/yr for section 10. 
o w 
The D value would not be expected to compare favorably with the Twente 
w 
and Jee result since no effort was made to exclude any tissue not ir-
radiated by alpha particles. The D value might be expected to compare, 
however. If we examine their technique, they used the full 5.15 MeV 
239 
Pu alpha energy, whereas this work used only the average energy ab-
sorbed in the 10 u,m layer, 1.39 MeV. If we increase our value of D 
for section #10 by 5.15/1.39 we obtain 29,900 rads/yr, a difference of 
24%. Considering the vast differences inherent in the techniques, even 
the basic detection system was different, these two values are about equal. 
6.2.4 NTA Emulsion Exposure 
We were also interested in noting the locations of the tracks 
appearing on our polycarbonate foils with respect to the special struc-
tures of bone. Therefore a set of Kodak NTA emulsion plates were exposed 
to the bone samples and developed to obtain autoradiograms. To make the 
comparison of the two methods, polycarbonate foils and emulsions possible, 
a procedure allowing the simultaneous exposure of the two was required. 
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The following technique was developed. First a rectangular section of 
corrugated cardboard was cut the same size as the standard microscope 
slides. Next a plain microscope slide was placed over one section of 
cardboard A rectangular section of polycarbonate foil was positioned 
on the slide with the foil masking removed on the side of the foil facing 
upward. Then one of the bone sections was fixed to the foil and outlined 
on the foil with a dissecting needle. This completes the portion that 
can be accomplished outside the darkroom. It is a good policy to give 
prior consideration to the procedure to be followed during the handling 
of these emulsions so that as many portions as possible of the technique 
can be carried out in room light. In the darkroom, one NTA, 25 ^m thick 
emulsion slide was placed, emulsion side down, over the sample. Then a 
second piece of corrugated cardboard was positioned over the emulsion slide 
completing the "sandwich," as shown on Figure 34. Lastly two hosecock 
clamps were tightened around the cardboard sections to hold the slide and 
foil snugly against the bone section. Several assemblies of this kind 
were placed in a gallon paint can with appropriate cushioning materials. 
The can was sealed tightly with duct tape upon filling and placed in a re-
frigerator during the exposure period since it is best to keep NTA emulsion 
plates cool at all times. After the desired exposure time, the can was 
opened in the darkroom. The polycarbonate foils were developed by the 
electrochemical etching procedure. The photographic plates were developed 
in Kodak D-19 Developer for seven minutes, then placed in Kodak Fixer for 
10 minutes, Kodak Photo-Flo-200 solution for two minutes and hung to dry. 
During each phase of the developing procedure gentle agitation of the 
V// / / /////// //////Az' 
\ L /Plain 
Corrugated card-
board 
L microscope s l i d e 
f f Polycarbonate f o i l 
i- ( , Bone sample 
__ _ l_ • _ _ , _ " " , , _ * „ NTA Emulsion p l a t e 
V/V / / / S / / / / / y S S \ corrugated card-
board 
Figure 34. Sketch of the Relative Position of the Two Pieces 
of Corrugated Cardboard, NTA Emulsion Plate, Bone 
Sample, Polycarbonate Foil and Plain Microscope Slide 
solutions over the plates was maintained. The darkroom lights are not 
needed after 2 or 3 minutes have elapsed in the "fixing" portion of the 
developing procedure. The foil and plates were superimposed to observe 
any relation between the tracks appearing on the two. Results are shown 
in Figures 35-37. Figure 35 shows the characteristic trabecular deposi-
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tion of Pu on the NTA emulsion plate. The bone used was a distal 
femur from dog T56P5.5 and section #4. Magnification was 100X and expo-
sure time 49 days. The image on the emulsion was formed by the ionization 
of the medium by alpha particles since no thermal neutron irradiation was 
used. Figure 36 shows the same bone sample only here the bone sample ex-
posed a polycarbonate foil for 49 days. We again discovered the trabecu-
lar bone surface outline after electrochemically etching the foil (mag-
nification was 100X). As far as we know this is the first report of a 
bone image on a polycarbonate foil, after electrochemical etching, formed 
by exposure to alpha particles alone. Figure 37 is a photograph of the 
image of a portion of trabecular surface formed by superposition of poly-
carbonate foil image and NTA emulsion image. The hazy image is the NTA 
image and the small black dots, the etched tracks view at 100X. It is 
possible more quantitative information could be obtained concerning the 
239 
dose delivered by Pu to endosteal tissues since the outline of the sur-
faces is so well defined and each track easy to count. 
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Figure 35. Photograph of NTA Image of the Trabecular Tissues 
of Bone T56P5.5 Section #4 Formed by 49 Days Ex-
posure and Viewed at 100X 
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Figure 36. Photograph of Polycarbonate Foil Showing Trabecular 
Surface Image After Exposure for 49 Days and Etched 
Electrochemically. Bone T56P5.5 Section #4 Was Used 
Magnification Was 100X 
Figure 37. Photograph of Superimposed Image of Trabecular 
Surface Using Images Shown on Figures 35 and 36 
Hazy Image Is NTA Emulsion Image and Black Dots 
Are the Etched Pits. 
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CHAPTER VII 
CONCLUSIONS AND RECOMMENDATIONS 
7.1 Conclusions 
The first objective of this research project after selecting the 
electrochemical etching system as the dosimetry system of choice was 
demonstrating the feasibility of polycarbonate foils as an alpha particle 
detector. The ability of polycarbonate foils to register alpha particle 
tracks when amplified by electrochemical etching was indicated on the 
photographs on Figures 21 and 31. The sensitivities found for this sys-
tem were between 1 x 10 tracks per alpha (approximately equal to the 
_3 
efficiency of fast neutron detection) and 3.77 x 10 tracks per alpha. 
Sensitivity "Was dependent upon the alpha source (whether it was very thin 
or infinitely thick for alpha particles), etching time and waiting period 
between irradiation and etching. If the source was a thin alpha particle 
source, the sensitivity depended on whether or not the LET was at the max-
imum of the Bragg peak as a result of the use of absorbers to decrease the 
energy of the alpha particle. The sensitivity for the electrochemical 
etching system was considerably less than the sensitivity of photographic 
emulsions but the electrochemical etching system offers simplicity, no 
fading, smaller size, lower cost and tissue equivalence not found with 
emulsions. 
Increasing the time between irradiation and etching, termed the 
waiting period, was found to increase the apparent efficiency of etchable 
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track production dramatically but the effect is still not clearly under-
stood. This result was surprising and was examined closely and quantified, 
as shown on Figure 22. By choice of waiting time the sensitivity of the 
method can be improved. Track diameter as a function of etching time was 
also studied and one of the results was the discovery of two categories 
of tracks on etched foils after exposure to alpha particle radiations. A 
proposed explanation for this important effect was offered. The two track 
size discovery could become important because it provides a mechanism to 
obtain information on LET. The background routinely achievable was found 
2 
to be 2.0 tracks/cm , for the selected foil material, and bulk etching 
rate was 0.16 p.m/hr. 
As the next major objective, it was found possible to use the elec-
239 
trochemical etching system for the purpose of the dosimetry of Pu in 
bone. Actual dose measurements were made. Briefly the procedure devel-
oped was (1) to prepare undecalcified, 300 p,m thick bone sections, (2) 
press polycarbonate sheet, masking side up, tightly against the bone sec-
tions interspaced with calibration sources (see Table 12), (3) after the 
exposure time, remove polycarbonate and etch the portion of foil above 
bone sections and calibration sources simultaneously, (4) count foils 
using randomly scanned 120 ^m square areas to obtain the average number 
of tracks in that foil volume, (5) calculate the dose rate. The calibra-
tion procedure accounted for waiting time effects and any effects possibly 
inherent in any particular portion of foil since calibration sources were 
always developed and counted the same way as the foils exposed to the bone 
sections. By compiling data on different foils used in this research it 
was determined that measurements were accurate within ± 157o. Factors 
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affecting accuracy were observational errors, statistical errors, low 
efficiency, positional errors and inhomogeniety of the samples. The re-
sults showed a wide point-to-point variation in dose measured. This 
variation was believed to be caused by inhomogeneities in the three di-
mensional deposition of plutonium in bone. Results were presented for a 
dose rate, D , that included all scans of the 120 ^m square resulting in 
no counts and D , that did not include these zero scans. Thus an attempt 
was made to determine dose only for tissue masses actually receiving the 
alpha particle dose. As deposition of plutonium varies so does the dose 
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from Pu. Therefore quoting average concentrations or bone burdens may 
not be very meaningful in giving information as to these highly localized 
doses because low skeletal burden can result in high doses in localized 
areas. These effects could explain the differences between Thome's, 
Spier's and Marshall's normalized calculations and this work. Agreement 
was found between the experimental measurements of Twente and Jee using 
photographic emulsions and this work, when comparing our D values with 
Twente and Jee experimental values. D for the dog bones ranged from 
16.7 rads/yr to 39580 rads/yr for dog T56P5.5 section #3 (skeletal burden 
20.74 |j,Ci) and dog T42P5 section #1 (skeletal burden 13.57 p,Ci) , respec-
tively. D ranged from 440 rads/yr to 317900 rads/yr for dog T56P5.5 
section #3 (skeletal burden 20.74 ^Ci) and dog T47P5 section #7 (skeletal 
burden 18.43 |j,Ci) , respectively, considering 10 ^m thick osteogenic cell 
layers only and plutonium in the citrate. 
The dose rate per microcurie (observed dose rate -r skeletal burden) 
for these bones was as follows. For D , dose rate per microcurie was 0.81 
o r 
rad/yr/^Ci for bone T56P5.5 section #3 and 2917 rads/yr/^Ci for bone T42P5 
section #1. For D we found 21.2 rads/yr/^Ci for bone T56P5.5 section #3 
and 17250 rads/yr/|i,Ci for bone T47P5 section #7. Again this is not a 
completely accurate way to state these results since the procedure of 
calculating dose/^Ci in effect averages the dose to a 120 yjn square over 
the entire skeleton producing an unrealistic value and does not take into 
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consideration the inhomogeneities in the Pu distribution we found. 
ICRP has set a limit of 30 rem/yr to the bone as a whole and 15 
rem/yr (0.3 rad/yr) to the endosteum of bone. If one wishes to use the 
results of the present investigation to relate to such a limit, one has to 
extrapolate these results to the skeleton as a whole. The results show 
there is an enormous variation in dose rate from point to point even in 
close proximity on the same bone so different values of maximum permissible 
skeletal burden can be obtained by this extrapolation procedure depending 
on the dose rate considered. We scaled the recorded dose rates down to 
the ICRP value of 0.3 rad/yr and scaled the Utah total skeletal burden by 
the same factor to arrive at the maximum permissible skeletal burden ex-
trapolated from the bone section considered. It is found that the average 
value of all the experimental maximum permissible skeletal burdens cal-
culated from the D values for a 10 pjn osteogenic layer is half the pres-
ent ICRP value of 0.036 ^Ci and the maximum and minimum values are four 
times greater than and 700 times less than the ICRP values, respectively. 
We also examined the possible effects of body burden on bone turn-
239 
over. It is known high skeletal burdens of Pu cause necroses of tis-
sues and turnover essentially ceases. There is some possibility the large 
dose observed for dog T50P3 was partly due to these turnover effects since 
a skeletal burden of only 0.606 p.Ci existed whereas other burdens were a 
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factor of 20 higher. We cannot be conclusive on this point, however, 
because not enough data exist for small skeletal burdens here and none 
for intermediate skeletal burdens, i.e. 3, 4, 5, 6 p.Ci, etc. When such 
data are obtained some of the scatter in the dose rates observed due to 




While conducting this research related to the dosimetry of Pu 
in bone a number of new and interesting areas that could be explored were 
realized. Now that this new technique for bone dosimetry has been de-
veloped, namely (1) expose infinitely thick bones to polycarbonate foils, 
tightly pressed against the bone sections, (2) remove foils and etch, 
(3) count using the small squares on a Whipple disk, (4) calculate an 
average number of tracks, (5) insert these values in the equation 
N N 
D - — 56.41 for dose rate 0-10 u.m or D = — 62.701 for the dose rate 
0-20 (j,m removed from the endosteal surfaces, it is important to use this 
technique as much as possible to add to the collective body of data. This 
would include not only bones of differing plutonium content but also 
241 
other bone-seeking alpha emitters such as Am. 
We have shown the existence of the two track sizes on alpha par-
ticla irradiated polycarbonate foils and quantified this effect as a func-
tion of alpha particle energy. Other experiments need to be performed 
to examine this effect. One could irradiate one group of foils with 
accelerator-produced alpha particles of various energies and a second 
group with accelerator produced carbon and oxygen nuclei and compare 
track diameter frequency histograms. Additionally, one could polarize 
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the incident alpha particles to maximize the probability of interaction 
with carbon and oxygen nuclei to see if the effect is enhanced. The 
nature of the interaction could be confirmed by such an experiment. 
Another interesting effect observed was an increase in sensitivity 
of the system as waiting time increased. Waiting time was defined as the 
time between irradiation and etching. This new and somewhat surprising 
result needs to be examined further to determine if it is only observed 
after alpha particle irradiation, what conditions enhance or reduce the 
effect and the precise mechanism that yields the increase in sensitivity. 
It is possible the sensitivity of the electrochemical etching system can 
be greatly improved by waiting time variation. 
During this work we have used planar bone sections and placed our 
239 
dosimeter flat against one face. We know the distribution of Pu in 
osseous tissue is highly inhomogeneous in three dimensions as well as 
two, as the present work clearly indicates. Therefore, knowledge con-
cerning the three dimensional dose distribution could be obtained by 
using cubes of trabecular tissue, rather than flat sections, and pressing 
foils against each face of the cube. 
The dosimetry technique described herein is quite general and not 
difficult to perform. In fact there is really no technical problem in-
surmountable in nature that would prevent the identical technique, in-
cluding data reduction, to be used to determine the dosimetry of other 
tissues. Therefore we would like to see this technique applied to tissues 
such as lung, liver, etc. or any organ where internally deposited alpha 
emitters are found. This technique has the advantage of detecting the 
actual particle irradiating tissue jLn vivo and not using fission fragments 
184 
to calculate activity and then dose. Here, dose was obtained directly. 
Some of the recommendations mentioned above are proposed to be 
carried out under current contracts with the Department of Energy and 
other recommendations are as yet untried. These are only a few of the 
possibilities one could imagine to use this general technique. 
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